data_2lgh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lgh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.593 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 7.8 t30 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.458 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' NE2' ' A' ' 54' ' ' HIS . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.469 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 HG21 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.458 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.522 HE21 ' HB2' ' A' ' 94' ' ' ALA . 45.7 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.43 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.527 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HB3' HD13 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.526 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.51 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.566 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.415 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.6 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.454 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.521 HG12 HD11 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.521 HD11 HG12 ' A' ' 132' ' ' VAL . 32.3 mt . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.482 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.464 HD21 HG22 ' A' ' 124' ' ' ILE . 3.0 t-20 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.436 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.606 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.512 HG23 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.514 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.464 HG22 HD21 ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' O ' HG21 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 132' ' ' VAL . 82.8 mt . . . . . 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' HB1' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.516 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.472 ' HA ' HG23 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HA ' HG11 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.554 HD11 HG13 ' A' ' 132' ' ' VAL . 77.4 mt . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.456 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.547 0.865 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.456 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 HD13 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB3' ' HG ' ' A' ' 137' ' ' LEU . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.54 HD13 HG11 ' A' ' 132' ' ' VAL . 79.8 mt . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.476 ' HE1' HG12 ' A' ' 3' ' ' ILE . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.476 HG12 ' HE1' ' A' ' 1' ' ' MET . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG13 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.487 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.458 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.756 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.549 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.515 HD21 ' N ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' HD21 ' A' ' 30' ' ' ASN . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.42 ' HE1' HD23 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 HD21 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.435 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.439 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.467 ' O ' HG21 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 132' ' ' VAL . 78.1 mt . . . . . 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG3' ' HB1' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.611 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.533 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.658 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.437 HG12 ' HE2' ' A' ' 53' ' ' HIS . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.447 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.515 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.531 ' HA ' HD13 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.443 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.48 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.506 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.48 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.8 t30 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.427 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.449 ' HB3' HG22 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.435 HG23 HG22 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.521 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.531 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.514 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.402 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.608 HD22 ' HA ' ' A' ' 37' ' ' HIS . 2.2 p30 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.608 ' HA ' HD22 ' A' ' 30' ' ' ASN . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.5 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.537 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB3' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.458 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.406 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HA ' HG22 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.422 HG12 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 79' ' ' LEU . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.43 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.446 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.5 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.519 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.5 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 37.0 tt0 . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 CA--C 1.554 1.114 0 CA-C-O 119.137 -0.459 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HB3' HD13 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.458 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 132' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.586 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.401 HG23 HG23 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HB3' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.666 HG23 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.417 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.471 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.428 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.586 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.422 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.602 HD22 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.409 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.602 ' HB3' HD22 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' HG21 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.513 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.422 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.507 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.47 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.429 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.5 ' O ' HG21 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.523 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.668 ' HA ' HG22 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.568 HG23 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.463 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.463 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.433 ' HE1' ' HB3' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.552 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.563 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.428 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 29.1 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.574 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.408 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.452 HD11 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.432 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.488 ' HG1' ' HB3' ' A' ' 30' ' ' ASN . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB2' ' HG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.503 ' HG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.474 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.505 ' HE3' HG22 ' A' ' 89' ' ' VAL . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.661 ' HG2' HG23 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG22 ' HE3' ' A' ' 83' ' ' MET . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.408 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' HA ' HE22 ' A' ' 117' ' ' GLN . 9.4 pt-20 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 109' ' ' GLU . 36.9 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.574 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.461 ' HE1' HD21 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' N ' HD21 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 51' ' ' PHE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.551 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 66' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.643 HG22 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.461 HD21 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.533 ' HE2' ' HB2' ' A' ' 87' ' ' ARG . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.643 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB2' ' HE2' ' A' ' 83' ' ' MET . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.528 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.587 ' HG ' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.498 ' HG3' ' HB2' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HE21 ' A' ' 122' ' ' GLN . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.482 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.403 ' HE1' ' HG ' ' A' ' 25' ' ' CYS . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG23 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.551 HG23 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.428 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.503 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.498 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.594 HE21 HD12 ' A' ' 5' ' ' ILE . 13.7 mm-40 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.506 ' O ' HG21 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.427 HD11 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.557 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.476 ' HE2' HG22 ' A' ' 43' ' ' VAL . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.44 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . 0.448 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.556 1.185 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.427 ' HB2' HD11 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.408 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.557 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt . . . . . 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.554 ' ND2' HD12 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.562 HG21 ' ND2' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.562 ' ND2' HG21 ' A' ' 26' ' ' ILE . 26.0 m-80 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.554 HD12 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.49 ' HE3' ' HB3' ' A' ' 30' ' ' ASN . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.534 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.418 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.47 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 85' ' ' ASP . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' THR . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.423 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.459 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 21.3 mm-40 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.432 HG12 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 3.3 mm? . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.481 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.695 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.68 HG23 HG23 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.586 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.446 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.483 HG23 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.652 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLN . . . . . 0.652 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . 0.514 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.478 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.414 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.593 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.511 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.475 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 7.8 t30 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.593 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.458 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.469 ' SG ' ' NE2' ' A' ' 54' ' ' HIS . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.469 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.536 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 HG21 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.427 ' H ' HG23 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.49 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.624 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.458 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.478 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.522 HE21 ' HB2' ' A' ' 94' ' ' ALA . 45.7 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.43 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.527 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -71.12 123.08 21.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -55.77 -24.6 36.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.962 0.905 . . . . 0.0 113.133 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -76.2 -38.65 56.24 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.074 0.55 . . . . 0.0 111.895 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -101.09 159.67 15.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.896 0.478 . . . . 0.0 111.107 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p -72.71 122.12 86.73 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.455 ' HB3' HD13 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.526 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.478 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.428 HG11 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt 60.91 21.38 11.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -61.91 105.74 0.61 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.653 1.181 . . . . 0.0 110.53 -173.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -84.42 -39.51 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -67.32 117.8 9.8 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.624 0.769 . . . . 0.0 110.759 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -139.18 142.51 37.94 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -71.28 98.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -68.18 127.22 32.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.955 0.502 . . . . 0.0 109.663 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.378 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.488 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.51 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.465 HD11 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.496 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.566 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.415 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.6 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.6 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.586 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.564 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.604 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.82 144.43 31.05 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -89.39 -23.62 22.13 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.969 0.35 . . . . 0.0 111.537 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -92.93 4.16 54.44 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.456 0.703 . . . . 0.0 111.221 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -134.79 135.94 42.18 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m -63.25 122.95 78.69 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.454 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.566 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.488 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.521 HG12 HD11 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.521 HD11 HG12 ' A' ' 132' ' ' VAL . 32.3 mt 60.66 26.84 16.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -24.71 65.51 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.679 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -67.86 -16.66 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.95 0.5 . . . . 0.0 111.922 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -64.03 -48.24 77.08 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 68.81 154.42 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.687 1.595 . . . . 0.0 113.235 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -172.5 55.55 0.02 OUTLIER 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.615 1.166 . . . . 0.0 108.993 165.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -63.29 136.0 57.4 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 124.306 1.042 . . . . 0.0 110.098 -176.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.473 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.482 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.464 HD21 HG22 ' A' ' 124' ' ' ILE . 3.0 t-20 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.436 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.606 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.512 HG23 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.645 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.514 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.401 ' O ' ' HA ' ' A' ' 91' ' ' VAL . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.409 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.41 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 158.97 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.3 t -87.81 -13.3 42.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -168.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -68.16 -43.32 78.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.894 0.478 . . . . 0.0 110.695 -173.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -114.3 172.64 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.302 0.641 . . . . 0.0 109.803 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -82.28 140.38 45.49 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.081 0.553 . . . . 0.0 109.67 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.445 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.464 HG22 HD21 ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' O ' HG21 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.511 HG12 HD11 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.511 HD11 HG12 ' A' ' 132' ' ' VAL . 82.8 mt 60.7 67.12 0.85 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.0 128.52 36.56 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.024 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.9 78.47 0.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 O-C-N 124.106 0.879 . . . . 0.0 110.165 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -75.32 73.35 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.495 1.14 . . . . 0.0 109.977 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -173.54 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.998 -168.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -62.37 94.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.603 0.761 . . . . 0.0 110.761 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.32 -15.32 10.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.117 171.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.881 0.872 . . . . 0.0 109.022 171.724 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HG3' ' HB1' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD12 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.436 ' CZ2' HD22 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 22' ' ' ASP . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.516 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.516 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.436 HD22 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.541 HG11 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.472 ' HA ' HG23 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.541 ' HA ' HG11 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.68 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.457 ' HA ' HD12 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.68 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.422 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.459 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.511 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.456 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.37 138.72 39.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -85.16 -12.56 52.47 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.3 t -100.79 16.95 23.38 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -136.12 134.66 38.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p -61.48 120.99 60.72 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.511 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.429 ' O ' HG22 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.554 HG13 HD11 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 140' ' ' HIS . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.554 HD11 HG13 ' A' ' 132' ' ' VAL . 77.4 mt -81.95 -12.52 58.33 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.87 87.57 0.72 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.311 1.044 . . . . 0.0 110.939 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 70.63 -11.92 0.58 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.358 1.063 . . . . 0.0 113.014 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 73.9 m-70 -69.3 93.28 0.63 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -163.42 85.13 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -123.21 100.23 6.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.869 0.868 . . . . 0.0 110.484 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -177.86 -44.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 110.219 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.836 1.654 . . . . 0.0 110.036 -173.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' HG3' ' HE2' ' A' ' 139' ' ' HIS . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.404 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.559 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.524 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.404 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.42 ' HA ' HD12 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG23 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.456 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.517 ' HG2' HG23 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.25 129.5 34.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 t -72.9 -19.78 61.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.3 t -90.06 -7.72 53.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.078 0.399 . . . . 0.0 111.789 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -120.77 152.52 38.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.916 0.486 . . . . 0.0 110.091 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p -71.02 135.9 85.04 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 122.967 0.507 . . . . 0.0 109.926 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.456 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.401 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.54 HG11 HD13 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB3' ' HG ' ' A' ' 137' ' ' LEU . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.54 HD13 HG11 ' A' ' 132' ' ' VAL . 79.8 mt -73.03 5.11 3.58 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -46.46 115.49 1.04 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.685 1.194 . . . . 0.0 111.941 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.482 ' HE2' ' HG3' ' A' ' 12' ' ' GLU . 8.5 p-80 -124.89 86.73 2.6 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.768 0.794 . . . . 0.0 110.965 -175.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -163.17 94.33 0.82 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.95 157.96 37.3 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.748 0.309 . . . . 0.0 110.839 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -75.05 171.4 14.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.385 0.674 . . . . 0.0 110.253 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -62.33 134.27 56.24 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.294 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HE1' HG12 ' A' ' 3' ' ' ILE . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.476 HG12 ' HE1' ' A' ' 1' ' ' MET . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG13 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.487 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.487 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.571 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.458 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.756 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.549 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.549 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.515 HD21 ' N ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' N ' HD21 ' A' ' 30' ' ' ASN . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.464 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.462 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.42 ' HE1' HD23 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 HD21 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.583 HG23 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.583 ' HG2' HG23 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.439 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.435 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.439 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.43 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HB3' HG11 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.587 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.67 151.1 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -90.66 -5.73 55.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.7 m -76.45 -51.42 11.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.937 0.495 . . . . 0.0 110.16 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -101.43 156.79 17.25 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.389 0.675 . . . . 0.0 110.028 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m -65.22 125.04 88.57 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.467 ' O ' HG21 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.503 HG13 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 132' ' ' VAL . 78.1 mt 55.55 58.43 4.56 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 62.2 -76.78 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.293 1.837 . . . . 0.0 112.118 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.7 t60 69.3 13.07 8.51 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.196 1.399 . . . . 0.0 112.873 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 30.87 75.9 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.374 1.869 . . . . 0.0 114.397 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.36 97.48 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.068 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.94 131.79 39.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.443 1.097 . . . . 0.0 108.444 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -152.37 -179.45 7.57 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.131 0.972 . . . . 0.0 110.494 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.111 0.565 . . . . 0.0 109.796 175.078 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.423 ' HG3' ' HB1' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 HG23 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.611 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.531 HD13 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.533 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.658 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.658 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.437 HG12 ' HE2' ' A' ' 53' ' ' HIS . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.447 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.54 HG21 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.54 ' HB2' HG21 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.515 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.625 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.515 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.531 ' HA ' HD13 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.443 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.48 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.506 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.486 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.506 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.504 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 -97.59 137.01 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -77.46 -11.68 59.88 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.99 0.516 . . . . 0.0 110.841 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.7 t -89.96 -2.6 58.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.702 0.801 . . . . 0.0 109.695 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -126.16 141.83 51.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.793 1.237 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m -60.16 115.12 11.84 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.494 0.718 . . . . 0.0 110.907 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.523 ' HG2' HG23 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.48 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.462 ' O ' HG21 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.462 HG21 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.547 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt -80.36 31.85 0.28 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -73.07 102.83 3.64 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.946 0.898 . . . . 0.0 108.963 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -115.87 -46.85 2.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.159 0.984 . . . . 0.0 109.762 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -82.22 76.83 9.08 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.182 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -163.29 104.54 0.98 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.353 0.661 . . . . 0.0 110.897 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -136.81 97.75 3.61 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 m80 68.38 78.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.042 1.337 . . . . 0.0 109.367 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.707 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.531 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.519 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.406 ' HB3' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.503 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 65.8 t30 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.534 ' HB1' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.427 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.427 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.514 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.534 ' SD ' ' HB1' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.449 ' HB3' HG22 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.514 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 HG22 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.423 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.435 HG23 HG22 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.503 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.503 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.503 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.435 HG22 HG23 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.521 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.531 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.514 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.514 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.497 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.464 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.521 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 -86.54 116.67 24.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 p -78.12 -16.57 57.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.142 0.977 . . . . 0.0 111.884 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.7 m -68.99 -30.14 68.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.428 0.632 . . . . 0.0 109.692 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.74 154.66 18.13 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 109.718 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p -69.2 125.35 91.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.193 0.597 . . . . 0.0 109.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.497 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.519 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.433 ' O ' HG21 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.433 HG21 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt 54.74 91.44 0.03 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -58.0 105.76 0.3 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -163.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -130.02 21.74 5.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.811 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -114.37 150.28 34.84 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.711 0.805 . . . . 0.0 110.159 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -76.19 85.93 3.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.529 0.681 . . . . 0.0 109.335 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -119.68 3.14 11.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.339 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.1 p80 47.6 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 126.064 1.746 . . . . 0.0 113.195 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.263 178.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.537 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.402 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.608 HD22 ' HA ' ' A' ' 37' ' ' HIS . 2.2 p30 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.608 ' HA ' HD22 ' A' ' 30' ' ' ASN . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.5 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.5 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.556 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.454 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.537 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.556 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.487 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.487 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.46 124.25 39.4 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -71.0 -12.36 61.49 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-O 120.914 0.387 . . . . 0.0 110.329 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.1 t -69.18 -32.56 71.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.206 1.003 . . . . 0.0 111.703 175.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -108.63 162.08 14.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.276 0.63 . . . . 0.0 109.996 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p -74.27 124.96 90.33 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.644 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt 60.92 105.43 0.02 OUTLIER 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.27 101.82 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.429 1.092 . . . . 0.0 113.199 -161.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.47 108.33 7.18 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 62.08 75.72 0.39 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.168 0.987 . . . . 0.0 109.712 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.407 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.54 -32.74 72.89 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.712 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 46.22 -161.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.498 1.519 . . . . 0.0 112.055 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.063 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.526 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.407 ' HB3' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.458 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.406 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.423 ' HA ' HG22 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.422 HG12 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 HG23 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.535 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.43 ' CD1' HD12 ' A' ' 79' ' ' LEU . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.43 HD12 ' CD1' ' A' ' 70' ' ' PHE . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.537 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.446 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.5 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.537 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.519 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.519 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.526 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.547 ' HG2' ' H ' ' A' ' 111' ' ' SER . 37.0 tt0 -101.63 147.24 26.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.8 p -82.78 -19.31 38.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.547 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 16.1 m -72.4 -53.15 13.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.99 0.516 . . . . 0.0 110.507 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -66.87 151.57 96.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.544 0.528 . . . . 0.0 111.098 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HB3' HD13 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.423 HG22 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.458 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.526 HG11 HD11 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.526 HD11 HG11 ' A' ' 132' ' ' VAL . 93.5 mt -71.13 9.42 0.74 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.42 3.4 18.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.767 1.227 . . . . 0.0 112.034 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -61.42 93.03 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.512 0.672 . . . . 0.0 110.995 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -84.83 175.14 9.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.593 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 61.4 83.65 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.961 0.788 . . . . 0.0 109.639 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -164.09 -179.92 6.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.784 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -163.64 -59.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.815 0.846 . . . . 0.0 109.611 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.481 1.108 0 C-N-CA 124.938 1.295 . . . . 0.0 107.718 -177.536 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.586 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.627 HD12 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.533 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG23 HG23 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.527 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.474 ' HB3' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.482 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.474 ' HG3' ' HB3' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.666 HG23 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.502 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 ' HA ' HD12 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.443 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.502 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.463 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.539 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -82.59 126.29 32.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -21.22 63.76 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.734 0.814 . . . . 0.0 112.068 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -80.04 -22.21 42.6 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.334 0.654 . . . . 0.0 111.201 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -101.26 156.57 17.36 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.509 0.724 . . . . 0.0 109.894 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m -59.97 116.63 18.0 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.548 0.739 . . . . 0.0 111.117 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.539 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.417 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.471 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.428 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.586 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt -88.91 23.45 2.36 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.17 102.87 1.77 Allowed 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.525 1.13 . . . . 0.0 109.949 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.44 55.02 3.24 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.821 0.82 . . . . 0.0 110.019 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -173.07 157.9 3.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.14 1.376 . . . . 0.0 108.332 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 67.65 97.29 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.7 1.2 . . . . 0.0 110.24 -173.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.41 156.44 16.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.553 0.741 . . . . 0.0 110.506 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -85.88 95.29 9.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.205 0.602 . . . . 0.0 110.568 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.185 175.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.507 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.612 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.612 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 HG23 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.602 HD22 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HB3' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.415 HG23 HD12 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.409 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.602 ' HB3' HD22 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.489 ' HZ2' ' HB2' ' A' ' 58' ' ' LYS . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 HG23 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.513 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.544 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.552 HG21 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HG3' HG21 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.544 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.513 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.507 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.411 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.47 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.36 116.26 32.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -70.58 -12.61 61.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.292 0.637 . . . . 0.0 111.788 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -77.77 -17.57 57.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.016 0.526 . . . . 0.0 110.102 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.56 168.27 10.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.285 1.034 . . . . 0.0 110.787 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p -77.23 116.73 60.08 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.992 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.47 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.429 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.5 ' O ' HG21 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 91.7 mt 65.39 23.89 12.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.92 105.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.498 1.519 . . . . 0.0 113.475 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -66.92 -24.01 66.04 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -127.63 70.2 1.32 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.818 0.447 . . . . 0.0 110.852 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -58.22 -64.18 1.0 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.653 0.781 . . . . 0.0 110.48 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 52.03 77.28 0.15 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.293 0.996 . . . . 0.0 108.36 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -48.16 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.656 1.222 . . . . 0.0 112.949 -163.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.2 p80 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.199 178.299 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.523 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.42 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HB3' HG22 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.668 ' HA ' HG22 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.505 HG21 HD11 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.525 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.568 HG23 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.426 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.481 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -120.49 150.14 41.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -80.04 -5.37 55.7 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 p -91.14 -2.25 57.59 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.422 0.689 . . . . 0.0 109.989 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -121.65 153.87 37.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 161.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m -75.08 118.82 73.44 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.481 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.426 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp 53.37 -80.42 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -95.26 111.86 23.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.358 1.063 . . . . 0.0 109.562 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -121.7 50.47 1.42 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 67.41 171.55 0.26 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.479 -163.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.73 138.32 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -57.61 111.33 1.09 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.112 0.882 . . . . 0.0 112.136 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -110.99 -174.62 2.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.721 . . . . 0.0 110.887 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.416 0.686 . . . . 0.0 110.044 178.471 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.402 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.527 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.434 HE22 ' HG3' ' A' ' 138' ' ' GLU . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD12 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.427 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.463 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.463 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.545 ' SG ' HG21 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' HB3' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.433 ' HE1' ' HB3' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.545 HG21 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.605 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.513 ' HA ' HD12 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.605 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.563 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.552 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.563 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.441 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.428 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 -75.98 157.48 33.06 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -90.95 -7.42 52.11 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.788 -0.57 . . . . 0.0 112.109 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.2 t -58.11 -40.92 82.42 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.877 0.871 . . . . 0.0 112.355 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -139.42 -176.34 4.5 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.756 0.822 . . . . 0.0 109.868 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p -81.45 151.04 68.31 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 29.1 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.527 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt 69.41 -67.65 0.22 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.434 ' HG3' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -68.91 -22.88 64.14 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.98 -0.45 . . . . 0.0 111.291 175.216 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -72.18 80.79 0.98 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.591 0.756 . . . . 0.0 109.365 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 69.39 152.72 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.966 1.707 . . . . 0.0 111.795 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -74.91 133.9 41.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.184 0.594 . . . . 0.0 111.471 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -130.12 -65.08 0.83 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.097 . . . . 0.0 108.879 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -126.54 139.33 53.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.563 0.745 . . . . 0.0 110.003 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.481 1.112 0 C-N-CA 125.526 1.53 . . . . 0.0 110.276 -174.724 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.472 ' HB3' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.574 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.447 ' NE2' ' HB2' ' A' ' 139' ' ' HIS . 50.9 tp60 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 139' ' ' HIS . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.474 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.408 ' CZ2' HG23 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.452 HD11 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.488 ' HB3' ' HG1' ' A' ' 38' ' ' THR . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.432 ' HA ' ' HB1' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.488 ' HG1' ' HB3' ' A' ' 30' ' ' ASN . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB2' ' HG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.503 ' HG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.554 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.41 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.497 HG23 HG22 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.444 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.474 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.444 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.518 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.661 HG23 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.505 ' HE3' HG22 ' A' ' 89' ' ' VAL . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.481 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.661 ' HG2' HG23 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG22 ' HE3' ' A' ' 83' ' ' MET . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.408 HG23 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' HA ' HE22 ' A' ' 117' ' ' GLN . 9.4 pt-20 -138.07 72.62 1.42 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.487 ' H ' HE22 ' A' ' 117' ' ' GLN . 71.0 p -127.33 -32.6 2.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.921 174.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m -113.42 -48.5 2.95 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.496 -161.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -171.53 -165.42 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 124.836 1.254 . . . . 0.0 109.672 -159.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p -57.75 139.85 81.58 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.534 HE22 ' HA ' ' A' ' 109' ' ' GLU . 36.9 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.574 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.34 -140.9 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.1 -75.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 0.0 110.289 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 t-80 60.74 7.1 1.31 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.375 1.07 . . . . 0.0 112.851 175.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 39.2 46.78 1.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.057 1.343 . . . . 0.0 111.893 -164.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.12 164.87 15.49 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.715 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -87.67 -142.79 0.12 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -60.33 -33.37 72.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.509 0.724 . . . . 0.0 110.556 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.244 0.807 0 C-N-CA 124.012 0.925 . . . . 0.0 108.97 173.782 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.424 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.561 HD12 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' HB2' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . 0.442 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.461 ' HE1' HD21 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.511 HD12 HG23 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' N ' HD21 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 51' ' ' PHE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.551 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.586 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 66' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.584 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.643 HG22 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.561 ' HA ' HD12 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.461 HD21 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.533 ' HE2' ' HB2' ' A' ' 87' ' ' ARG . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.643 ' HB2' HG22 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.533 ' HB2' ' HE2' ' A' ' 83' ' ' MET . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.527 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.454 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.01 116.31 6.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -64.82 -23.9 67.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.566 0.746 . . . . 0.0 112.205 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.2 t -76.27 -36.38 58.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.185 0.594 . . . . 0.0 111.298 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.434 ' HE1' ' HG2' ' A' ' 116' ' ' GLN . 19.6 t-80 -97.45 155.37 16.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.336 0.255 . . . . 0.0 111.327 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.449 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p -63.22 116.02 22.09 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.119 0.968 . . . . 0.0 110.681 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.434 ' HG2' ' HE1' ' A' ' 112' ' ' HIS . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.421 ' HB2' HG22 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.401 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.422 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.466 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.41 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.528 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.587 ' HG ' ' HB2' ' A' ' 15' ' ' ALA . 3.7 mm? 56.09 16.7 2.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -89.08 174.92 7.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.17 1.388 . . . . 0.0 109.701 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.1 m80 45.93 67.8 0.69 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.165 1.386 . . . . 0.0 111.724 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -142.03 26.7 1.84 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.847 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -59.35 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.112 1.365 . . . . 0.0 111.078 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -166.08 28.69 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.038 0.935 . . . . 0.0 109.517 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.8 m80 67.18 18.5 10.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.983 1.313 . . . . 0.0 112.799 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.498 ' HG3' ' HB2' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.594 HD12 HE21 ' A' ' 122' ' ' GLN . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.495 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.482 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.557 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.403 ' HE1' ' HG ' ' A' ' 25' ' ' CYS . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.517 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.557 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG23 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.551 HG23 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' H ' HG23 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' PHE . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.428 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.426 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.443 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.503 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.503 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.498 ' HB2' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.623 ' HG2' ' H ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -137.31 176.84 8.35 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -93.48 13.05 22.96 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.107 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.623 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 17.7 m -96.38 -51.72 4.26 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.833 -0.542 . . . . 0.0 110.517 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -79.1 146.56 33.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 171.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.407 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m -65.39 113.98 13.7 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.594 HE21 HD12 ' A' ' 5' ' ' ILE . 13.7 mm-40 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.506 ' O ' HG21 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.404 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt 56.87 24.56 9.42 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 155.27 24.4 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 125.089 1.356 . . . . 0.0 108.601 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -86.41 40.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.833 0.853 . . . . 0.0 111.071 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -60.59 -38.6 85.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.717 1.207 . . . . 0.0 111.338 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -92.86 -6.1 49.5 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.663 0.785 . . . . 0.0 111.452 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 84.8 t60 66.77 9.06 6.44 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.62 1.168 . . . . 0.0 111.314 -177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -166.15 109.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.427 HD11 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.557 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.502 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.544 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.438 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.482 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.482 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.476 ' HE2' HG22 ' A' ' 43' ' ' VAL . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.461 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.582 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.544 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.438 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.44 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.445 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.448 ' HB3' ' HB1' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.445 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.89 121.75 19.58 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.8 t -68.02 -18.44 64.71 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.411 0.684 . . . . 0.0 112.256 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -73.23 -32.05 64.51 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.165 0.586 . . . . 0.0 111.813 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -117.55 165.54 13.44 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.649 0.78 . . . . 0.0 110.558 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m -69.8 119.33 70.59 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.03 0.532 . . . . 0.0 111.092 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.427 ' HB2' HD11 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.408 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.445 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.557 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt 73.27 -34.8 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.33 89.65 2.09 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.234 0.54 . . . . 0.0 109.545 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -115.81 -22.42 9.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.071 0.948 . . . . 0.0 110.51 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -84.28 101.78 12.18 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -85.98 -172.39 4.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.996 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -79.97 65.65 5.19 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.983 0.897 . . . . 0.0 110.52 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -69.16 95.67 0.77 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.819 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.425 -175.384 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB2' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.643 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.554 ' ND2' HD12 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.562 HG21 ' ND2' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.572 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.562 ' ND2' HG21 ' A' ' 26' ' ' ILE . 26.0 m-80 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.554 HD12 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.418 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.49 ' HE3' ' HB3' ' A' ' 30' ' ' ASN . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.445 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.534 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.418 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.47 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.599 ' HG3' ' HB ' ' A' ' 110' ' ' THR . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 105' ' ' THR . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.423 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.423 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.44 70.73 1.36 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.599 ' HB ' ' HG3' ' A' ' 87' ' ' ARG . 9.7 t -129.65 -21.48 3.1 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.511 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 17.3 m -111.14 -63.24 1.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.778 0.799 . . . . 0.0 109.444 -166.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.494 ' HB2' HE21 ' A' ' 116' ' ' GLN . 18.9 m-70 174.39 -168.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 127.105 2.162 . . . . 0.0 107.682 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p -43.84 143.65 1.65 Allowed Pre-proline 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.494 HE21 ' HB2' ' A' ' 112' ' ' HIS . 0.7 OUTLIER -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' A' ' 111' ' ' SER . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.443 ' HB2' HD11 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.459 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 21.3 mm-40 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.432 HG12 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . 3.3 mm? 56.31 37.99 29.34 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.03 169.52 15.8 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.46 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -74.05 81.56 1.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.116 0.566 . . . . 0.0 110.308 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -77.63 81.52 4.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -151.27 -50.56 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.637 0.775 . . . . 0.0 109.057 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -124.39 96.68 5.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -84.94 -5.58 59.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.088 0.555 . . . . 0.0 111.341 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.631 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.494 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.456 ' HB2' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.567 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.695 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.481 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.695 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.68 HG23 HG23 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.586 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.446 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.446 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 HG23 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.576 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.483 HG23 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.607 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.607 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.415 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.652 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 -88.33 129.87 35.28 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.5 p -72.13 -11.46 60.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.377 0.671 . . . . 0.0 112.31 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -83.28 -41.39 18.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.474 0.71 . . . . 0.0 111.057 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.89 150.04 22.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.537 0.735 . . . . 0.0 110.637 -173.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p -66.95 115.84 29.36 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.532 0.733 . . . . 0.0 110.604 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.652 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.567 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . 0.514 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.482 HD21 ' HE1' ' A' ' 140' ' ' HIS . 74.6 mt -75.02 74.97 2.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.84 64.04 1.61 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.348 1.459 . . . . 0.0 107.475 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.5 p80 47.48 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.673 1.589 . . . . 0.0 111.817 -172.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' HIS . . . . . 0.482 ' HE1' HD21 ' A' ' 137' ' ' LEU . 36.7 m80 -71.79 74.84 0.86 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.686 0.755 . . . . 0.0 110.106 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -152.88 87.47 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -57.37 91.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 O-C-N 124.447 1.092 . . . . 0.0 111.493 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -75.52 87.84 2.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.798 0.839 . . . . 0.0 109.755 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -179.654 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.609 ' HB2' HD22 ' A' ' 45' ' ' LEU . 11.6 p-10 -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.454 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' SER . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.627 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.1 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HB3' HD11 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.608 HG13 HD12 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 132' ' ' VAL . 32.3 mt . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 124' ' ' ILE . 51.9 t30 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.588 HD12 HG13 ' A' ' 132' ' ' VAL . 82.8 mt . . . . . 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.538 ' HA ' HG13 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' HD11 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.53 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 HD12 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 132' ' ' VAL . 77.4 mt . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 16' ' ' VAL . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.472 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.547 0.865 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.472 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.61 HD12 HG13 ' A' ' 132' ' ' VAL . 79.8 mt . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 114' ' ' PRO . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.492 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.495 ' HE1' HD23 ' A' ' 79' ' ' LEU . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.763 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.559 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.559 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 26' ' ' ILE . 33.7 p30 -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HD21 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.477 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' HB3' HG13 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HB3' HD11 ' A' ' 3' ' ' ILE . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 132' ' ' VAL . 78.1 mt . . . . . 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB2' HD22 ' A' ' 45' ' ' LEU . 7.9 p-10 -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 43' ' ' VAL . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.459 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' VAL . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.563 ' HB2' HG22 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 47' ' ' VAL . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.488 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.549 ' HG2' HG21 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.554 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.524 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.415 ' O ' HD11 ' A' ' 26' ' ' ILE . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 20' ' ' TRP . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.454 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.454 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.548 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.405 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.427 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HG ' ' HH ' ' A' ' 131' ' ' TYR . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.435 HD21 ' HG2' ' A' ' 55' ' ' MET . 1.9 p-10 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.506 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.45 HG21 HG23 ' A' ' 82' ' ' VAL . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 71' ' ' THR . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 132' ' ' VAL . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HH ' ' HG ' ' A' ' 25' ' ' CYS . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 128' ' ' PHE . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' HG23 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' ALA . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG13 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' ASP . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.439 ' HZ ' HG13 ' A' ' 43' ' ' VAL . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' HH2' ' A' ' 17' ' ' TRP . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.534 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.412 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.509 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.528 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 37.0 tt0 . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 CA--C 1.554 1.114 0 CA-C-O 119.137 -0.459 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CH2' HG21 ' A' ' 89' ' ' VAL . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 132' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.636 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.407 HG22 HG21 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.674 HG22 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 82' ' ' VAL . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.702 ' HA ' HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 HG21 ' A' ' 71' ' ' THR . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.418 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.418 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.475 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.456 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.646 ' HB3' HD21 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 34' ' ' SER . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.566 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.453 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 132' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.483 ' O ' HD11 ' A' ' 26' ' ' ILE . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HB3' HG23 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 101' ' ' TRP . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HE3' ' HB3' ' A' ' 94' ' ' ALA . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.659 HG23 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.408 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 23' ' ' PRO . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG22 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' HE1' ' HB1' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.551 HG22 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.542 ' HA ' HD11 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.603 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.603 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 22.3 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' PHE . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 101' ' ' TRP . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 HG23 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 70' ' ' PHE . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.403 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 121' ' ' TRP . 6.2 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.439 ' HE1' HE21 ' A' ' 117' ' ' GLN . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' H ' ' HA2' ' A' ' 99' ' ' GLY . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.515 ' HE1' HD23 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.631 HD13 HG21 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG21 HD13 ' A' ' 26' ' ' ILE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.588 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' HD11 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.661 ' HB2' HG23 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 11' ' ' GLN . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' HG21 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.479 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.602 ' HG ' ' HB1' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HB1' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.559 ' SG ' HG22 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.559 HG22 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.501 ' H ' HG22 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.597 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.559 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' HIS . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.606 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.556 1.185 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.597 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt . . . . . 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 16' ' ' VAL . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.566 ' ND2' HD13 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.44 HG23 ' OD1' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 26' ' ' ILE . 10.3 m120 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' H ' ' A' ' 33' ' ' SER . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.566 HD13 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG2' ' HB2' ' A' ' 85' ' ' ASP . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG13 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.3 mm? . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 45' ' ' LEU . 7.8 p-10 -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG21 HG21 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.491 ' SG ' HG22 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.653 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLN . . . . . 0.653 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 30' ' ' ASN . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 132' ' ' VAL . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.579 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' TYR . . . . . 0.518 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 128' ' ' PHE . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 138' ' ' GLU . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.609 ' HB2' HD22 ' A' ' 45' ' ' LEU . 11.6 p-10 -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.454 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' SER . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.627 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 102' ' ' VAL . 7.1 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -71.12 123.08 21.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -55.77 -24.6 36.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.962 0.905 . . . . 0.0 113.133 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -76.2 -38.65 56.24 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.074 0.55 . . . . 0.0 111.895 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -101.09 159.67 15.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.896 0.478 . . . . 0.0 111.107 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p -72.71 122.12 86.73 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HB3' HD11 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt 60.91 21.38 11.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 11' ' ' GLN . 19.1 mm-40 -61.91 105.74 0.61 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.653 1.181 . . . . 0.0 110.53 -173.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -84.42 -39.51 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -67.32 117.8 9.8 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.624 0.769 . . . . 0.0 110.759 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -139.18 142.51 37.94 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -71.28 98.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -68.18 127.22 32.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.955 0.502 . . . . 0.0 109.663 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.378 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.82 144.43 31.05 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -89.39 -23.62 22.13 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.969 0.35 . . . . 0.0 111.537 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -92.93 4.16 54.44 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.456 0.703 . . . . 0.0 111.221 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -134.79 135.94 42.18 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m -63.25 122.95 78.69 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.608 HG13 HD12 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 132' ' ' VAL . 32.3 mt 60.66 26.84 16.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -24.71 65.51 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.679 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -67.86 -16.66 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.95 0.5 . . . . 0.0 111.922 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -64.03 -48.24 77.08 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 68.81 154.42 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.687 1.595 . . . . 0.0 113.235 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -172.5 55.55 0.02 OUTLIER 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.615 1.166 . . . . 0.0 108.993 165.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -63.29 136.0 57.4 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 124.306 1.042 . . . . 0.0 110.098 -176.683 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.411 ' HA ' HG23 ' A' ' 124' ' ' ILE . 51.9 t30 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 158.97 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.3 t -87.81 -13.3 42.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -168.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -68.16 -43.32 78.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.894 0.478 . . . . 0.0 110.695 -173.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -114.3 172.64 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.302 0.641 . . . . 0.0 109.803 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -82.28 140.38 45.49 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.081 0.553 . . . . 0.0 109.67 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.411 HG23 ' HA ' ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.588 HD12 HG13 ' A' ' 132' ' ' VAL . 82.8 mt 60.7 67.12 0.85 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.0 128.52 36.56 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.024 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -70.9 78.47 0.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 O-C-N 124.106 0.879 . . . . 0.0 110.165 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -75.32 73.35 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.495 1.14 . . . . 0.0 109.977 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -173.54 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.998 -168.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -62.37 94.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.603 0.761 . . . . 0.0 110.761 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.32 -15.32 10.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.117 171.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.881 0.872 . . . . 0.0 109.022 171.724 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.538 ' HA ' HG13 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' HD11 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 21.4 tm0? -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.37 138.72 39.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -85.16 -12.56 52.47 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.3 t -100.79 16.95 23.38 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -136.12 134.66 38.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p -61.48 120.99 60.72 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.53 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 HD12 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 140' ' ' HIS . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 132' ' ' VAL . 77.4 mt -81.95 -12.52 58.33 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.87 87.57 0.72 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.311 1.044 . . . . 0.0 110.939 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 70.63 -11.92 0.58 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.358 1.063 . . . . 0.0 113.014 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 73.9 m-70 -69.3 93.28 0.63 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -163.42 85.13 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -123.21 100.23 6.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.869 0.868 . . . . 0.0 110.484 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -177.86 -44.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 110.219 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.836 1.654 . . . . 0.0 110.036 -173.811 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 16' ' ' VAL . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.472 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.25 129.5 34.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 t -72.9 -19.78 61.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.3 t -90.06 -7.72 53.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.078 0.399 . . . . 0.0 111.789 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -120.77 152.52 38.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.916 0.486 . . . . 0.0 110.091 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p -71.02 135.9 85.04 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 122.967 0.507 . . . . 0.0 109.926 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.472 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.61 HD12 HG13 ' A' ' 132' ' ' VAL . 79.8 mt -73.03 5.11 3.58 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -46.46 115.49 1.04 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.685 1.194 . . . . 0.0 111.941 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -124.89 86.73 2.6 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.768 0.794 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -163.17 94.33 0.82 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.95 157.96 37.3 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.748 0.309 . . . . 0.0 110.839 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -75.05 171.4 14.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.385 0.674 . . . . 0.0 110.253 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -62.33 134.27 56.24 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.294 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 114' ' ' PRO . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.492 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.495 ' HE1' HD23 ' A' ' 79' ' ' LEU . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.763 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.559 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.559 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 26' ' ' ILE . 33.7 p30 -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 21.9 p-80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HD21 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.477 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' HB3' HG13 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.67 151.1 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -90.66 -5.73 55.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.7 m -76.45 -51.42 11.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.937 0.495 . . . . 0.0 110.16 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -101.43 156.79 17.25 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.389 0.675 . . . . 0.0 110.028 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m -65.22 125.04 88.57 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HB3' HD11 ' A' ' 3' ' ' ILE . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.6 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 132' ' ' VAL . 78.1 mt 55.55 58.43 4.56 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 62.2 -76.78 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.293 1.837 . . . . 0.0 112.118 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.7 t60 69.3 13.07 8.51 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.196 1.399 . . . . 0.0 112.873 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 30.87 75.9 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.374 1.869 . . . . 0.0 114.397 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.36 97.48 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.068 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.94 131.79 39.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.443 1.097 . . . . 0.0 108.444 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -152.37 -179.45 7.57 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.131 0.972 . . . . 0.0 110.494 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.111 0.565 . . . . 0.0 109.796 175.078 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB2' HD22 ' A' ' 45' ' ' LEU . 7.9 p-10 -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 43' ' ' VAL . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.459 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' VAL . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.563 ' HB2' HG22 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 47' ' ' VAL . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.488 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 -97.59 137.01 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -77.46 -11.68 59.88 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.99 0.516 . . . . 0.0 110.841 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.7 t -89.96 -2.6 58.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.702 0.801 . . . . 0.0 109.695 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -126.16 141.83 51.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.793 1.237 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m -60.16 115.12 11.84 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.494 0.718 . . . . 0.0 110.907 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.549 ' HG2' HG21 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.554 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt -80.36 31.85 0.28 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -73.07 102.83 3.64 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.946 0.898 . . . . 0.0 108.963 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -115.87 -46.85 2.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.159 0.984 . . . . 0.0 109.762 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -82.22 76.83 9.08 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.182 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -163.29 104.54 0.98 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.353 0.661 . . . . 0.0 110.897 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -136.81 97.75 3.61 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 m80 68.38 78.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.042 1.337 . . . . 0.0 109.367 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.707 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.524 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.415 ' O ' HD11 ' A' ' 26' ' ' ILE . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 20' ' ' TRP . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.454 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.454 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.548 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.405 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 -86.54 116.67 24.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 p -78.12 -16.57 57.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.142 0.977 . . . . 0.0 111.884 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.7 m -68.99 -30.14 68.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.428 0.632 . . . . 0.0 109.692 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.74 154.66 18.13 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 109.718 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p -69.2 125.35 91.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.193 0.597 . . . . 0.0 109.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt 54.74 91.44 0.03 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -58.0 105.76 0.3 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -163.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -130.02 21.74 5.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.811 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -114.37 150.28 34.84 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.711 0.805 . . . . 0.0 110.159 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -76.19 85.93 3.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.529 0.681 . . . . 0.0 109.335 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 28.6 p-80 -119.68 3.14 11.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.339 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.1 p80 47.6 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 126.064 1.746 . . . . 0.0 113.195 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.263 178.746 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.427 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 33.2 m-80 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HG ' ' HH ' ' A' ' 131' ' ' TYR . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.435 HD21 ' HG2' ' A' ' 55' ' ' MET . 1.9 p-10 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.506 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.45 HG21 HG23 ' A' ' 82' ' ' VAL . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 71' ' ' THR . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.46 124.25 39.4 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -71.0 -12.36 61.49 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-O 120.914 0.387 . . . . 0.0 110.329 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.1 t -69.18 -32.56 71.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.206 1.003 . . . . 0.0 111.703 175.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -108.63 162.08 14.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.276 0.63 . . . . 0.0 109.996 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p -74.27 124.96 90.33 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.644 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 132' ' ' VAL . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HH ' ' HG ' ' A' ' 25' ' ' CYS . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 128' ' ' PHE . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt 60.92 105.43 0.02 OUTLIER 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.27 101.82 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.429 1.092 . . . . 0.0 113.199 -161.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.47 108.33 7.18 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 62.08 75.72 0.39 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.168 0.987 . . . . 0.0 109.712 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 68.2 t60 -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.407 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.54 -32.74 72.89 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.712 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 46.22 -161.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.498 1.519 . . . . 0.0 112.055 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.063 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' HG23 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' ALA . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG13 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' ASP . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.439 ' HZ ' HG13 ' A' ' 43' ' ' VAL . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' HH2' ' A' ' 17' ' ' TRP . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.534 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.412 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.509 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.528 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.597 ' HG2' ' H ' ' A' ' 111' ' ' SER . 37.0 tt0 -101.63 147.24 26.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.8 p -82.78 -19.31 38.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.597 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 16.1 m -72.4 -53.15 13.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.99 0.516 . . . . 0.0 110.507 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -66.87 151.57 96.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.544 0.528 . . . . 0.0 111.098 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CH2' HG21 ' A' ' 89' ' ' VAL . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 132' ' ' VAL . 93.5 mt -71.13 9.42 0.74 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.42 3.4 18.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.767 1.227 . . . . 0.0 112.034 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -61.42 93.03 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.512 0.672 . . . . 0.0 110.995 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -84.83 175.14 9.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.593 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 61.4 83.65 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.961 0.788 . . . . 0.0 109.639 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -164.09 -179.92 6.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.784 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -163.64 -59.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.815 0.846 . . . . 0.0 109.611 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.481 1.108 0 C-N-CA 124.938 1.295 . . . . 0.0 107.718 -177.536 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.636 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.407 HG22 HG21 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.674 HG22 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 82' ' ' VAL . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.702 ' HA ' HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 HG21 ' A' ' 71' ' ' THR . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.418 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -82.59 126.29 32.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -21.22 63.76 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.734 0.814 . . . . 0.0 112.068 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -80.04 -22.21 42.6 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.334 0.654 . . . . 0.0 111.201 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -101.26 156.57 17.36 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.509 0.724 . . . . 0.0 109.894 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m -59.97 116.63 18.0 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.548 0.739 . . . . 0.0 111.117 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.418 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.475 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt -88.91 23.45 2.36 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.17 102.87 1.77 Allowed 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.525 1.13 . . . . 0.0 109.949 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.44 55.02 3.24 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.821 0.82 . . . . 0.0 110.019 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -173.07 157.9 3.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.14 1.376 . . . . 0.0 108.332 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 67.65 97.29 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.7 1.2 . . . . 0.0 110.24 -173.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 33.9 p-80 -98.41 156.44 16.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.553 0.741 . . . . 0.0 110.506 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -85.88 95.29 9.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.205 0.602 . . . . 0.0 110.568 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.185 175.849 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.456 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.646 ' HB3' HD21 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 34' ' ' SER . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.566 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.36 116.26 32.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -70.58 -12.61 61.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.292 0.637 . . . . 0.0 111.788 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -77.77 -17.57 57.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.016 0.526 . . . . 0.0 110.102 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.56 168.27 10.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.285 1.034 . . . . 0.0 110.787 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p -77.23 116.73 60.08 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.992 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.453 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 132' ' ' VAL . 91.7 mt 65.39 23.89 12.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.92 105.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.498 1.519 . . . . 0.0 113.475 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -66.92 -24.01 66.04 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -127.63 70.2 1.32 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.818 0.447 . . . . 0.0 110.852 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -58.22 -64.18 1.0 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.653 0.781 . . . . 0.0 110.48 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 52.03 77.28 0.15 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.293 0.996 . . . . 0.0 108.36 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -48.16 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.656 1.222 . . . . 0.0 112.949 -163.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.2 p80 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.199 178.299 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.483 ' O ' HD11 ' A' ' 26' ' ' ILE . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HB3' HG23 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 101' ' ' TRP . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HE3' ' HB3' ' A' ' 94' ' ' ALA . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -120.49 150.14 41.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -80.04 -5.37 55.7 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 p -91.14 -2.25 57.59 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.422 0.689 . . . . 0.0 109.989 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -121.65 153.87 37.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 161.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m -75.08 118.82 73.44 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.659 HG23 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp 53.37 -80.42 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -95.26 111.86 23.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.358 1.063 . . . . 0.0 109.562 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -121.7 50.47 1.42 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 67.41 171.55 0.26 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.479 -163.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.73 138.32 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -57.61 111.33 1.09 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.112 0.882 . . . . 0.0 112.136 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -110.99 -174.62 2.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.721 . . . . 0.0 110.887 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.416 0.686 . . . . 0.0 110.044 178.471 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.431 HE22 ' HG3' ' A' ' 138' ' ' GLU . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 23' ' ' PRO . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG22 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' HE1' ' HB1' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.551 HG22 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.542 ' HA ' HD11 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.603 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.603 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 -75.98 157.48 33.06 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -90.95 -7.42 52.11 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.788 -0.57 . . . . 0.0 112.109 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.2 t -58.11 -40.92 82.42 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.877 0.871 . . . . 0.0 112.355 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -139.42 -176.34 4.5 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.756 0.822 . . . . 0.0 109.868 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p -81.45 151.04 68.31 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 22.3 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' PHE . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt 69.41 -67.65 0.22 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -68.91 -22.88 64.14 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.98 -0.45 . . . . 0.0 111.291 175.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -72.18 80.79 0.98 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.591 0.756 . . . . 0.0 109.365 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 69.39 152.72 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.966 1.707 . . . . 0.0 111.795 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -74.91 133.9 41.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.184 0.594 . . . . 0.0 111.471 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -130.12 -65.08 0.83 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.097 . . . . 0.0 108.879 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -126.54 139.33 53.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.563 0.745 . . . . 0.0 110.003 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.481 1.112 0 C-N-CA 125.526 1.53 . . . . 0.0 110.276 -174.724 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 101' ' ' TRP . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 139' ' ' HIS . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 HG23 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 70' ' ' PHE . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.403 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -138.07 72.62 1.42 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.427 ' H ' HE22 ' A' ' 117' ' ' GLN . 71.0 p -127.33 -32.6 2.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.921 174.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m -113.42 -48.5 2.95 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.496 -161.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -171.53 -165.42 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 124.836 1.254 . . . . 0.0 109.672 -159.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p -57.75 139.85 81.58 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.439 HE21 ' HE1' ' A' ' 121' ' ' TRP . 6.2 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.439 ' HE1' HE21 ' A' ' 117' ' ' GLN . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.34 -140.9 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.1 -75.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 0.0 110.289 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 t-80 60.74 7.1 1.31 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.375 1.07 . . . . 0.0 112.851 175.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 39.2 46.78 1.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.057 1.343 . . . . 0.0 111.893 -164.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.12 164.87 15.49 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.715 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -87.67 -142.79 0.12 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -60.33 -33.37 72.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.509 0.724 . . . . 0.0 110.556 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.244 0.807 0 C-N-CA 124.012 0.925 . . . . 0.0 108.97 173.782 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' H ' ' HA2' ' A' ' 99' ' ' GLY . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.515 ' HE1' HD23 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.631 HD13 HG21 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG21 HD13 ' A' ' 26' ' ' ILE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.588 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' HD11 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.661 ' HB2' HG23 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 11' ' ' GLN . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.2 mm-40 -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.01 116.31 6.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -64.82 -23.9 67.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.566 0.746 . . . . 0.0 112.205 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.2 t -76.27 -36.38 58.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.185 0.594 . . . . 0.0 111.298 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -97.45 155.37 16.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.336 0.255 . . . . 0.0 111.327 -172.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p -63.22 116.02 22.09 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.119 0.968 . . . . 0.0 110.681 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' HG21 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.479 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.602 ' HG ' ' HB1' ' A' ' 15' ' ' ALA . 3.7 mm? 56.09 16.7 2.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -89.08 174.92 7.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.17 1.388 . . . . 0.0 109.701 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.1 m80 45.93 67.8 0.69 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.165 1.386 . . . . 0.0 111.724 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -142.03 26.7 1.84 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.847 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -59.35 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.112 1.365 . . . . 0.0 111.078 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -166.08 28.69 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.038 0.935 . . . . 0.0 109.517 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.8 m80 67.18 18.5 10.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.983 1.313 . . . . 0.0 112.799 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.888 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HB1' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.559 ' SG ' HG22 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.559 HG22 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.501 ' H ' HG22 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.698 ' HG2' ' H ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -137.31 176.84 8.35 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -93.48 13.05 22.96 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.107 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.698 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 17.7 m -96.38 -51.72 4.26 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.833 -0.542 . . . . 0.0 110.517 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -79.1 146.56 33.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 171.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m -65.39 113.98 13.7 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt 56.87 24.56 9.42 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 155.27 24.4 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 125.089 1.356 . . . . 0.0 108.601 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -86.41 40.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.833 0.853 . . . . 0.0 111.071 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -60.59 -38.6 85.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.717 1.207 . . . . 0.0 111.338 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -92.86 -6.1 49.5 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.663 0.785 . . . . 0.0 111.452 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 84.8 t60 66.77 9.06 6.44 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.62 1.168 . . . . 0.0 111.314 -177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -166.15 109.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.597 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.559 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' HIS . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.606 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.89 121.75 19.58 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.8 t -68.02 -18.44 64.71 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.411 0.684 . . . . 0.0 112.256 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -73.23 -32.05 64.51 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.165 0.586 . . . . 0.0 111.813 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -117.55 165.54 13.44 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.649 0.78 . . . . 0.0 110.558 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m -69.8 119.33 70.59 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.03 0.532 . . . . 0.0 111.092 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.597 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt 73.27 -34.8 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.33 89.65 2.09 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.234 0.54 . . . . 0.0 109.545 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -115.81 -22.42 9.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.071 0.948 . . . . 0.0 110.51 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -84.28 101.78 12.18 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -85.98 -172.39 4.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.996 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -79.97 65.65 5.19 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.983 0.897 . . . . 0.0 110.52 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -69.16 95.67 0.77 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.819 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.425 -175.384 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 16' ' ' VAL . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.566 ' ND2' HD13 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.44 HG23 ' OD1' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.44 ' OD1' HG23 ' A' ' 26' ' ' ILE . 10.3 m120 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' H ' ' A' ' 33' ' ' SER . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.566 HD13 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.629 ' HG3' ' HB ' ' A' ' 110' ' ' THR . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.44 70.73 1.36 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.629 ' HB ' ' HG3' ' A' ' 87' ' ' ARG . 9.7 t -129.65 -21.48 3.1 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.506 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 17.3 m -111.14 -63.24 1.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.778 0.799 . . . . 0.0 109.444 -166.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 174.39 -168.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 127.105 2.162 . . . . 0.0 107.682 -166.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p -43.84 143.65 1.65 Allowed Pre-proline 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.506 ' HG2' ' HB2' ' A' ' 111' ' ' SER . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG13 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.3 mm? 56.31 37.99 29.34 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.03 169.52 15.8 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.46 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -74.05 81.56 1.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.116 0.566 . . . . 0.0 110.308 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -77.63 81.52 4.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -151.27 -50.56 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.637 0.775 . . . . 0.0 109.057 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -124.39 96.68 5.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -84.94 -5.58 59.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.088 0.555 . . . . 0.0 111.341 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.631 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 45' ' ' LEU . 7.8 p-10 -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG21 HG21 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.491 ' SG ' HG22 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.653 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 -88.33 129.87 35.28 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.5 p -72.13 -11.46 60.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.377 0.671 . . . . 0.0 112.31 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -83.28 -41.39 18.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.474 0.71 . . . . 0.0 111.057 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.89 150.04 22.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.537 0.735 . . . . 0.0 110.637 -173.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p -66.95 115.84 29.36 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.532 0.733 . . . . 0.0 110.604 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.653 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 30' ' ' ASN . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 132' ' ' VAL . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.579 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' TYR . . . . . 0.518 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 128' ' ' PHE . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 140' ' ' HIS . 74.6 mt -75.02 74.97 2.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.84 64.04 1.61 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.348 1.459 . . . . 0.0 107.475 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.5 p80 47.48 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.673 1.589 . . . . 0.0 111.817 -172.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' HIS . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 36.7 m80 -71.79 74.84 0.86 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.686 0.755 . . . . 0.0 110.106 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -152.88 87.47 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -57.37 91.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 O-C-N 124.447 1.092 . . . . 0.0 111.493 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -75.52 87.84 2.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.798 0.839 . . . . 0.0 109.755 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -179.654 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.609 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 t30 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.454 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' SER . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.426 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.627 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.581 HE21 ' HB2' ' A' ' 94' ' ' ALA . 45.7 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HE21 ' A' ' 92' ' ' GLN . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.459 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HB3' HD11 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.557 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m . . . . . 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.608 HG13 HD12 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 132' ' ' VAL . 32.3 mt . . . . . 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 124' ' ' ILE . 3.0 t-20 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.616 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p . . . . . 0 CA--C 1.551 0.99 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.588 HD12 HG13 ' A' ' 132' ' ' VAL . 82.8 mt . . . . . 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.538 ' HA ' HG13 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' HD11 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p . . . . . 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.53 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.417 HE22 HD23 ' A' ' 125' ' ' LEU . 22.4 tp60 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.417 HD23 HE22 ' A' ' 122' ' ' GLN . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 HD12 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 132' ' ' VAL . 77.4 mt . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.404 ' HB ' HE21 ' A' ' 122' ' ' GLN . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 16' ' ' VAL . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.472 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p . . . . . 0 CA--C 1.547 0.865 0 CA-C-O 119.078 -0.487 . . . . 0.0 109.926 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.472 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.404 HE21 ' HB ' ' A' ' 5' ' ' ILE . 8.2 tp-100 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.61 HD12 HG13 ' A' ' 132' ' ' VAL . 79.8 mt . . . . . 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 114' ' ' PRO . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.492 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.495 ' HE1' HD23 ' A' ' 79' ' ' LEU . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.763 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.559 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.559 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HD21 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.477 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.56 ' HB3' HG13 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HB3' HD11 ' A' ' 3' ' ' ILE . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.419 HD23 HE21 ' A' ' 122' ' ' GLN . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 132' ' ' VAL . 78.1 mt . . . . . 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 43' ' ' VAL . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.459 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' VAL . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.563 ' HB2' HG22 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 47' ' ' VAL . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.488 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 . . . . . 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.552 1.035 0 CA-C-O 118.724 -0.655 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.549 ' HG2' HG21 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.554 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.524 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.415 ' O ' HD11 ' A' ' 26' ' ' ILE . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 20' ' ' TRP . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.416 HD21 ' HB3' ' A' ' 53' ' ' HIS . 65.8 t30 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.454 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.454 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.548 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.405 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 . . . . . 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p . . . . . 0 CA--C 1.545 0.781 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt . . . . . 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.427 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HG ' ' HH ' ' A' ' 131' ' ' TYR . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 37' ' ' HIS . 2.2 p30 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.643 ' HA ' HD21 ' A' ' 30' ' ' ASN . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.506 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.45 HG21 HG23 ' A' ' 82' ' ' VAL . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 71' ' ' THR . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 . . . . . 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 119.148 -0.453 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 132' ' ' VAL . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HH ' ' HG ' ' A' ' 25' ' ' CYS . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 128' ' ' PHE . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt . . . . . 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.44 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' HG23 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' ALA . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG13 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' ASP . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.439 ' HZ ' HG13 ' A' ' 43' ' ' VAL . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' HH2' ' A' ' 17' ' ' TRP . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.534 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.412 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.509 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.528 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' HG3' ' NH2' ' A' ' 87' ' ' ARG . 37.0 tt0 . . . . . 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p . . . . . 0 CA--C 1.554 1.114 0 CA-C-O 119.137 -0.459 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CH2' HG21 ' A' ' 89' ' ' VAL . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 132' ' ' VAL . 93.5 mt . . . . . 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.636 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.407 HG22 HG21 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.674 HG22 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 82' ' ' VAL . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.702 ' HA ' HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 HG21 ' A' ' 71' ' ' THR . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.418 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m . . . . . 0 CA--C 1.55 0.953 0 CA-C-O 118.829 -0.605 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.418 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.475 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt . . . . . 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.456 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.646 ' HB3' HD21 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 34' ' ' SER . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.566 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p . . . . . 0 CA--C 1.554 1.104 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.453 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 132' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.483 ' O ' HD11 ' A' ' 26' ' ' ILE . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HB3' HG23 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 101' ' ' TRP . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HE3' ' HB3' ' A' ' 94' ' ' ALA . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.659 HG23 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.408 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HG3' ' HB3' ' A' ' 15' ' ' ALA . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 23' ' ' PRO . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.532 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG22 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.434 ' HE1' ' HB1' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.551 HG22 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.542 ' HA ' HD11 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.603 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.603 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 . . . . . 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 29.1 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' PHE . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 101' ' ' TRP . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 50.9 tp60 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 HG23 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 70' ' ' PHE . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.403 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.569 ' HA ' HE22 ' A' ' 117' ' ' GLN . 9.4 pt-20 . . . . . 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.569 HE22 ' HA ' ' A' ' 109' ' ' GLU . 36.9 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.402 ' H ' ' HA2' ' A' ' 99' ' ' GLY . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.515 ' HE1' HD23 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.631 HD13 HG21 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.631 HG21 HD13 ' A' ' 26' ' ' ILE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.588 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' HD11 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.661 ' HB2' HG23 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 11' ' ' GLN . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 119.28 -0.39 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' HG21 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.479 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.602 ' HG ' ' HB1' ' A' ' 15' ' ' ALA . 3.7 mm? . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.637 HD12 HE21 ' A' ' 122' ' ' GLN . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.484 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HB1' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.559 ' SG ' HG22 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.559 HG22 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.501 ' H ' HG22 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m . . . . . 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.637 HE21 HD12 ' A' ' 5' ' ' ILE . 13.7 mm-40 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt . . . . . 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.597 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.559 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' HIS . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.606 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m . . . . . 0 CA--C 1.556 1.185 0 CA-C-O 119.072 -0.489 . . . . 0.0 111.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.597 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt . . . . . 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 16' ' ' VAL . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.566 ' ND2' HD13 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.592 HG23 ' ND2' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.592 ' ND2' HG23 ' A' ' 26' ' ' ILE . 26.0 m-80 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' H ' ' A' ' 33' ' ' SER . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.566 HD13 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG2' ' HB2' ' A' ' 85' ' ' ASP . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p . . . . . 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.463 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 21.3 mm-40 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.463 HG13 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.3 mm? . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.579 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.724 HG21 HG21 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.491 ' SG ' HG22 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.653 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLN . . . . . 0.653 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 30' ' ' ASN . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 132' ' ' VAL . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.579 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . 0.518 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 128' ' ' PHE . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 74.6 mt . . . . . 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.4 ttp . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -106.67 137.02 45.46 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.333 0.653 . . . . 0.0 110.045 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.484 HD11 ' HB3' ' A' ' 114' ' ' PRO . 54.3 mt -109.63 126.48 66.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 170.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.9 t -113.93 119.02 35.82 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.898 0.479 . . . . 0.0 110.329 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 pt -113.34 173.48 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 125.176 1.39 . . . . 0.0 108.929 172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -151.11 169.99 20.5 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.55 132.36 7.7 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.567 1.147 . . . . 0.0 109.191 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -103.97 83.49 2.12 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.468 HG12 ' HG3' ' A' ' 129' ' ' LYS . 31.4 mt -79.45 115.43 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -75.63 76.16 2.63 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.411 0.624 . . . . 0.0 109.461 -178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.413 HE22 ' HA ' ' A' ' 138' ' ' GLU . 7.2 tp-100 -163.94 164.44 23.26 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.573 1.149 . . . . 0.0 108.231 -173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -74.15 145.73 44.03 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 122.997 0.519 . . . . 0.0 110.759 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.2 tt -58.31 -25.39 27.12 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 C-N-CA 124.107 0.963 . . . . 0.0 111.15 177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -65.58 -52.63 50.79 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.433 0.693 . . . . 0.0 110.624 175.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -68.83 -34.09 74.92 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 122.909 0.484 . . . . 0.0 111.655 -177.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.5 t -69.52 -51.17 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.415 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 60.1 t-105 -61.1 -37.5 82.96 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.655 0.382 . . . . 0.0 110.697 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -60.74 -51.46 69.26 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.114 0.566 . . . . 0.0 109.83 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.53 71.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.391 0.677 . . . . 0.0 111.563 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 58.3 t-105 -74.04 -43.38 58.07 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.039 -177.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.609 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.97 -26.05 15.71 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 -168.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 26' ' ' ILE . 13.3 t70 -72.95 114.81 34.1 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 123.369 0.668 . . . . 0.0 109.864 -175.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 41' ' ' SER . 52.5 Cg_exo -56.34 -34.35 93.84 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 123.517 2.811 . . . . 0.0 114.27 -174.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.53 -36.44 78.83 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.341 0.656 . . . . 0.0 110.096 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 77.0 m -69.24 -45.41 69.84 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.121 0.569 . . . . 0.0 111.058 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 22' ' ' ASP . 55.8 mt -60.52 -26.9 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 124.063 0.945 . . . . 0.0 111.002 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.58 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -57.97 -32.5 67.92 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 123.681 0.792 . . . . 0.0 112.745 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -84.13 -52.74 6.04 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 122.361 -0.212 . . . . 0.0 110.668 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.6 p-90 -84.71 -153.32 0.15 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 119.155 -0.45 . . . . 0.0 110.102 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 t30 80.82 -58.05 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 125.566 1.547 . . . . 0.0 110.513 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -72.85 101.32 3.12 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 166.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.06 -54.29 48.66 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.966 0.506 . . . . 0.0 110.995 -175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 m -55.44 132.58 48.68 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 124.188 0.995 . . . . 0.0 111.812 172.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.8 m -73.29 -21.34 60.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.654 0.782 . . . . 0.0 111.05 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -69.79 -8.26 46.72 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.734 0.814 . . . . 0.0 111.259 171.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -121.58 162.52 20.48 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.576 1.15 . . . . 0.0 108.423 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -162.96 135.91 5.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.58 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 21.2 m -72.89 111.49 8.06 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.8 t -84.23 -13.66 52.06 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.26 0.624 . . . . 0.0 111.298 -174.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.69 150.09 12.89 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 23' ' ' PRO . 75.3 m -141.69 101.24 3.93 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.911 0.884 . . . . 0.0 109.948 175.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 51' ' ' PHE . 2.5 tpm_? -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.348 0.529 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 171.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.67 112.23 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -107.78 75.83 1.03 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 171.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.609 HD22 ' HB2' ' A' ' 21' ' ' ASN . 36.7 tp -72.69 81.3 1.12 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.5 -1.227 . . . . 0.0 111.226 -174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -143.6 164.83 15.04 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 C-N-CA 125.75 1.62 . . . . 0.0 107.885 170.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG22 ' H ' ' A' ' 73' ' ' VAL . 63.6 t -71.51 104.29 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.96 -3.43 41.34 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.701 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.28 157.36 44.5 Favored Glycine 0 C--N 1.345 1.081 0 CA-C-O 119.796 -0.447 . . . . 0.0 112.382 176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.44 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 15.9 mtp180 -104.26 158.11 16.67 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 117.491 0.645 . . . . 0.0 112.266 -176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.454 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 51.5 p90 -129.02 152.4 48.67 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.452 172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 41' ' ' SER . 19.5 t -150.13 103.09 3.15 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.296 0.638 . . . . 0.0 110.148 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 79.3 m-70 -105.02 87.35 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.203 0.601 . . . . 0.0 110.264 -173.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.426 ' NE2' ' SG ' ' A' ' 52' ' ' CYS . 23.7 m-70 -73.51 124.48 25.93 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.939 0.896 . . . . 0.0 109.895 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.546 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.0 mtm -117.28 124.42 48.95 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.418 0.687 . . . . 0.0 109.207 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -103.99 145.05 30.71 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 123.346 0.658 . . . . 0.0 109.429 176.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.5 157.05 36.21 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -64.03 -28.31 69.71 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -102.27 -2.27 29.44 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 122.805 0.442 . . . . 0.0 110.143 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.32 26.03 70.29 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 116.453 -0.339 . . . . 0.0 113.528 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.6 t -77.1 -22.73 52.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.663 0.385 . . . . 0.0 110.691 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -151.35 166.82 29.82 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.586 0.754 . . . . 0.0 111.008 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.31 161.77 27.63 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.238 176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -160.37 131.13 5.54 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -128.37 141.6 51.37 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.438 0.695 . . . . 0.0 110.703 -167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.461 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 55.9 m-85 -110.41 88.15 2.7 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.203 1.001 . . . . 0.0 110.368 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.43 HG22 ' SG ' ' A' ' 52' ' ' CYS . 35.3 p -87.17 158.08 19.22 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.329 0.651 . . . . 0.0 110.867 174.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.57 -168.19 41.27 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.856 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 50.7 m -139.03 127.9 23.55 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.686 0.794 . . . . 0.0 110.521 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 67.8 m-85 -63.47 120.21 11.24 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.902 0.881 . . . . 0.0 109.365 169.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.3 p -93.35 -22.38 18.99 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.284 0.633 . . . . 0.0 111.0 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 58.4 ttt180 -161.79 135.0 6.24 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.241 1.016 . . . . 0.0 108.814 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 47' ' ' VAL . 50.6 t -128.39 113.56 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 108.228 -1.026 . . . . 0.0 108.228 177.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -119.22 78.96 1.34 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 176.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -74.82 137.15 73.4 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.441 0.696 . . . . 0.0 111.056 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 19.9 Cg_endo -98.83 14.44 28.53 Favored 'Cis proline' 0 C--N 1.373 1.85 0 CA-C-N 119.595 0.891 . . . . 0.0 113.25 -4.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -90.37 -10.65 43.18 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -165.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.0 ttm105 -169.12 145.17 3.37 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.117 0.567 . . . . 0.0 111.287 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' HG ' ' HD1' ' A' ' 81' ' ' PHE . 20.9 tp -139.04 121.98 16.66 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.843 0.857 . . . . 0.0 109.161 173.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.627 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.0 m -117.08 130.42 56.64 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.454 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 36.2 p90 -158.65 152.94 24.03 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.356 0.663 . . . . 0.0 110.487 -176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.5 t -110.47 141.48 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 175.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 82.8 mtp -90.55 172.75 8.48 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.338 0.655 . . . . 0.0 110.017 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -63.51 -27.81 69.52 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.366 0.667 . . . . 0.0 111.325 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.483 ' HB2' ' HG3' ' A' ' 87' ' ' ARG . 5.1 m-20 -77.18 -10.46 59.42 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.873 0.869 . . . . 0.0 110.606 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.93 -4.82 61.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.78 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 47.2 mtt180 -62.69 109.02 1.28 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 122.971 0.508 . . . . 0.0 109.916 -177.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.444 ' H ' ' HB3' ' A' ' 107' ' ' ASP . 40.1 mt-10 -78.62 101.88 7.69 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 173.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 72.8 t -107.18 123.32 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.443 1.497 . . . . 0.0 110.297 -168.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -130.18 106.17 8.42 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.995 0.918 . . . . 0.0 109.67 -172.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.48 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.8 t -104.44 114.47 44.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.354 1.062 . . . . 0.0 109.079 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.581 HE21 ' HB2' ' A' ' 94' ' ' ALA . 45.7 tt0 -99.83 128.41 45.92 Favored 'General case' 0 C--O 1.22 -0.478 0 C-N-CA 123.757 0.823 . . . . 0.0 109.038 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -109.04 98.23 7.73 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB2' HE21 ' A' ' 92' ' ' GLN . . . -100.56 134.46 43.49 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.177 0.591 . . . . 0.0 109.954 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 67.3 m -82.13 129.54 34.84 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.881 0.372 . . . . 0.0 110.322 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.459 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 10.3 pt-20 -138.97 151.22 67.68 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 124.25 1.02 . . . . 0.0 109.316 -177.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -52.89 -21.56 15.81 Favored 'Trans proline' 0 C--N 1.369 1.647 0 C-N-CA 122.944 2.429 . . . . 0.0 114.692 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -88.65 -18.59 54.46 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.643 -0.532 . . . . 0.0 114.38 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.459 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 152.02 -112.21 0.53 Allowed Glycine 0 N--CA 1.467 0.739 0 CA-C-N 117.609 0.704 . . . . 0.0 111.731 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.8 m -138.24 116.66 11.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.181 0.992 . . . . 0.0 109.236 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 24.2 t90 -82.74 94.66 7.66 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.236 0.614 . . . . 0.0 109.4 173.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 45.0 t -87.28 98.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 176.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -101.1 105.16 16.3 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.48 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -90.24 136.31 33.13 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 179.706 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.6 m -138.81 108.54 6.25 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 43.5 p90 -115.78 152.72 32.75 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.444 ' HB3' ' H ' ' A' ' 88' ' ' GLU . 24.3 t70 -80.92 132.76 35.45 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.8 126.31 30.1 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 123.515 0.509 . . . . 0.0 110.013 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 65.9 tt0 -71.12 123.08 21.31 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.312 0.645 . . . . 0.0 109.502 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.9 t -55.77 -24.6 36.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.962 0.905 . . . . 0.0 113.133 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.7 t -76.2 -38.65 56.24 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.074 0.55 . . . . 0.0 111.895 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -101.09 159.67 15.03 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.896 0.478 . . . . 0.0 111.107 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 66.6 p -72.71 122.12 86.73 Favored Pre-proline 0 CA--C 1.552 1.057 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.569 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.484 ' HB3' HD11 ' A' ' 3' ' ' ILE . 88.5 Cg_exo -46.94 -46.07 19.45 Favored 'Trans proline' 0 C--N 1.383 2.383 0 C-N-CA 124.319 3.346 . . . . 0.0 115.379 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.7 -38.27 90.44 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.071 0.548 . . . . 0.0 111.943 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.557 HE21 ' HA ' ' A' ' 116' ' ' GLN . 0.0 OUTLIER -67.19 -33.46 75.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.72 0.408 . . . . 0.0 111.228 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -65.02 -47.12 78.57 Favored 'General case' 0 C--O 1.218 -0.567 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -55.64 -37.45 68.22 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.263 1.025 . . . . 0.0 111.032 178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -69.16 -40.49 78.15 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.546 0.738 . . . . 0.0 111.224 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.67 -45.53 92.58 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.195 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -69.45 -37.77 77.51 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.731 0.812 . . . . 0.0 111.41 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -70.77 -28.29 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.774 0.43 . . . . 0.0 110.135 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.89 -44.2 89.56 Favored Glycine 0 C--N 1.343 0.95 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.9 mt -72.98 -33.6 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.628 0.771 . . . . 0.0 111.264 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 52.0 tp -74.27 -36.68 63.83 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.572 0.749 . . . . 0.0 109.782 178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.16 -40.91 95.0 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.632 0.773 . . . . 0.0 109.64 171.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -69.12 -32.16 71.36 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.122 0.569 . . . . 0.0 110.173 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -71.08 -53.13 15.73 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.618 174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.468 ' HG3' HG12 ' A' ' 9' ' ' ILE . 52.4 tttm -58.35 -46.06 86.99 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.183 0.993 . . . . 0.0 110.535 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -65.39 -32.92 74.81 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.048 177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -64.21 -44.6 91.43 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.377 0.271 . . . . 0.0 110.696 172.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.442 HG13 HD12 ' A' ' 137' ' ' LEU . 98.8 t -60.53 -40.67 85.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.783 0.433 . . . . 0.0 109.871 179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -74.06 -29.99 62.17 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.885 0.874 . . . . 0.0 111.781 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.63 -51.43 9.27 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.731 0.777 . . . . 0.0 109.647 -175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.64 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.963 172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 83.5 -76.27 2.27 Favored Glycine 0 C--N 1.341 0.836 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.483 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 57.9 mt 60.91 21.38 11.61 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.296 1.038 . . . . 0.0 110.901 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.413 ' HA ' HE22 ' A' ' 11' ' ' GLN . 19.1 mm-40 -61.91 105.74 0.61 Allowed 'General case' 0 C--N 1.355 0.809 0 C-N-CA 124.653 1.181 . . . . 0.0 110.53 -173.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.0 t-80 -84.42 -39.51 18.91 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 173.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -67.32 117.8 9.8 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 123.624 0.769 . . . . 0.0 110.759 173.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 92.6 m-70 -139.18 142.51 37.94 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -71.28 98.96 1.84 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -68.18 127.22 32.11 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.955 0.502 . . . . 0.0 109.663 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.248 1.019 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.378 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -127.06 127.7 45.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.469 0.707 . . . . 0.0 110.025 176.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.9 mt -99.14 129.21 49.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.838 0.855 . . . . 0.0 108.701 172.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -113.55 120.68 41.79 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.978 0.511 . . . . 0.0 109.928 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 29.4 pt -116.85 166.23 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.925 1.29 . . . . 0.0 108.622 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -153.01 166.17 33.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.83 119.43 3.62 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.637 1.175 . . . . 0.0 109.905 -171.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 40.6 m-70 -95.59 91.89 6.36 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG12 ' HG3' ' A' ' 129' ' ' LYS . 37.5 mt -82.84 124.26 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.113 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -80.36 69.75 6.88 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 122.094 0.95 . . . . 0.0 110.289 177.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -163.74 161.23 23.33 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.648 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -62.27 140.24 58.5 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.904 0.882 . . . . 0.0 111.087 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 tt -58.24 -23.6 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 C-N-CA 124.403 1.081 . . . . 0.0 111.357 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -65.55 -54.63 25.31 Favored 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 123.968 0.907 . . . . 0.0 110.259 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.18 -26.75 62.19 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.556 0.742 . . . . 0.0 111.166 -175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.8 t -66.22 -53.64 34.77 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.889 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.699 171.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -61.7 -37.17 83.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 122.673 0.389 . . . . 0.0 110.963 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -60.1 -55.4 34.35 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.764 0.826 . . . . 0.0 109.1 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -62.41 -34.94 77.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.402 0.681 . . . . 0.0 112.117 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 67.8 t-105 -63.91 -42.07 97.5 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.122 0.569 . . . . 0.0 111.145 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 45.7 m-80 -103.97 -9.96 18.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -173.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -78.91 121.69 83.7 Favored Pre-proline 0 N--CA 1.494 1.75 0 CA-C-N 119.006 0.821 . . . . 0.0 111.419 -178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.6 -44.61 47.89 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.139 2.559 . . . . 0.0 114.184 -176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.29 -40.7 95.12 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.529 0.68 . . . . 0.0 110.868 -178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.557 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 42.1 t -65.19 -51.5 60.67 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.403 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 53' ' ' HIS . 61.1 mt -60.52 -30.6 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 124.467 1.107 . . . . 0.0 111.298 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.6 -36.74 79.3 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.459 0.647 . . . . 0.0 111.354 175.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 ttp-105 -88.16 -40.72 13.51 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 114.431 -1.259 . . . . 0.0 111.448 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -93.11 -166.62 1.56 Allowed 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.598 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.2 OUTLIER 79.04 -31.09 0.14 Allowed 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 125.527 1.531 . . . . 0.0 111.314 178.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' HB2' ' HA ' ' A' ' 37' ' ' HIS . . . -51.32 104.37 0.08 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.016 1.326 . . . . 0.0 111.552 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.24 -11.36 60.26 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.908 0.883 . . . . 0.0 111.935 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -134.77 164.15 28.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.577 0.751 . . . . 0.0 110.282 174.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.0 m -72.9 -35.32 67.08 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.503 0.721 . . . . 0.0 110.105 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -79.44 -3.55 47.07 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.017 0.927 . . . . 0.0 111.506 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -119.28 155.77 31.18 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.059 0.944 . . . . 0.0 109.778 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.437 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 2.8 p80 -166.39 145.37 5.7 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.326 1.05 . . . . 0.0 108.605 -176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.568 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 27.2 m -75.49 100.49 4.53 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 t -88.36 -9.64 52.04 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.829 -174.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.68 91.06 0.16 Allowed Glycine 0 C--N 1.35 1.316 0 N-CA-C 112.295 -0.322 . . . . 0.0 112.295 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.2 m -95.74 100.51 12.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 176.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.597 ' HD3' ' HB3' ' A' ' 52' ' ' CYS . 2.1 mpt_? -90.5 127.47 36.24 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 174.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 44.0 t -138.04 107.59 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -120.59 79.17 1.45 Allowed 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 167.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -71.02 78.09 0.66 Allowed 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.532 -177.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.44 148.33 20.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 C-N-CA 125.258 1.423 . . . . 0.0 108.558 178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.7 t -68.98 109.25 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.35 -25.82 9.55 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.864 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.36 177.52 47.32 Favored Glycine 0 C--N 1.349 1.263 0 C-N-CA 123.163 0.411 . . . . 0.0 112.95 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 38.8 mtt180 -118.1 171.5 8.06 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 122.268 1.032 . . . . 0.0 112.827 -174.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -130.22 167.33 18.6 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 113.13 -1.85 . . . . 0.0 107.538 159.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.597 ' HB3' ' HD3' ' A' ' 42' ' ' ARG . 41.2 t -153.92 138.14 16.56 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 123.666 0.786 . . . . 0.0 108.998 170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 16.0 m-70 -119.95 91.64 3.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -76.89 86.26 3.45 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 52.5 ttp -80.22 125.37 29.76 Favored 'General case' 0 C--O 1.218 -0.585 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 172.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.79 148.79 32.27 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 123.479 0.712 . . . . 0.0 109.431 -169.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.86 128.01 34.29 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.771 0.669 . . . . 0.0 110.786 177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -65.01 -25.58 67.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.096 0.958 . . . . 0.0 109.453 168.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -92.95 -18.46 22.72 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.083 0.953 . . . . 0.0 111.519 -175.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.03 165.38 32.19 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 113.902 0.321 . . . . 0.0 113.902 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.0 m -77.74 -2.57 36.92 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.751 0.82 . . . . 0.0 112.914 -174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.74 136.45 55.51 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.274 0.63 . . . . 0.0 110.545 175.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.41 133.64 2.81 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 113.991 0.356 . . . . 0.0 113.991 -175.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -101.79 141.93 33.89 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.193 0.997 . . . . 0.0 110.256 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -103.31 112.67 25.65 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.32 0.648 . . . . 0.0 109.428 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.531 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.6 m-85 -89.57 77.39 7.22 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 177.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 84' ' ' ASP . 1.8 t -108.83 130.41 55.41 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.57 -1.196 . . . . 0.0 110.967 -173.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -147.46 150.85 23.15 Favored Glycine 0 C--N 1.341 0.806 0 N-CA-C 111.152 -0.779 . . . . 0.0 111.152 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.6 m -94.53 123.08 37.74 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -64.74 121.61 14.94 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 123.304 0.642 . . . . 0.0 110.303 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 32.1 p -101.86 -44.52 5.49 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.698 0.799 . . . . 0.0 109.993 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.612 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.9 ttt180 -137.9 115.29 11.12 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.716 0.806 . . . . 0.0 108.864 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 66.4 t -116.11 111.0 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.26 81.85 1.97 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.94 136.37 87.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.187 0.595 . . . . 0.0 111.08 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 62.0 Cg_endo -101.57 21.33 17.98 Favored 'Cis proline' 0 C--N 1.375 1.952 0 CA-C-N 119.62 0.9 . . . . 0.0 113.817 -8.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.1 p -85.52 -36.24 20.62 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -168.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -146.47 149.6 33.98 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.357 0.663 . . . . 0.0 110.39 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.5 tp -137.22 108.46 6.82 Favored 'General case' 0 C--N 1.341 0.197 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 171.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.612 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 28.8 t -114.01 136.79 52.53 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -177.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 29.0 p90 -157.48 165.51 35.45 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 124.396 1.078 . . . . 0.0 108.88 -176.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -118.6 124.25 72.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 51.9 tpp -68.98 163.74 23.88 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.074 0.95 . . . . 0.0 109.205 -176.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HB2' HG23 ' A' ' 67' ' ' THR . 35.6 t70 -57.97 -31.47 66.92 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 113.72 1.008 . . . . 0.0 113.72 -170.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.54 -9.74 58.06 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.53 0.332 . . . . 0.0 111.699 -178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 113.89 -6.96 23.79 Favored Glycine 0 N--CA 1.479 1.509 0 CA-C-O 119.267 -0.74 . . . . 0.0 114.79 -177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -70.44 108.97 4.52 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 117.902 0.851 . . . . 0.0 111.235 -176.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.42 120.43 24.42 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 24.7 t -121.39 133.53 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 C-N-CA 125.086 1.355 . . . . 0.0 109.014 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -130.32 131.13 45.25 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.168 0.987 . . . . 0.0 108.594 175.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -114.77 112.48 40.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -175.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -99.41 114.76 27.86 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.903 0.881 . . . . 0.0 109.622 -173.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -103.02 147.13 27.35 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.0 99.02 1.94 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 122.964 0.506 . . . . 0.0 110.035 -174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 t -54.15 131.58 41.41 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.388 0.675 . . . . 0.0 110.116 173.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -141.4 156.29 67.17 Favored Pre-proline 0 N--CA 1.481 1.094 0 C-N-CA 123.569 0.748 . . . . 0.0 110.32 -170.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.44 89.59 0.1 OUTLIER 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.769 2.313 . . . . 0.0 112.316 173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 145.5 -31.79 1.65 Allowed Glycine 0 N--CA 1.469 0.837 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.504 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 170.66 -118.29 0.74 Allowed Glycine 0 C--N 1.347 1.174 0 N-CA-C 111.966 -0.454 . . . . 0.0 111.966 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 52.4 m -151.21 126.19 9.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.594 1.158 . . . . 0.0 109.541 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.0 t90 -81.44 126.08 31.22 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 171.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.8 t -115.91 142.56 28.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 175.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -137.74 136.96 37.81 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -122.29 107.84 12.57 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.614 0.721 . . . . 0.0 109.276 175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -101.62 118.19 36.44 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.153 -0.93 . . . . 0.0 108.746 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -129.89 143.69 50.94 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.715 0.406 . . . . 0.0 110.636 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -68.49 135.05 51.03 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.49 0.494 . . . . 0.0 109.793 172.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.2 143.67 27.85 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -170.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -81.82 144.43 31.05 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.7 t -89.39 -23.62 22.13 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 117.969 0.35 . . . . 0.0 111.537 176.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 19.5 m -92.93 4.16 54.44 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.456 0.703 . . . . 0.0 111.221 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -134.79 135.94 42.18 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.0 m -63.25 122.95 78.69 Favored Pre-proline 0 CA--C 1.553 1.081 0 CA-C-O 118.362 -0.827 . . . . 0.0 110.764 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -47.55 -39.58 29.43 Favored 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 124.358 3.372 . . . . 0.0 114.678 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.0 -44.93 91.72 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.166 0.586 . . . . 0.0 111.956 173.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -73.71 -26.44 60.7 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.679 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -67.58 -51.56 49.01 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 173.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -53.47 -39.24 64.33 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.983 176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.76 -39.3 80.33 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.457 0.703 . . . . 0.0 111.918 178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -77.28 -52.47 5.62 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 116.484 -0.325 . . . . 0.0 113.193 -175.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -63.64 -39.96 95.67 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.596 0.759 . . . . 0.0 111.261 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.4 tp-100 -77.4 -21.12 53.61 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 120.902 0.382 . . . . 0.0 110.296 174.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.59 96.06 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 168.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 30' ' ' ASN . 69.9 mt -81.4 -35.33 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 124.229 1.012 . . . . 0.0 111.373 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 42.8 tp -74.09 -42.05 60.73 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 -176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.22 -24.77 46.9 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.446 0.699 . . . . 0.0 111.194 175.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -65.01 -38.54 91.27 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 166.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -67.44 -45.87 74.77 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.636 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.507 ' HG3' HG12 ' A' ' 9' ' ' ILE . 51.1 tttm -57.67 -49.78 75.34 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.758 0.823 . . . . 0.0 109.973 177.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -58.0 -44.81 87.43 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.78 178.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.557 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 67.8 t80 -56.0 -56.46 20.52 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.511 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.608 HG13 HD12 ' A' ' 137' ' ' LEU . 85.6 t -62.76 -40.86 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.518 0.727 . . . . 0.0 111.419 -172.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -78.91 -25.49 43.73 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.13 0.572 . . . . 0.0 111.558 -176.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -80.64 -43.14 20.93 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.187 0.518 . . . . 0.0 110.351 177.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.62 -33.11 72.19 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.732 -1.122 . . . . 0.0 110.648 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 91.05 -55.58 3.29 Favored Glycine 0 C--N 1.338 0.649 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.833 -176.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.608 HD12 HG13 ' A' ' 132' ' ' VAL . 32.3 mt 60.66 26.84 16.57 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.877 1.271 . . . . 0.0 111.129 -174.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -24.71 65.51 Favored 'General case' 0 C--O 1.223 -0.337 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.679 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -67.86 -16.66 64.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.95 0.5 . . . . 0.0 111.922 177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -64.03 -48.24 77.08 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 167.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 68.81 154.42 0.11 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.687 1.595 . . . . 0.0 113.235 177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 38.4 t-80 -172.5 55.55 0.02 OUTLIER 'General case' 0 C--O 1.247 0.962 0 C-N-CA 124.615 1.166 . . . . 0.0 108.993 165.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 10.8 p-80 -63.29 136.0 57.4 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.859 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 . . . . . 0 N--CA 1.487 1.379 0 C-N-CA 124.306 1.042 . . . . 0.0 110.098 -176.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -121.52 115.31 22.58 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.5 mt -85.2 121.35 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 123.548 0.739 . . . . 0.0 109.664 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 16.6 t -100.98 131.99 46.59 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 104' ' ' GLU . 38.9 pt -116.84 161.19 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.292 1.037 . . . . 0.0 108.654 174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.49 163.39 32.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -174.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.79 121.13 4.41 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.018 0.927 . . . . 0.0 109.422 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -90.33 84.45 6.04 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 176.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 21.0 mt -80.08 112.16 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.783 -174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -75.72 81.39 2.68 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.446 0.641 . . . . 0.0 110.295 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -172.09 160.48 5.27 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.095 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.531 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 12.5 tp10 -66.81 142.23 57.42 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.647 0.779 . . . . 0.0 110.43 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.1 tt -59.79 -22.85 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.485 0.714 . . . . 0.0 111.613 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 38.3 mt-10 -65.22 -54.3 31.52 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.186 0.594 . . . . 0.0 110.556 175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.01 -38.53 82.71 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.286 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.1 t -61.18 -51.68 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.372 175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 63.4 t-105 -61.69 -36.38 80.72 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 119.397 -0.335 . . . . 0.0 110.77 177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.1 t90 -62.61 -45.42 92.94 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.027 0.531 . . . . 0.0 111.264 -178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.26 -26.72 63.95 Favored 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HE1' HD23 ' A' ' 79' ' ' LEU . 15.6 t-105 -81.05 -19.99 42.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.828 0.451 . . . . 0.0 109.83 172.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -86.7 -38.08 17.34 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.609 0.763 . . . . 0.0 110.616 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.435 ' O ' HG13 ' A' ' 26' ' ' ILE . 16.8 t70 -71.48 120.61 80.84 Favored Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.853 0.721 . . . . 0.0 109.632 -173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 37.0 Cg_endo -61.65 -38.63 59.95 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.681 2.254 . . . . 0.0 112.998 -171.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -76.42 -29.47 57.04 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.233 -177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 22' ' ' ASP . 42.6 t -72.28 -40.12 67.82 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.108 176.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 22' ' ' ASP . 80.7 mt -55.03 -52.23 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.64 -14.83 34.37 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 115.304 -0.862 . . . . 0.0 113.318 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -87.03 -44.08 11.84 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.535 1.134 . . . . 0.0 111.063 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.8 p-90 -92.7 -21.41 20.0 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.51 HD22 HG21 ' A' ' 124' ' ' ILE . 3.0 t-20 -83.08 88.83 6.87 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.678 -0.489 . . . . 0.0 109.678 -178.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -145.25 138.86 26.74 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.118 0.967 . . . . 0.0 108.762 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.35 -38.69 88.17 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 123.46 0.475 . . . . 0.0 110.489 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -145.27 169.1 18.9 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.024 0.929 . . . . 0.0 109.608 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.6 t -72.96 -17.25 61.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.438 0.695 . . . . 0.0 110.96 175.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -82.1 -7.67 59.63 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.419 0.688 . . . . 0.0 110.303 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HE3' ' HG2' ' A' ' 55' ' ' MET . 45.4 m95 -113.39 147.64 37.35 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.907 0.883 . . . . 0.0 109.189 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -149.61 127.52 11.85 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -174.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 60.8 m -76.42 102.4 5.96 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 t -86.68 -18.03 32.27 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.595 -1.184 . . . . 0.0 111.737 -172.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.12 84.18 0.17 Allowed Glycine 0 C--N 1.345 1.081 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -105.97 102.8 12.21 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.486 0.714 . . . . 0.0 110.434 -177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.616 ' HB3' ' SG ' ' A' ' 52' ' ' CYS . 6.8 tpp180 -77.21 136.1 38.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 163.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 23' ' ' PRO . 93.1 t -143.36 112.26 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 170.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -110.17 83.2 1.72 Allowed 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 166.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 31.1 tp -75.55 72.93 2.56 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.843 0.83 . . . . 0.0 110.847 -174.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.7 m -142.56 163.88 17.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 C-N-CA 126.264 1.826 . . . . 0.0 107.546 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.26 103.89 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 110.65 -15.95 29.01 Favored Glycine 0 C--N 1.343 0.928 0 O-C-N 124.023 0.827 . . . . 0.0 112.954 -176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -71.13 151.3 48.61 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 117.17 0.485 . . . . 0.0 112.927 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.25 152.76 19.92 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.209 0.604 . . . . 0.0 110.392 -172.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -130.01 153.66 48.19 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.291 0.636 . . . . 0.0 109.418 170.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 42' ' ' ARG . 31.3 p -153.47 106.57 2.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 172.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -94.62 86.86 4.9 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 65' ' ' ASP . 72.6 m-70 -82.22 111.13 18.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.62 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.547 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 44.4 ttp -120.16 145.04 47.33 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.306 1.043 . . . . 0.0 108.263 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -146.85 153.64 40.39 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 123.228 0.611 . . . . 0.0 109.922 -175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.0 150.9 47.89 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.127 0.571 . . . . 0.0 110.448 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 61.3 pttt -71.34 -20.48 62.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.785 0.434 . . . . 0.0 110.167 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.82 -26.92 63.52 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.402 1.081 . . . . 0.0 109.842 174.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 117.39 -68.59 0.31 Allowed Glycine 0 C--N 1.357 1.707 0 N-CA-C 113.976 0.35 . . . . 0.0 113.976 169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.8 t -58.79 -44.77 90.83 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 124.143 0.977 . . . . 0.0 113.14 -165.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.79 125.33 26.41 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.073 0.549 . . . . 0.0 110.222 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.09 144.9 13.73 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -154.75 141.62 19.13 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.232 1.013 . . . . 0.0 108.615 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' HB3' ' HA ' ' A' ' 54' ' ' HIS . 7.1 p-10 -139.2 154.83 48.1 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -173.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -118.49 92.17 3.75 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.177 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' CYS . 81.6 p -89.56 158.01 17.83 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.703 -0.481 . . . . 0.0 109.703 175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.18 -162.62 35.89 Favored Glycine 0 C--N 1.342 0.866 0 N-CA-C 112.69 -0.164 . . . . 0.0 112.69 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 75.5 m -145.84 136.71 24.45 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.761 0.824 . . . . 0.0 110.626 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -69.05 112.78 5.89 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.828 0.851 . . . . 0.0 110.05 174.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.2 p -92.51 -16.62 25.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.762 0.825 . . . . 0.0 112.2 -172.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 38.5 ttm180 -166.95 117.8 0.91 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.5 t -113.38 107.93 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.658 ' HB2' ' HB2' ' A' ' 78' ' ' ARG . 28.0 mm-40 -110.75 61.62 0.61 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.906 0.882 . . . . 0.0 109.483 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.16 133.11 94.6 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.516 0.727 . . . . 0.0 111.316 -173.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 27.9 Cg_endo -100.14 11.94 23.81 Favored 'Cis proline' 0 C--N 1.381 2.266 0 CA-C-N 120.195 1.105 . . . . 0.0 114.251 -0.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.526 HG22 ' HG3' ' A' ' 78' ' ' ARG . 39.3 m -75.66 -44.69 41.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.687 0.795 . . . . 0.0 112.6 -171.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.658 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 62.4 mtt180 -144.53 159.86 42.08 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.359 0.664 . . . . 0.0 111.055 -170.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 20' ' ' TRP . 30.9 tp -144.83 145.71 31.75 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.097 169.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.6 m -138.52 137.89 37.51 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 123.908 0.883 . . . . 0.0 108.79 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -159.36 137.6 10.5 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.52 0.728 . . . . 0.0 109.194 176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 59.0 t -110.14 136.3 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 61.3 mtt -92.1 171.72 8.91 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.288 0.635 . . . . 0.0 110.606 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -66.43 -22.6 66.22 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.196 0.999 . . . . 0.0 113.32 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -89.43 9.01 27.94 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.303 0.641 . . . . 0.0 110.53 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 84.33 0.94 89.52 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 113.242 178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.425 ' HA ' ' HB2' ' A' ' 107' ' ' ASP . 24.3 mmt180 -77.56 108.73 10.96 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -177.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 106' ' ' PHE . 33.7 mt-10 -78.56 132.97 37.37 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 124.104 0.877 . . . . 0.0 108.885 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 105' ' ' THR . 18.4 t -122.18 109.71 25.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 O-C-N 124.066 0.854 . . . . 0.0 108.737 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -119.32 106.53 12.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.4 t -103.32 114.7 43.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.99 0.916 . . . . 0.0 110.916 -172.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -99.05 124.58 44.15 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.642 1.177 . . . . 0.0 108.971 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -105.06 96.65 6.67 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -90.23 126.71 35.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.351 0.66 . . . . 0.0 109.374 178.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.3 t -77.11 133.53 38.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.248 0.619 . . . . 0.0 110.183 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.52 151.18 59.43 Favored Pre-proline 0 N--CA 1.486 1.341 0 C-N-CA 123.311 0.644 . . . . 0.0 110.932 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.14 -15.43 44.0 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.24 2.627 . . . . 0.0 113.56 176.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -135.8 32.08 2.57 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-O 119.829 -0.428 . . . . 0.0 112.927 177.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 155.16 -145.76 13.09 Favored Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.392 0.517 . . . . 0.0 114.392 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.0 m -147.93 116.16 6.54 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.579 1.152 . . . . 0.0 108.549 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 11.1 t90 -82.77 92.95 7.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.257 0.551 . . . . 0.0 109.656 178.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.1 t -89.54 125.68 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.149 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -125.17 120.36 31.12 Favored 'General case' 0 C--O 1.212 -0.894 0 C-N-CA 124.785 1.234 . . . . 0.0 107.843 -169.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.432 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.7 tt0 -113.54 109.4 18.57 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.541 0.61 . . . . 0.0 109.879 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 25.5 m -98.28 128.1 44.55 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.449 ' HA ' ' O ' ' A' ' 88' ' ' GLU . 43.8 p90 -138.46 143.8 39.79 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.349 0.66 . . . . 0.0 109.395 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.425 ' HB2' ' HA ' ' A' ' 87' ' ' ARG . 3.5 m-20 -66.27 137.63 57.09 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 123.08 0.237 . . . . 0.0 110.924 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.19 126.22 30.6 Favored 'General case' 0 C--N 1.349 0.569 0 C-N-CA 123.494 0.718 . . . . 0.0 109.924 176.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.47 158.97 16.19 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.523 0.729 . . . . 0.0 110.431 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 10.3 t -87.81 -13.3 42.56 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -168.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.9 t -68.16 -43.32 78.49 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.894 0.478 . . . . 0.0 110.695 -173.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -114.3 172.64 6.89 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.302 0.641 . . . . 0.0 109.803 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -82.28 140.38 45.49 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.081 0.553 . . . . 0.0 109.67 176.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.97 -35.33 60.29 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.909 3.072 . . . . 0.0 114.692 -174.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.44 -47.18 86.47 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.374 0.67 . . . . 0.0 112.448 178.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.11 -39.24 93.62 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.949 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -62.29 -49.15 76.81 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.349 177.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.448 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.6 tt0 -57.28 -42.76 82.26 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.664 0.786 . . . . 0.0 110.739 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.35 -33.52 65.14 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.902 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -70.07 -50.23 29.69 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 116.427 -0.352 . . . . 0.0 112.529 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.6 m95 -65.44 -37.5 87.09 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.051 0.54 . . . . 0.0 110.593 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -63.41 -34.57 78.03 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.632 0.373 . . . . 0.0 110.137 175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.71 -36.66 80.05 Favored Glycine 0 C--N 1.345 1.063 0 O-C-N 123.475 0.484 . . . . 0.0 112.301 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.51 HG21 HD22 ' A' ' 30' ' ' ASN . 50.7 mt -80.95 -39.92 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 123.985 0.914 . . . . 0.0 111.714 -178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 60.7 tp -71.67 -40.67 69.46 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-O 121.543 0.687 . . . . 0.0 110.341 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -68.54 -29.76 68.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.266 1.026 . . . . 0.0 110.589 173.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -70.06 -32.44 70.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 122.505 0.322 . . . . 0.0 110.461 173.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HG23 ' A' ' 132' ' ' VAL . 43.3 t80 -66.61 -48.27 70.03 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.057 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -59.76 -44.65 93.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.611 0.764 . . . . 0.0 110.977 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -62.61 -37.84 87.85 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.84 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -66.18 -40.39 90.42 Favored 'General case' 0 CA--C 1.539 0.547 0 O-C-N 123.875 0.734 . . . . 0.0 110.936 178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.588 HG13 HD12 ' A' ' 137' ' ' LEU . 74.8 t -63.7 -35.83 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 122.848 0.459 . . . . 0.0 110.402 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -83.68 -23.03 31.91 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.498 0.719 . . . . 0.0 112.026 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.75 -43.47 22.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.626 0.727 . . . . 0.0 110.169 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -79.2 -32.14 43.97 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.164 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 88.61 -53.31 4.05 Favored Glycine 0 C--N 1.342 0.883 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.828 -174.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.588 HD12 HG13 ' A' ' 132' ' ' VAL . 82.8 mt 60.7 67.12 0.85 Allowed 'General case' 0 C--N 1.35 0.613 0 C-N-CA 125.066 1.347 . . . . 0.0 109.815 -175.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -62.0 128.52 36.56 Favored 'General case' 0 C--N 1.352 0.708 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.024 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.9 78.47 0.63 Allowed 'General case' 0 CA--C 1.547 0.84 0 O-C-N 124.106 0.879 . . . . 0.0 110.165 176.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -75.32 73.35 2.4 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 122.495 1.14 . . . . 0.0 109.977 -174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -173.54 -23.78 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.998 -168.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -62.37 94.1 0.06 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.603 0.761 . . . . 0.0 110.761 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -117.32 -15.32 10.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.117 171.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.881 0.872 . . . . 0.0 109.022 171.724 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 26.3 ptt? . . . . . 0 N--CA 1.47 0.567 0 CA-C-O 120.353 0.12 . . . . 0.0 110.698 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -132.1 159.3 39.29 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.224 1.009 . . . . 0.0 109.742 175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.7 mt -126.33 141.12 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 123.793 0.837 . . . . 0.0 109.687 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 32.6 m -106.12 124.22 49.23 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.068 0.947 . . . . 0.0 110.42 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.6 pt -123.72 160.38 27.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.49 1.116 . . . . 0.0 109.023 168.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -146.19 168.79 20.15 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.056 0.542 . . . . 0.0 111.39 -176.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -164.01 122.39 1.87 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.663 1.185 . . . . 0.0 109.672 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -93.54 83.82 4.58 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 121.728 0.775 . . . . 0.0 109.127 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 10.4 mt -79.79 123.62 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -81.98 63.95 6.44 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.886 0.85 . . . . 0.0 110.133 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -141.99 159.3 42.5 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.091 -169.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -64.25 135.32 56.13 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.637 0.775 . . . . 0.0 110.157 170.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.5 tt -61.86 -26.26 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 123.432 0.693 . . . . 0.0 110.386 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.65 -48.68 78.29 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 123.525 0.73 . . . . 0.0 110.853 174.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.61 -29.85 59.36 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.499 0.719 . . . . 0.0 111.9 -176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.51 -53.91 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.292 0.637 . . . . 0.0 109.491 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.449 ' CZ2' HD21 ' A' ' 45' ' ' LEU . 53.2 t-105 -62.76 -35.64 80.48 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.881 177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 73.6 t90 -65.06 -46.12 82.52 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.572 0.749 . . . . 0.0 110.696 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.7 71.82 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.86 0.464 . . . . 0.0 111.423 176.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -77.61 -35.27 52.97 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.095 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -83.74 -37.98 21.97 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.324 0.649 . . . . 0.0 112.08 -172.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -76.19 124.01 88.13 Favored Pre-proline 0 N--CA 1.47 0.55 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.829 -171.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.3 -37.57 94.57 Favored 'Trans proline' 0 C--N 1.379 2.152 0 C-N-CA 123.018 2.478 . . . . 0.0 113.388 -175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -72.02 -40.73 68.25 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 122.687 0.395 . . . . 0.0 110.419 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 75.2 m -67.04 -50.09 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.203 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 19.8 tt -63.51 -32.96 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 C-N-CA 123.494 0.718 . . . . 0.0 110.885 -179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -66.3 -22.26 66.28 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -90.41 -24.12 20.85 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.518 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 53.4 p-90 -104.57 -26.51 12.32 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -77.67 74.4 4.23 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 121.788 0.804 . . . . 0.0 109.492 -177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.29 145.36 31.96 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.818 -173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -82.34 -21.09 36.13 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.114 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.7 t -163.81 174.17 11.88 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.757 1.223 . . . . 0.0 109.028 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.8 p -69.1 -14.79 63.21 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.321 0.648 . . . . 0.0 111.095 174.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.93 -20.01 46.7 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.22 0.608 . . . . 0.0 110.36 175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -95.93 130.32 42.93 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.336 0.654 . . . . 0.0 109.341 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.33 128.16 29.22 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.5 m -75.61 101.19 4.85 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -86.24 -25.33 25.62 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.877 -173.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -119.11 89.33 0.46 Allowed Glycine 0 C--N 1.344 1.027 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 170.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.8 p -112.57 117.14 31.49 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.976 0.51 . . . . 0.0 110.859 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -141.86 135.75 29.85 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 172.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -120.32 114.41 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -103.57 72.78 1.15 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' CZ2' ' A' ' 17' ' ' TRP . 53.0 tp -83.74 85.02 7.35 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.885 0.474 . . . . 0.0 112.08 -166.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.5 m -139.25 167.78 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.8 1.24 . . . . 0.0 108.833 169.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG13 ' HA ' ' A' ' 72' ' ' ARG . 29.4 t -73.71 104.5 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.06 14.51 36.09 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.23 -161.46 35.5 Favored Glycine 0 C--N 1.349 1.295 0 C-N-CA 123.13 0.395 . . . . 0.0 112.794 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -153.61 149.29 27.44 Favored 'General case' 0 C--O 1.208 -1.121 0 C-N-CA 122.733 0.413 . . . . 0.0 110.837 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -121.16 134.0 55.21 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 168.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 67' ' ' THR . 75.8 m -122.62 106.82 11.32 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -123.4 89.75 3.16 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.556 0.342 . . . . 0.0 110.652 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -76.76 111.25 12.08 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 72.3 mtp -89.4 131.72 35.32 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.81 124.91 21.52 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.02 0.528 . . . . 0.0 110.565 -175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -71.2 152.37 43.43 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.129 0.572 . . . . 0.0 110.0 174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.6 mmtp -63.09 -22.31 66.77 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.692 0.797 . . . . 0.0 113.124 -174.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -78.18 -27.22 47.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.096 0.407 . . . . 0.0 110.155 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.25 -1.24 82.26 Favored Glycine 0 C--N 1.346 1.124 0 N-CA-C 114.625 0.61 . . . . 0.0 114.625 169.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.0 p -86.75 -40.03 15.4 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 117.693 0.746 . . . . 0.0 110.209 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -90.8 123.33 34.27 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.861 0.864 . . . . 0.0 109.308 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -156.11 115.25 0.65 Allowed Glycine 0 C--N 1.343 0.929 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -95.3 173.3 7.61 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.826 0.85 . . . . 0.0 111.272 177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -133.46 116.45 16.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.935 0.894 . . . . 0.0 109.684 178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -108.23 74.35 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.552 1.141 . . . . 0.0 108.358 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 52' ' ' CYS . 61.3 p -110.76 148.57 32.05 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.433 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.05 -178.38 46.73 Favored Glycine 0 C--N 1.339 0.739 0 CA-C-O 119.934 -0.37 . . . . 0.0 112.531 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 m -116.6 128.71 55.65 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.02 0.928 . . . . 0.0 111.187 -174.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.457 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 73.7 m-85 -70.79 116.76 11.46 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.1 p -87.38 -23.35 24.59 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.274 0.63 . . . . 0.0 111.58 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.538 ' HA ' HG13 ' A' ' 47' ' ' VAL . 17.3 ttm180 -161.69 144.28 11.89 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.804 0.842 . . . . 0.0 109.066 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG22 ' A' ' 47' ' ' VAL . 90.3 t -133.48 105.98 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 177.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.685 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 43.1 mt-10 -109.23 76.16 0.99 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -71.91 139.16 82.59 Favored Pre-proline 0 CA--C 1.547 0.829 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.484 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -98.69 14.33 29.14 Favored 'Cis proline' 0 C--N 1.375 1.963 0 CA-C-N 119.088 0.71 . . . . 0.0 112.752 -4.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' HD11 ' A' ' 13' ' ' ILE . 10.5 t -95.77 -10.1 29.98 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -163.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.685 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -164.79 143.48 6.76 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.268 0.485 . . . . 0.0 110.291 -173.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.2 tp -144.19 129.06 18.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.196 0.598 . . . . 0.0 109.765 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.514 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 5.0 m -116.75 131.86 56.84 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.457 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 11.2 p90 -157.46 162.16 38.92 Favored 'General case' 0 C--O 1.225 -0.229 0 C-N-CA 123.04 0.536 . . . . 0.0 110.376 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.57 144.0 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 44.7 tpp -76.5 150.5 36.62 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.12 -14.15 45.13 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.243 0.617 . . . . 0.0 112.21 174.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -77.91 -21.66 50.83 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.006 0.923 . . . . 0.0 110.834 173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 105.74 -7.44 42.08 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.993 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.2 mmp_? -71.12 107.64 4.26 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-N 117.47 0.635 . . . . 0.0 109.607 172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -74.64 144.01 44.04 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -140.92 116.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -122.33 107.54 12.21 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.33 114.68 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 123.123 0.569 . . . . 0.0 109.82 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 29.1 pt20 -99.79 133.99 43.33 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -109.98 98.95 8.14 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -88.47 111.63 22.03 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 52.0 p -66.78 122.43 17.66 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.418 ' HG2' ' O ' ' A' ' 94' ' ' ALA . 32.5 mm-40 -124.47 155.43 68.94 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.38 1.072 . . . . 0.0 111.33 -167.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -62.2 -25.53 77.04 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.708 2.272 . . . . 0.0 112.036 173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -97.03 -8.27 56.9 Favored Glycine 0 C--N 1.347 1.179 0 CA-C-N 115.84 -0.618 . . . . 0.0 114.164 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.68 -111.44 0.49 Allowed Glycine 0 C--N 1.346 1.114 0 CA-C-N 117.642 0.721 . . . . 0.0 112.66 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 67.4 m -149.17 113.42 5.23 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.689 1.196 . . . . 0.0 108.723 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 30.8 t90 -82.89 97.45 8.67 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.466 0.65 . . . . 0.0 109.716 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 65.3 t -89.65 116.21 30.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.635 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -124.35 113.99 18.94 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -100.56 132.87 45.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.851 0.861 . . . . 0.0 109.324 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 26.7 m -122.95 111.2 16.33 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.0 p90 -120.14 131.7 55.13 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -68.54 120.31 14.38 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.659 1.184 . . . . 0.0 109.149 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -94.29 163.07 13.59 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.405 0.682 . . . . 0.0 110.926 -172.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.37 138.72 39.74 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.819 -176.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.4 p -85.16 -12.56 52.47 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.3 t -100.79 16.95 23.38 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.587 0.708 . . . . 0.0 109.578 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 31.5 m170 -136.12 134.66 38.56 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.8 p -61.48 120.99 60.72 Favored Pre-proline 0 CA--C 1.558 1.27 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.46 -41.85 73.97 Favored 'Trans proline' 0 C--N 1.387 2.576 0 C-N-CA 123.655 2.904 . . . . 0.0 113.351 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.66 -34.28 76.76 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 122.856 0.462 . . . . 0.0 111.946 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -71.05 -40.69 71.51 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.04 0.536 . . . . 0.0 110.398 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -63.33 -43.49 97.63 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.432 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.53 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.0 tt0 -60.92 -41.24 95.77 Favored 'General case' 0 C--O 1.211 -0.972 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.233 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.4 -31.14 72.09 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.115 0.566 . . . . 0.0 110.977 177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.55 -58.41 7.82 Favored Glycine 0 C--N 1.348 1.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 112.397 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -69.21 -36.95 77.8 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.2 0.6 . . . . 0.0 111.934 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.417 HE22 HD23 ' A' ' 125' ' ' LEU . 22.4 tp60 -63.2 -31.0 72.04 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 122.883 0.473 . . . . 0.0 109.94 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -65.56 -46.33 85.29 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.115 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.59 -35.22 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 123.448 0.699 . . . . 0.0 110.373 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.417 HD23 HE22 ' A' ' 122' ' ' GLN . 53.0 tp -72.51 -34.99 68.01 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.822 0.849 . . . . 0.0 110.101 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -63.3 -41.53 98.96 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.076 0.551 . . . . 0.0 110.312 173.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -63.73 -39.06 93.37 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 122.895 0.478 . . . . 0.0 109.959 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.458 ' O ' HG23 ' A' ' 132' ' ' VAL . 24.5 t80 -60.4 -63.14 1.4 Allowed 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.811 0.695 . . . . 0.0 110.438 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -62.31 -37.36 85.29 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.93 0.492 . . . . 0.0 111.253 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -61.92 -48.18 81.58 Favored 'General case' 0 N--CA 1.475 0.782 0 O-C-N 123.455 0.472 . . . . 0.0 110.036 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -58.97 -49.28 78.46 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.034 0.933 . . . . 0.0 111.349 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.569 HG13 HD12 ' A' ' 137' ' ' LEU . 89.4 t -61.34 -41.49 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.366 0.666 . . . . 0.0 111.115 -175.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -83.22 -25.86 31.33 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.083 -177.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -86.34 -28.63 23.54 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.06 0.544 . . . . 0.0 110.419 -178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.13 -32.93 69.6 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.552 0.741 . . . . 0.0 109.848 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 140' ' ' HIS . . . 79.86 56.39 3.32 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.569 HD12 HG13 ' A' ' 132' ' ' VAL . 77.4 mt -81.95 -12.52 58.33 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 122.883 0.473 . . . . 0.0 111.325 178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -70.87 87.57 0.72 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.311 1.044 . . . . 0.0 110.939 -174.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 70.63 -11.92 0.58 Allowed 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 124.358 1.063 . . . . 0.0 113.014 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 136' ' ' GLY . 73.9 m-70 -69.3 93.28 0.63 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -163.42 85.13 0.49 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -123.21 100.23 6.75 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.869 0.868 . . . . 0.0 110.484 -174.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -177.86 -44.65 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.448 0.699 . . . . 0.0 110.219 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.1 m-70 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 125.836 1.654 . . . . 0.0 110.036 -173.811 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -109.57 125.47 52.58 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 68.0 mt -98.48 112.92 31.74 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.6 p -97.26 119.47 35.83 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.387 0.675 . . . . 0.0 109.866 175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.404 ' HB ' HE21 ' A' ' 122' ' ' GLN . 35.4 pt -115.37 164.64 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 125.102 1.361 . . . . 0.0 108.972 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -134.84 173.82 11.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.18 123.03 1.35 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.588 1.155 . . . . 0.0 109.24 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -91.8 100.64 13.29 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 34.6 mt -97.65 115.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 122.935 0.494 . . . . 0.0 109.917 -177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -78.87 75.73 5.38 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 121.99 0.9 . . . . 0.0 109.252 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -169.88 159.06 7.65 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.074 -1.421 . . . . 0.0 108.314 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 16' ' ' VAL . 22.9 mm-40 -67.16 143.22 56.72 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.986 0.914 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.465 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.8 tt -56.91 -34.28 43.82 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.147 0 C-N-CA 124.258 1.023 . . . . 0.0 112.583 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' HG2' ' HG3' ' A' ' 76' ' ' PRO . 37.2 mt-10 -71.85 -41.31 68.25 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.74 0.416 . . . . 0.0 110.433 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.05 -33.46 71.97 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.165 0.586 . . . . 0.0 110.762 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 12' ' ' GLU . 76.1 t -64.1 -48.37 86.14 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.828 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -61.52 -37.21 82.89 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.782 0.833 . . . . 0.0 111.08 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -60.85 -50.92 71.5 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.696 0.798 . . . . 0.0 109.967 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.87 -32.42 74.12 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.533 0.733 . . . . 0.0 111.492 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 58.8 t-105 -67.87 -37.86 82.36 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.03 0.532 . . . . 0.0 110.824 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -88.75 -34.57 17.08 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.515 0.726 . . . . 0.0 112.368 -173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 26' ' ' ILE . 19.4 t70 -66.5 115.17 21.49 Favored Pre-proline 0 N--CA 1.474 0.745 0 CA-C-O 118.558 -0.734 . . . . 0.0 111.04 -170.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.82 -31.23 87.99 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 123.305 2.67 . . . . 0.0 113.716 -173.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -79.75 -31.92 41.01 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.818 0.447 . . . . 0.0 110.245 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.0 m -67.46 -46.15 73.87 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.966 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 22' ' ' ASP . 78.0 mt -56.63 -37.24 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.894 1.278 . . . . 0.0 111.023 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.14 -12.37 5.01 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.78 0.832 . . . . 0.0 112.774 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -105.95 -52.37 2.82 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.41 1.084 . . . . 0.0 111.548 -178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 57.4 p-90 -90.02 -22.83 21.68 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -171.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.33 -5.38 44.45 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 122.622 0.369 . . . . 0.0 111.867 -173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.87 99.97 0.06 Allowed 'General case' 0 C--N 1.351 0.656 0 C-N-CA 123.215 0.606 . . . . 0.0 109.863 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.55 -36.5 83.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.609 0.763 . . . . 0.0 110.249 177.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 87.8 p -139.68 163.78 31.67 Favored 'General case' 0 C--O 1.242 0.708 0 C-N-CA 124.226 1.01 . . . . 0.0 108.768 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 49.0 m -72.6 -14.36 61.59 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.229 0.611 . . . . 0.0 111.841 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -87.54 -21.94 25.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.393 0.677 . . . . 0.0 110.935 175.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 22.8 m95 -109.48 108.45 18.95 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.815 0.817 . . . . 0.0 108.938 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -101.08 133.01 46.25 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.097 177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.2 m -74.41 113.3 11.49 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.2 p -85.25 -7.7 58.89 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.454 1.101 . . . . 0.0 111.981 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 166.36 152.32 7.22 Favored Glycine 0 C--N 1.348 1.213 0 CA-C-O 120.002 -0.332 . . . . 0.0 112.351 174.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 73.0 m -136.75 104.61 5.57 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.404 0.682 . . . . 0.0 111.44 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -88.51 103.76 16.18 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -115.11 110.63 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.29 0.636 . . . . 0.0 109.478 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -98.23 79.61 2.58 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 172.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.6 tp -74.47 74.5 1.93 Allowed 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.043 -173.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 23.6 m -143.32 161.77 16.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 C-N-CA 125.19 1.396 . . . . 0.0 108.416 177.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 54.3 t -71.21 114.32 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 96.84 -9.29 65.99 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.557 -175.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.24 171.1 51.58 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 173.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 34.9 mtm180 -124.4 172.21 9.32 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.694 0.397 . . . . 0.0 110.707 -176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -136.08 153.81 51.21 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 170.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 41' ' ' SER . 74.7 m -141.4 115.81 9.5 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 85.6 m-70 -98.94 98.97 9.97 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 171.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 m170 -71.03 107.49 4.13 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 78.5 mtp -121.14 135.64 55.13 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -148.88 155.96 41.63 Favored 'General case' 0 N--CA 1.463 0.185 0 O-C-N 123.657 0.598 . . . . 0.0 110.693 -175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.62 159.01 30.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.989 0.915 . . . . 0.0 110.296 171.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -65.13 -41.04 95.18 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.246 0.618 . . . . 0.0 111.658 -176.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -68.15 -25.78 65.44 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.162 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.05 14.44 77.11 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.166 -176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.4 t -67.27 -29.05 68.55 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.493 0.717 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -130.03 152.13 49.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.363 1.065 . . . . 0.0 109.314 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 175.83 128.94 1.16 Allowed Glycine 0 C--N 1.341 0.856 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 174.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 99.9 m-85 -136.11 167.28 21.55 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-O 121.783 0.801 . . . . 0.0 111.209 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.89 110.45 22.34 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 114.07 -1.423 . . . . 0.0 109.253 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.579 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 13.0 m-85 -89.61 77.95 7.1 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.1 t -123.21 160.9 25.58 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 113.467 -1.697 . . . . 0.0 110.806 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -179.0 169.76 41.26 Favored Glycine 0 C--N 1.34 0.766 0 O-C-N 123.905 0.753 . . . . 0.0 112.468 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.4 m -107.24 126.78 52.85 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.788 0.435 . . . . 0.0 110.326 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -64.33 115.34 4.98 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.952 0.901 . . . . 0.0 110.782 174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.9 p -87.9 -33.57 18.46 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.614 0.766 . . . . 0.0 110.855 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 44.2 ttm105 -152.78 117.7 5.12 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.2 114.58 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.06 85.91 2.43 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 173.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -72.45 137.23 80.87 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.165 -177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 46.8 Cg_endo -99.45 17.59 25.37 Favored 'Cis proline' 0 C--N 1.378 2.1 0 CA-C-N 119.508 0.86 . . . . 0.0 113.009 -6.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' HD11 ' A' ' 13' ' ' ILE . 7.9 m -79.35 -32.97 43.37 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.658 0.783 . . . . 0.0 112.729 -164.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -163.73 148.89 10.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.706 0.402 . . . . 0.0 110.864 -174.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.38 127.22 31.19 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.532 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -127.16 130.05 49.04 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -176.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -154.98 158.71 39.6 Favored 'General case' 0 C--O 1.222 -0.353 0 C-N-CA 123.321 0.649 . . . . 0.0 110.337 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 88' ' ' GLU . 56.2 t -111.57 132.83 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 173.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 27.4 ttt -79.74 144.18 33.86 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.58 -7.41 14.72 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -170.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -83.64 1.28 43.11 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 118.046 0.385 . . . . 0.0 111.103 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.29 28.82 Favored Glycine 0 C--N 1.35 1.318 0 C-N-CA 123.66 0.647 . . . . 0.0 113.364 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.472 HH22 ' HZ2' ' A' ' 121' ' ' TRP . 57.7 mtm180 -77.64 143.58 38.1 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 122.795 0.438 . . . . 0.0 111.44 -176.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 82' ' ' VAL . 42.7 mt-10 -92.17 136.78 32.91 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.94 0.496 . . . . 0.0 109.798 173.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 35.9 t -129.78 119.81 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.901 0.88 . . . . 0.0 109.697 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -126.67 130.29 50.12 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 t -117.79 110.78 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.019 0 C-N-CA 124.069 0.948 . . . . 0.0 109.345 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -98.17 122.42 41.3 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.885 0.874 . . . . 0.0 109.091 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -102.49 100.74 10.87 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.93 105.61 15.49 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.185 0.594 . . . . 0.0 110.576 -170.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.3 t -56.5 136.11 54.23 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.547 0.739 . . . . 0.0 111.07 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.1 162.01 60.14 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.022 0.929 . . . . 0.0 109.886 -177.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -63.04 104.54 0.4 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.151 1.901 . . . . 0.0 110.771 167.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.05 -13.6 12.67 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-O 119.599 -0.556 . . . . 0.0 113.94 177.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 174.82 -143.12 6.65 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 117.836 0.818 . . . . 0.0 113.567 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.2 m -134.11 111.92 10.73 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 125.027 1.331 . . . . 0.0 107.994 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -82.76 96.85 8.31 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.404 0.621 . . . . 0.0 109.351 178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 60.2 t -87.32 139.66 16.99 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.852 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -129.88 105.62 8.12 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.548 1.139 . . . . 0.0 108.657 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.509 ' HB3' HD22 ' A' ' 125' ' ' LEU . 35.6 tt0 -89.01 136.96 32.74 Favored 'General case' 0 C--O 1.218 -0.58 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 43.1 m -133.98 136.39 44.1 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.4 147.5 36.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 87' ' ' ARG . 23.1 t70 -72.28 150.8 43.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -81.59 131.22 35.26 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.765 0.426 . . . . 0.0 109.932 -176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -85.25 129.5 34.79 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 14.1 t -72.9 -19.78 61.2 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -166.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 29.3 t -90.06 -7.72 53.18 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 118.078 0.399 . . . . 0.0 111.789 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -120.77 152.52 38.22 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.916 0.486 . . . . 0.0 110.091 175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 37.7 p -71.02 135.9 85.04 Favored Pre-proline 0 CA--C 1.547 0.865 0 C-N-CA 122.967 0.507 . . . . 0.0 109.926 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -54.54 -42.93 63.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.228 2.619 . . . . 0.0 113.605 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.93 -48.65 80.72 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.221 0.609 . . . . 0.0 112.003 178.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -64.8 -40.02 94.55 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.571 0.349 . . . . 0.0 110.822 -178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -62.29 -44.43 96.54 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.005 176.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -57.36 -43.5 83.55 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 123.716 0.806 . . . . 0.0 110.098 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -71.48 -32.21 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.591 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -71.97 -48.05 28.71 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.344 -177.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.472 ' HZ2' HH22 ' A' ' 87' ' ' ARG . 41.3 m95 -71.12 -37.01 72.33 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.369 0.668 . . . . 0.0 110.814 177.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.404 HE21 ' HB ' ' A' ' 5' ' ' ILE . 8.2 tp-100 -65.46 -27.79 68.76 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 123.39 0.432 . . . . 0.0 109.857 173.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.61 -45.2 96.8 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 171.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 55.7 mt -72.07 -40.89 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.747 0.819 . . . . 0.0 110.87 -178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.509 HD22 ' HB3' ' A' ' 104' ' ' GLU . 40.1 tp -74.67 -38.15 62.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.902 0.881 . . . . 0.0 111.017 -175.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 29.9 t70 -72.08 -33.8 68.19 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.24 0.616 . . . . 0.0 110.451 173.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -68.45 -34.06 75.3 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.439 ' O ' HG23 ' A' ' 132' ' ' VAL . 38.2 t80 -65.71 -48.18 72.87 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.861 173.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 41.3 tttp -52.53 -60.54 3.12 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.544 0.738 . . . . 0.0 110.411 177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 18.6 mtm-85 -60.92 -35.8 77.63 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.177 0.923 . . . . 0.0 111.068 -173.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -56.01 -54.93 38.98 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.256 173.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 137' ' ' LEU . 97.8 t -62.94 -33.55 61.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 O-C-N 124.2 0.937 . . . . 0.0 110.843 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 63.7 mm-40 -62.2 -53.58 53.23 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.804 0.812 . . . . 0.0 110.413 177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -91.97 1.42 57.2 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.286 -169.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.96 -34.89 76.07 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.987 0.515 . . . . 0.0 110.425 177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 79.98 41.59 12.12 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.095 -176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.61 HD12 HG13 ' A' ' 132' ' ' VAL . 79.8 mt -73.03 5.11 3.58 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.016 0.926 . . . . 0.0 111.81 176.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -46.46 115.49 1.04 Allowed 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.685 1.194 . . . . 0.0 111.941 169.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -124.89 86.73 2.6 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 121.768 0.794 . . . . 0.0 110.965 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -163.17 94.33 0.82 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -70.95 157.96 37.3 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 120.748 0.309 . . . . 0.0 110.839 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -75.05 171.4 14.18 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.385 0.674 . . . . 0.0 110.253 177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -62.33 134.27 56.24 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.146 0.578 . . . . 0.0 110.622 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 CA--C 1.547 0.851 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.294 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -84.94 109.83 18.44 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.4 HD11 ' HB3' ' A' ' 114' ' ' PRO . 68.1 mt -84.64 111.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.0 t -102.11 109.64 21.4 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 104' ' ' GLU . 29.4 pt -116.16 172.34 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.439 1.096 . . . . 0.0 109.643 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.6 166.7 24.42 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -157.09 112.2 2.8 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.084 1.353 . . . . 0.0 107.366 171.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -96.1 106.23 18.38 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 29.0 mt -89.86 130.84 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.545 1.138 . . . . 0.0 109.33 -174.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -80.64 62.92 4.88 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.502 0.721 . . . . 0.0 109.679 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.9 tp-100 -166.69 158.51 13.16 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.251 -168.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -73.76 146.05 44.62 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.478 1.111 . . . . 0.0 110.736 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 tt -57.62 -25.75 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 124.204 1.002 . . . . 0.0 111.524 -178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -61.32 -58.33 8.7 Favored 'General case' 0 C--N 1.348 0.517 0 C-N-CA 123.744 0.818 . . . . 0.0 109.981 175.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' HA ' ' CE3' ' A' ' 18' ' ' TRP . . . -62.88 -41.15 99.29 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.153 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.0 t -56.08 -46.56 80.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.659 175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -64.89 -42.72 94.55 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 119.097 -0.478 . . . . 0.0 112.012 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.492 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 26.9 m0 -57.41 -48.44 79.1 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.301 0.572 . . . . 0.0 110.156 -178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -64.93 -33.36 75.84 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.64 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.495 ' HE1' HD23 ' A' ' 79' ' ' LEU . 51.8 t-105 -79.09 -25.91 43.02 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.682 0.393 . . . . 0.0 111.73 178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -96.76 -36.65 10.58 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -171.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.763 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.7 t70 -79.67 117.37 66.91 Favored Pre-proline 0 N--CA 1.489 1.476 0 CA-C-O 118.722 -0.656 . . . . 0.0 110.693 -171.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.37 -41.35 43.33 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.72 2.947 . . . . 0.0 114.611 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -67.91 -46.58 71.17 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.514 0.726 . . . . 0.0 111.18 -175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 31.6 p -69.71 -34.09 73.41 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 123.31 0.381 . . . . 0.0 110.517 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.559 ' HA ' ' NE1' ' A' ' 29' ' ' TRP . 76.7 mt -62.1 -45.33 98.98 Favored 'Isoleucine or valine' 0 C--N 1.36 1.023 0 C-N-CA 123.324 0.65 . . . . 0.0 110.535 175.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -58.58 -12.32 3.95 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.052 0.941 . . . . 0.0 113.054 -175.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -92.96 -35.31 13.37 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.107 0.963 . . . . 0.0 111.817 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.559 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 41.8 p-90 -102.41 -19.53 14.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -176.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -69.8 -23.83 63.39 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.66 0.663 . . . . 0.0 112.565 -173.341 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.561 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -53.04 112.74 0.91 Allowed 'General case' 0 C--N 1.358 0.94 0 C-N-CA 123.935 0.894 . . . . 0.0 111.836 -170.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.11 -24.98 67.46 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 123.933 0.77 . . . . 0.0 111.197 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.0 t -141.25 146.8 37.3 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.269 1.028 . . . . 0.0 109.479 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.8 m -70.6 -21.91 62.61 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.529 0.732 . . . . 0.0 111.066 174.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.37 -12.45 61.13 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.493 1.117 . . . . 0.0 110.892 175.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -114.39 165.79 12.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.382 1.073 . . . . 0.0 108.61 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -153.75 145.66 23.54 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.729 0.812 . . . . 0.0 109.78 -177.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 49.8 m -86.82 105.06 16.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.072 0.463 . . . . 0.0 109.967 -178.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.8 m -83.71 -17.8 40.1 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.52 1.128 . . . . 0.0 111.315 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.9 97.45 0.18 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.6 t -108.95 105.68 15.32 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.8 ttm180 -122.35 135.35 54.69 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.464 1.106 . . . . 0.0 108.521 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 93.5 t -123.59 117.55 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 123.754 0.822 . . . . 0.0 109.148 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -106.74 83.99 1.93 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 tp -70.29 74.01 0.5 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.145 0.978 . . . . 0.0 110.818 -174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.2 m -143.42 140.61 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 125.401 1.48 . . . . 0.0 107.855 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.7 t -71.66 104.0 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 122.45 -19.2 8.11 Favored Glycine 0 C--N 1.343 0.919 0 C-N-CA 123.768 0.699 . . . . 0.0 111.818 -175.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.71 -178.45 40.88 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 174.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 60.8 mtt180 -128.21 169.77 13.78 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.591 0.696 . . . . 0.0 111.798 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 67' ' ' THR . 41.5 p90 -123.58 118.17 26.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.108 -0.951 . . . . 0.0 108.436 164.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 50.8 t -92.7 126.63 37.87 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.805 0.842 . . . . 0.0 110.631 177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 18.8 m-70 -125.07 90.08 3.17 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 167.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 65' ' ' ASP . 15.7 t-80 -75.86 93.81 3.24 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.896 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 53.2 mtt -80.07 135.15 36.28 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.44 139.76 28.55 Favored 'General case' 0 C--O 1.223 -0.3 0 C-N-CA 124.415 1.086 . . . . 0.0 108.374 -173.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.35 138.63 58.59 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.039 0.536 . . . . 0.0 109.931 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -69.39 -35.53 75.88 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.41 0.684 . . . . 0.0 111.787 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -109.24 12.56 24.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.026 0.93 . . . . 0.0 111.172 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -145.04 153.61 25.37 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 113.54 0.176 . . . . 0.0 113.54 -172.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.6 p -75.4 -14.26 60.45 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.12 0.968 . . . . 0.0 112.025 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.59 132.32 44.91 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.578 1.151 . . . . 0.0 111.547 178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.66 138.23 6.06 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.686 -0.292 . . . . 0.0 113.383 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -123.77 119.3 29.32 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.552 1.141 . . . . 0.0 108.802 171.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 54' ' ' HIS . 9.2 p-10 -83.66 137.69 33.68 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.331 0.653 . . . . 0.0 109.607 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.48 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.8 m-85 -113.27 84.83 2.07 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' PHE . 61.7 p -109.41 104.13 13.17 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.424 -173.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.06 128.68 8.51 Favored Glycine 0 C--N 1.348 1.235 0 CA-C-O 119.329 -0.706 . . . . 0.0 111.852 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.6 m -85.13 120.49 26.69 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 117.435 0.618 . . . . 0.0 109.846 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.436 ' HE1' HD21 ' A' ' 79' ' ' LEU . 97.9 m-85 -65.48 120.84 13.59 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.329 0.652 . . . . 0.0 110.034 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.7 p -115.01 -15.73 11.73 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.271 0.628 . . . . 0.0 111.006 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 17.3 tpp180 -147.82 117.96 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.25 102.91 12.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -125.42 73.8 1.34 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.592 0.757 . . . . 0.0 109.669 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.98 136.3 87.34 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.823 0.849 . . . . 0.0 111.393 -175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 23.7 Cg_endo -97.48 11.15 35.82 Favored 'Cis proline' 0 C--N 1.377 2.045 0 CA-C-N 119.451 0.84 . . . . 0.0 113.432 -5.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.2 p -82.49 -19.98 37.71 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 -165.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -168.19 151.32 5.68 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.261 0.553 . . . . 0.0 110.489 -174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.495 HD23 ' HE1' ' A' ' 20' ' ' TRP . 31.8 tp -150.44 151.64 33.07 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.404 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.7 t -151.69 153.52 34.54 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -154.71 159.11 40.5 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.804 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG22 ' HG2' ' A' ' 88' ' ' GLU . 88.9 t -115.09 138.72 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.959 0.904 . . . . 0.0 108.808 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.0 mtp -88.58 166.58 14.05 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -59.29 -19.99 50.66 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 113.393 0.886 . . . . 0.0 113.393 -175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -73.58 -8.17 54.85 Favored 'General case' 0 CA--C 1.56 1.361 0 C-N-CA 124.216 1.006 . . . . 0.0 111.773 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.47 12.99 68.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 114.044 0.377 . . . . 0.0 114.044 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 32.6 mtt180 -109.66 147.04 33.8 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 117.451 0.625 . . . . 0.0 110.361 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.594 ' HG2' HG22 ' A' ' 82' ' ' VAL . 36.5 mt-10 -94.57 144.13 25.85 Favored 'General case' 0 N--CA 1.479 0.994 0 O-C-N 123.878 0.736 . . . . 0.0 110.561 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.56 HG13 ' HB3' ' A' ' 106' ' ' PHE . 45.3 t -124.67 122.28 63.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 106.519 -1.659 . . . . 0.0 106.519 172.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -116.44 120.62 39.38 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -173.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.477 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 42.4 t -114.39 104.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 23.0 tm0? -102.64 130.38 49.52 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.0 1.32 . . . . 0.0 108.127 -175.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -107.21 101.48 10.86 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.638 0.775 . . . . 0.0 109.214 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -92.83 133.58 35.93 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.306 0.642 . . . . 0.0 110.228 178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 49.6 m -83.84 131.95 34.84 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 173.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 4.9 pt-20 -143.19 160.82 50.82 Favored Pre-proline 0 N--CA 1.481 1.084 0 C-N-CA 123.157 0.583 . . . . 0.0 110.752 -177.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -53.92 -32.33 67.2 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 123.595 2.864 . . . . 0.0 114.013 174.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.62 -19.96 67.22 Favored Glycine 0 C--N 1.35 1.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 114.077 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.466 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 151.12 -116.4 0.76 Allowed Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.563 -0.615 . . . . 0.0 111.563 -177.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.2 m -133.39 112.2 11.4 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.629 0.772 . . . . 0.0 109.252 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.451 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 8.2 t90 -82.81 95.93 8.06 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.331 0.652 . . . . 0.0 109.345 178.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.9 t -87.48 110.43 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -101.56 114.49 28.57 Favored 'General case' 0 C--O 1.222 -0.346 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' ILE . 43.1 tt0 -107.97 103.03 12.17 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.517 0.727 . . . . 0.0 109.29 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.4 m -107.41 118.65 37.27 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.56 ' HB3' HG13 ' A' ' 89' ' ' VAL . 50.9 p90 -130.72 145.39 51.93 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.911 0.484 . . . . 0.0 110.364 -173.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 15.6 m-20 -75.8 120.17 20.8 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.87 134.55 47.39 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.815 0.846 . . . . 0.0 110.918 -173.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -85.67 151.1 24.14 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.302 0.641 . . . . 0.0 109.82 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 17.5 p -90.66 -5.73 55.45 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.7 m -76.45 -51.42 11.82 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 122.937 0.495 . . . . 0.0 110.16 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -101.43 156.79 17.25 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.389 0.675 . . . . 0.0 110.028 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.6 m -65.22 125.04 88.57 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 118.132 -0.937 . . . . 0.0 109.444 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.4 ' HB3' HD11 ' A' ' 3' ' ' ILE . 76.4 Cg_exo -46.56 -42.79 23.3 Favored 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 124.11 3.207 . . . . 0.0 114.473 177.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.82 -39.64 94.94 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.94 0.496 . . . . 0.0 112.176 175.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -63.83 -36.6 84.44 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 122.636 0.375 . . . . 0.0 111.421 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -67.25 -44.2 80.03 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 123.704 0.627 . . . . 0.0 109.458 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 0.8 OUTLIER -55.68 -49.96 71.56 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.405 1.082 . . . . 0.0 109.145 179.014 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.5 -32.04 72.59 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.606 0.762 . . . . 0.0 111.636 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -73.64 -60.84 3.55 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 116.09 -0.504 . . . . 0.0 113.306 -177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -56.32 -45.26 80.39 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.78 0.832 . . . . 0.0 111.691 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 0.0 OUTLIER -68.73 -26.34 65.21 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 123.251 0.344 . . . . 0.0 110.074 177.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.16 -48.11 78.33 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 172.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.6 mt -67.62 -36.2 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 124.272 1.029 . . . . 0.0 110.377 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.419 HD23 HE21 ' A' ' 122' ' ' GLN . 37.7 tp -75.38 -28.94 59.68 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.618 1.167 . . . . 0.0 110.32 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -71.8 -38.55 70.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.016 0.926 . . . . 0.0 110.82 171.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -64.64 -35.81 82.22 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . 30.6 t80 -60.18 -60.6 3.56 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.811 0.845 . . . . 0.0 110.291 174.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -49.43 -48.76 47.13 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.798 1.239 . . . . 0.0 112.206 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -62.33 -43.46 98.76 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.148 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -61.06 -45.87 93.0 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 123.707 0.629 . . . . 0.0 111.359 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' A' ' 11' ' ' GLN . 58.5 t -61.17 -42.32 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.375 0.67 . . . . 0.0 110.508 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -80.45 -21.2 42.35 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.378 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.79 -34.75 26.94 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 122.714 0.406 . . . . 0.0 110.291 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -78.52 -38.33 40.92 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.797 0.839 . . . . 0.0 109.911 178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 90.92 -44.43 2.85 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.483 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.478 HD12 HG13 ' A' ' 132' ' ' VAL . 78.1 mt 55.55 58.43 4.56 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 125.124 1.369 . . . . 0.0 110.721 173.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 62.2 -76.78 0.03 OUTLIER 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.293 1.837 . . . . 0.0 112.118 -177.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 64.7 t60 69.3 13.07 8.51 Favored 'General case' 0 CA--C 1.567 1.628 0 C-N-CA 125.196 1.399 . . . . 0.0 112.873 175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 30.87 75.9 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 C-N-CA 126.374 1.869 . . . . 0.0 114.397 176.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -78.36 97.48 5.64 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.068 -175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -133.94 131.79 39.44 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.443 1.097 . . . . 0.0 108.444 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -152.37 -179.45 7.57 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.131 0.972 . . . . 0.0 110.494 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 . . . . . 0 C--O 1.251 1.159 0 C-N-CA 123.111 0.565 . . . . 0.0 109.796 175.078 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.8 ptm . . . . . 0 N--CA 1.479 1.0 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -148.99 151.03 33.85 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.687 0.795 . . . . 0.0 109.521 175.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.549 HG21 ' HG2' ' A' ' 118' ' ' GLN . 68.9 mt -122.82 133.35 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.996 0.918 . . . . 0.0 109.39 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.0 m -104.89 117.06 33.09 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.666 0.786 . . . . 0.0 110.087 177.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.5 pt -114.09 160.42 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 124.064 0.945 . . . . 0.0 108.627 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 163.99 37.22 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -145.66 131.77 19.36 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.505 1.122 . . . . 0.0 109.831 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 77.6 t60 -91.2 94.56 9.62 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 172.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 60.9 mt -102.0 109.76 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.63 ' HA ' ' HA2' ' A' ' 99' ' ' GLY . 45.3 mt-10 -77.28 86.98 3.7 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' NE2' ' HB2' ' A' ' 137' ' ' LEU . 6.0 tp-100 -166.31 153.69 9.8 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.595 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.461 ' HB3' ' HG2' ' A' ' 14' ' ' GLU . 0.7 OUTLIER -60.53 139.25 57.84 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.028 0.931 . . . . 0.0 110.527 174.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -58.81 -30.22 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 -174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 12' ' ' GLU . 11.0 pt-20 -66.15 -41.58 90.2 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.172 0.989 . . . . 0.0 111.365 176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -84.29 -25.7 29.12 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.647 0.779 . . . . 0.0 111.755 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 80.8 t -64.43 -48.34 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 168.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 73.4 t-105 -66.87 -31.54 72.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.429 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -61.16 -53.95 50.49 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.83 -10.75 60.18 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.174 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.459 ' HA ' ' HZ2' ' A' ' 29' ' ' TRP . 45.9 t-105 -84.66 -48.32 9.59 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 122.676 0.39 . . . . 0.0 110.638 173.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.559 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -95.29 -23.85 17.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -165.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.4 t70 -62.82 129.28 92.97 Favored Pre-proline 0 N--CA 1.48 1.039 0 CA-C-O 118.593 -0.718 . . . . 0.0 109.678 -174.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -55.22 -36.61 93.74 Favored 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 122.827 2.351 . . . . 0.0 113.544 -171.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -63.5 -49.2 74.51 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.7 0.8 . . . . 0.0 111.828 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 16.8 p -73.62 -52.43 13.42 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.933 -176.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.436 HD13 HG21 ' A' ' 43' ' ' VAL . 11.2 tt -57.88 -27.9 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.776 0.83 . . . . 0.0 112.727 -178.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.21 -31.13 49.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 122.992 0.517 . . . . 0.0 111.171 173.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -74.79 -58.66 3.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.889 0.876 . . . . 0.0 110.776 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.459 ' HZ2' ' HA ' ' A' ' 20' ' ' TRP . 65.4 p-90 -87.47 123.8 32.77 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 173.6 -35.1 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.222 1.409 . . . . 0.0 109.041 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -80.51 136.82 36.37 Favored 'General case' 0 C--N 1.347 0.477 0 C-N-CA 123.836 0.854 . . . . 0.0 110.671 -175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.31 24.62 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.889 0.876 . . . . 0.0 112.434 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.2 t -143.69 153.74 42.78 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.275 1.03 . . . . 0.0 109.415 177.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.0 m -83.1 -14.38 53.8 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.522 0.729 . . . . 0.0 111.126 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -82.53 -4.0 56.86 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.543 0.737 . . . . 0.0 111.266 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.0 m95 -110.89 112.82 24.94 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -102.27 134.76 45.04 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.705 1.202 . . . . 0.0 109.472 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 32.2 m -75.92 108.74 9.0 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.389 0.675 . . . . 0.0 109.669 172.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -90.03 -22.77 21.71 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.467 0.707 . . . . 0.0 111.313 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -138.84 133.35 6.18 Favored Glycine 0 C--N 1.342 0.871 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 36.1 t -160.42 125.34 3.82 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 117.413 0.607 . . . . 0.0 110.66 -172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -138.73 130.4 27.63 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.235 1.014 . . . . 0.0 108.61 174.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 51' ' ' PHE . 95.8 t -123.43 121.87 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.682 0.793 . . . . 0.0 109.377 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -113.0 81.75 1.54 Allowed 'General case' 0 C--O 1.239 0.547 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 173.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.559 HD22 ' HB2' ' A' ' 21' ' ' ASN . 32.5 tp -73.13 82.39 1.29 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.264 1.026 . . . . 0.0 111.108 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.93 164.22 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 166.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' VAL . 59.2 t -69.69 103.51 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.72 -17.76 17.74 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.918 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.57 165.16 51.26 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 77.6 ttt180 -129.99 149.98 51.47 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.278 0.631 . . . . 0.0 109.912 -175.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.563 ' HB2' HG22 ' A' ' 43' ' ' VAL . 41.2 p90 -113.48 161.4 17.39 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.276 0.631 . . . . 0.0 109.382 172.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.9 p -150.71 133.42 15.78 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 90.4 m-70 -130.89 90.95 2.98 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 173.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -76.03 88.86 2.98 Favored 'General case' 0 C--O 1.245 0.844 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 175.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 24.3 ptp -78.47 151.62 32.52 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 114.244 -1.344 . . . . 0.0 108.102 171.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -156.79 145.97 20.34 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -53.18 124.78 15.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.987 0.915 . . . . 0.0 109.784 172.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.8 pttm -65.78 -20.94 66.45 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.916 0.487 . . . . 0.0 110.107 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.47 -26.51 13.54 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.904 0.881 . . . . 0.0 111.099 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.87 162.1 24.92 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 114.051 0.38 . . . . 0.0 114.051 -168.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.0 p -74.38 -9.84 58.99 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.42 123.64 17.92 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.481 0.713 . . . . 0.0 110.72 177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -146.63 147.3 18.08 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-O 120.165 -0.242 . . . . 0.0 113.389 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -124.59 155.19 39.5 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.263 1.025 . . . . 0.0 109.715 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -114.81 108.93 17.4 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.564 0.746 . . . . 0.0 109.544 178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.528 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 41.2 t80 -91.84 90.32 7.43 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -129.17 152.12 49.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.691 0.796 . . . . 0.0 110.483 -167.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -171.75 142.16 6.78 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.648 0.593 . . . . 0.0 111.914 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 25.7 m -96.16 123.8 39.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 117.482 0.641 . . . . 0.0 109.306 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -66.83 118.99 11.11 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 110.071 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 61.3 p -89.24 -25.43 21.73 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.036 0.934 . . . . 0.0 110.463 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -156.46 135.9 12.27 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.038 0.935 . . . . 0.0 109.327 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 47' ' ' VAL . 96.3 t -118.1 102.66 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 19.9 tp10 -111.65 61.49 0.62 Allowed 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -70.96 133.19 86.19 Favored Pre-proline 0 N--CA 1.475 0.803 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.938 -171.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -99.18 8.71 27.9 Favored 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 119.984 1.03 . . . . 0.0 114.341 0.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.572 ' HA ' HD11 ' A' ' 13' ' ' ILE . 76.5 p -84.59 -16.92 40.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -165.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.495 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 41.0 ttt180 -167.22 150.8 6.5 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.206 0.527 . . . . 0.0 111.583 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.9 tp -144.93 119.47 9.71 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.467 0.707 . . . . 0.0 109.744 174.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 6.3 m -107.56 133.2 52.37 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -157.76 141.89 16.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.094 0.558 . . . . 0.0 110.846 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.2 t -111.52 133.03 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.444 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 27.2 mtt -89.16 157.79 18.15 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.567 0.747 . . . . 0.0 109.496 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -61.55 -16.78 51.01 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 123.646 0.778 . . . . 0.0 112.551 -176.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -74.55 -3.92 33.86 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.574 0.75 . . . . 0.0 111.472 177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.21 -2.88 85.53 Favored Glycine 0 C--N 1.355 1.619 0 C-N-CA 123.433 0.54 . . . . 0.0 112.151 -174.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.488 HH12 ' HZ2' ' A' ' 121' ' ' TRP . 42.9 mtm105 -77.43 107.83 10.15 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.844 0.858 . . . . 0.0 110.928 -178.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -82.19 125.72 31.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.168 0.587 . . . . 0.0 109.881 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 16.5 t -119.99 146.54 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.115 0.966 . . . . 0.0 109.107 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -140.6 140.79 35.16 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.942 0.897 . . . . 0.0 108.811 172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 104' ' ' GLU . 43.1 t -129.71 118.02 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 103' ' ' GLN . 28.8 mt-30 -99.79 144.34 28.97 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 124.324 1.05 . . . . 0.0 108.424 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -123.87 100.27 6.67 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 176.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -105.82 111.29 23.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.103 0.561 . . . . 0.0 110.221 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.6 m -62.02 140.96 58.33 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.388 0.675 . . . . 0.0 110.894 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.45 155.86 71.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 C-N-CA 123.921 0.889 . . . . 0.0 109.898 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.83 91.53 0.16 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 121.776 1.65 . . . . 0.0 109.969 163.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 89.29 44.47 4.99 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.271 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 10' ' ' GLU . . . 165.55 -170.34 40.37 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 117.346 0.573 . . . . 0.0 114.34 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.9 m -149.52 110.51 4.35 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.416 1.487 . . . . 0.0 108.186 171.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 9.3 t90 -82.1 99.07 8.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.179 0.592 . . . . 0.0 109.9 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 20.4 t -88.74 134.0 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 92' ' ' GLN . 51.1 mt-30 -135.05 103.6 5.62 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.609 0.764 . . . . 0.0 109.879 -164.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 91' ' ' VAL . 29.8 mp0 -92.1 138.94 31.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 64.4 m -134.88 109.02 8.23 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.493 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 39.4 p90 -118.89 134.58 55.08 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -172.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.46 129.39 39.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.427 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -103.96 152.63 21.77 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.507 0.723 . . . . 0.0 109.84 -176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.435 ' HG3' ' HD3' ' A' ' 87' ' ' ARG . 40.4 mt-10 -97.59 137.01 37.15 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.136 0.975 . . . . 0.0 108.785 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 24.8 p -77.46 -11.68 59.88 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.99 0.516 . . . . 0.0 110.841 174.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.7 t -89.96 -2.6 58.18 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.702 0.801 . . . . 0.0 109.695 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -126.16 141.83 51.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.793 1.237 . . . . 0.0 108.405 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.8 m -60.16 115.12 11.84 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 123.494 0.718 . . . . 0.0 110.907 -178.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.83 -41.63 73.44 Favored 'Trans proline' 0 C--N 1.388 2.643 0 C-N-CA 123.728 2.952 . . . . 0.0 113.022 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.22 -46.76 79.4 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.612 0.765 . . . . 0.0 112.436 173.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.94 -36.24 82.81 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.854 0.462 . . . . 0.0 111.592 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -69.94 -48.14 59.6 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.86 0.464 . . . . 0.0 110.674 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.549 ' HG2' HG21 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -58.89 -58.64 7.76 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.085 0.954 . . . . 0.0 110.218 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.55 -35.72 81.42 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.424 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.64 -51.4 57.78 Favored Glycine 0 C--N 1.35 1.35 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.161 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.488 ' HZ2' HH12 ' A' ' 87' ' ' ARG . 20.7 m95 -67.15 -39.85 86.58 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 112.349 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 28.5 tp60 -68.68 -26.23 65.19 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.07 0.548 . . . . 0.0 110.645 177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -69.49 -45.3 60.5 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.291 171.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 85.2 mt -60.83 -40.04 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 124.562 1.145 . . . . 0.0 110.188 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 56.0 tp -69.83 -35.78 75.05 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.628 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.3 -42.61 99.05 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.838 0.455 . . . . 0.0 110.133 175.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.06 -31.72 73.01 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.579 0.752 . . . . 0.0 110.397 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.479 ' O ' HG23 ' A' ' 132' ' ' VAL . 34.0 t80 -71.8 -57.61 4.2 Favored 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.132 0.895 . . . . 0.0 110.704 174.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -52.55 -55.18 23.95 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.003 1.321 . . . . 0.0 112.055 -176.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -66.12 -30.33 70.81 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.12 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.44 -54.67 42.74 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.07 0.548 . . . . 0.0 109.699 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 128' ' ' PHE . 61.0 t -61.0 -55.91 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 O-C-N 124.093 0.871 . . . . 0.0 111.701 -173.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.14 -35.67 61.64 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.369 -170.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -88.58 -9.51 51.99 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 122.451 0.3 . . . . 0.0 111.192 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.19 -40.71 82.13 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 166.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.82 71.7 0.96 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.283 -173.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.554 ' HB2' ' NE2' ' A' ' 11' ' ' GLN . 80.3 mt -80.36 31.85 0.28 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.566 0.747 . . . . 0.0 110.879 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -73.07 102.83 3.64 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.946 0.898 . . . . 0.0 108.963 175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 61.0 m80 -115.87 -46.85 2.81 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 124.159 0.984 . . . . 0.0 109.762 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -82.22 76.83 9.08 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.182 -175.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -163.29 104.54 0.98 Allowed 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.353 0.661 . . . . 0.0 110.897 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -136.81 97.75 3.61 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 58.1 m80 68.38 78.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.042 1.337 . . . . 0.0 109.367 -169.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 80.2 t60 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.707 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.548 ' HE3' ' HB2' ' A' ' 88' ' ' GLU . 58.5 mttp -89.23 108.27 19.52 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -177.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.1 mt -87.52 137.77 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.8 t -117.58 116.18 26.58 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.766 0.827 . . . . 0.0 108.943 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.524 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 32.1 pt -116.57 166.18 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 125.207 1.403 . . . . 0.0 109.113 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -141.43 163.1 33.86 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.387 0.675 . . . . 0.0 110.784 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -157.22 141.74 16.59 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.702 0.801 . . . . 0.0 109.86 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.2 m80 -107.63 86.75 2.36 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.524 HG12 ' HG3' ' A' ' 129' ' ' LYS . 16.9 mt -77.66 126.12 37.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -82.92 55.59 3.13 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 122.2 1.0 . . . . 0.0 110.794 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -147.26 156.37 42.88 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.175 0.99 . . . . 0.0 108.717 -175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -65.77 145.36 56.09 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.181 0.992 . . . . 0.0 110.874 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.514 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.3 tt -57.6 -35.31 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.989 0.916 . . . . 0.0 111.528 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -64.04 -42.59 97.02 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.111 0.882 . . . . 0.0 110.55 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.28 -39.27 59.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.826 0.85 . . . . 0.0 111.732 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.4 t -60.92 -44.69 98.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.524 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -62.53 -44.51 96.19 Favored 'General case' 0 C--O 1.214 -0.815 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.152 175.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -58.1 -47.14 84.16 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.036 0.935 . . . . 0.0 111.294 -175.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.78 -30.59 69.21 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.507 0.723 . . . . 0.0 111.605 178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.415 ' O ' HD11 ' A' ' 26' ' ' ILE . 59.3 t-105 -81.37 -19.06 43.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.456 0.703 . . . . 0.0 111.132 177.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -40.74 9.45 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.508 0.723 . . . . 0.0 110.034 -173.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -78.35 112.77 28.51 Favored Pre-proline 0 N--CA 1.475 0.797 0 CA-C-O 118.353 -0.832 . . . . 0.0 109.406 -169.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.1 -24.92 58.88 Favored 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 122.855 2.37 . . . . 0.0 112.922 -173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 29.1 t70 -76.82 -36.74 56.69 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.644 0.778 . . . . 0.0 110.082 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.5 m -71.46 -40.71 70.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.233 0.613 . . . . 0.0 110.482 174.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD11 ' O ' ' A' ' 20' ' ' TRP . 95.6 mt -60.48 -41.98 89.6 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 C-N-CA 123.775 0.83 . . . . 0.0 109.833 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.5 -28.29 63.3 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.095 0.558 . . . . 0.0 111.982 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 92.7 mtt180 -73.79 -16.8 61.15 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.78 0.832 . . . . 0.0 112.518 -179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -131.55 -65.75 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 122.933 0.493 . . . . 0.0 110.397 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.416 HD21 ' HB3' ' A' ' 53' ' ' HIS . 65.8 t30 45.51 -76.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 127.115 2.166 . . . . 0.0 114.002 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -68.31 178.06 2.09 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.318 1.047 . . . . 0.0 111.364 175.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -93.13 4.41 54.04 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.222 0.609 . . . . 0.0 111.71 175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 54.7 p -137.26 136.74 38.35 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.369 0.668 . . . . 0.0 111.473 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.7 m -72.04 -20.2 61.72 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.95 0.9 . . . . 0.0 111.729 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -69.97 -34.24 73.13 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.205 0.602 . . . . 0.0 111.211 175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -100.96 109.64 21.59 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 28.9 p80 -99.27 170.63 8.52 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.403 0.681 . . . . 0.0 109.352 176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.454 HG21 ' OG ' ' A' ' 41' ' ' SER . 22.2 m -103.24 122.67 45.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -85.53 -21.09 28.75 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.255 1.022 . . . . 0.0 110.385 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -169.79 113.25 0.5 Allowed Glycine 0 C--N 1.351 1.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.006 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.454 ' OG ' HG21 ' A' ' 38' ' ' THR . 52.1 m -101.6 116.77 33.5 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.569 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 2.5 mpt_? -109.08 122.58 47.57 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 167.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.49 103.18 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.54 84.94 2.5 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.0 tp -76.9 77.04 3.48 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.393 -170.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.7 m -139.56 164.63 23.82 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 47.6 t -71.3 108.29 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 106.47 -11.33 42.95 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 123.906 0.754 . . . . 0.0 112.415 -174.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.94 151.41 42.48 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-N 116.845 0.322 . . . . 0.0 112.874 -178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.2 mpt_? -104.91 156.26 18.19 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.432 0.693 . . . . 0.0 110.306 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -139.98 150.84 44.97 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.62 0.768 . . . . 0.0 110.139 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 27.0 p -149.01 107.29 3.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 0.0 109.205 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 8.3 m170 -98.5 88.86 4.23 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -75.32 117.39 17.07 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.595 -175.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 38.2 mtm -116.16 143.13 45.91 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.331 0.653 . . . . 0.0 109.999 -174.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.74 142.75 34.76 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.635 1.174 . . . . 0.0 109.24 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -74.18 135.88 42.81 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.3 tmmm? -67.37 -36.38 81.24 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.949 0.9 . . . . 0.0 110.662 -171.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -106.53 -24.09 12.29 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.45 1.1 . . . . 0.0 110.514 -172.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -124.09 163.57 17.75 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 116.705 -0.225 . . . . 0.0 112.987 -177.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.1 t -77.26 -1.47 29.81 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.99 122.4 18.13 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.365 0.529 . . . . 0.0 111.22 -177.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.86 154.58 24.46 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-N 116.395 -0.366 . . . . 0.0 112.752 -176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -152.62 157.1 40.51 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.894 0.878 . . . . 0.0 108.906 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' HG23 ' A' ' 67' ' ' THR . 36.3 m-20 -126.24 136.59 52.98 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 64.8 m-85 -95.2 81.42 3.65 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 165.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 65' ' ' ASP . 54.6 p -98.43 140.81 32.13 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.367 178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 177.56 -162.26 30.04 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 123.589 0.556 . . . . 0.0 112.504 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 85.3 m -142.56 126.7 17.46 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.269 1.028 . . . . 0.0 109.73 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.435 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 84.1 m-85 -62.06 123.57 18.46 Favored 'General case' 0 C--N 1.351 0.659 0 C-N-CA 124.12 0.968 . . . . 0.0 110.544 174.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG23 ' A' ' 82' ' ' VAL . 30.4 p -97.35 -31.81 12.2 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 123.763 0.825 . . . . 0.0 111.435 -176.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 46.2 ttm105 -154.74 118.52 4.61 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -176.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -114.69 99.03 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 18.3 mm-40 -102.73 71.64 1.18 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.4 128.98 89.45 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-O 118.627 -0.702 . . . . 0.0 110.917 -172.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.7 Cg_endo -101.26 11.59 19.65 Favored 'Cis proline' 0 C--N 1.382 2.331 0 CA-C-N 120.29 1.139 . . . . 0.0 114.524 -2.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.514 ' HA ' HD11 ' A' ' 13' ' ' ILE . 17.0 p -79.65 -14.18 58.97 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 37.7 ttm180 -170.65 147.52 2.86 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.909 0.484 . . . . 0.0 110.623 -177.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.1 tp -135.6 135.99 40.69 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 170.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 21.3 t -135.6 140.72 44.83 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.658 0.783 . . . . 0.0 109.043 -178.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.435 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 20.9 p90 -159.77 144.86 15.29 Favored 'General case' 0 C--O 1.223 -0.303 0 C-N-CA 124.275 1.03 . . . . 0.0 110.164 -177.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG23 HG21 ' A' ' 71' ' ' THR . 94.2 t -110.15 129.06 65.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 56.3 mtm -84.65 165.8 17.62 Favored 'General case' 0 C--O 1.241 0.642 0 O-C-N 123.605 0.566 . . . . 0.0 109.497 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.81 -32.3 70.51 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.585 1.154 . . . . 0.0 113.001 -167.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -90.62 17.38 7.59 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.503 0.668 . . . . 0.0 110.783 -174.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.38 -4.38 82.47 Favored Glycine 0 C--N 1.353 1.524 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.033 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.523 HH21 ' HG3' ' A' ' 109' ' ' GLU . 9.2 mpt_? -68.61 105.94 2.43 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 117.13 0.465 . . . . 0.0 110.037 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.548 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 37.2 mt-10 -83.04 122.44 28.32 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.1 137.7 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.526 1.13 . . . . 0.0 109.024 -173.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -145.51 106.63 4.17 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.705 0.802 . . . . 0.0 109.492 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.405 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 2.8 t -97.41 119.14 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.965 1.306 . . . . 0.0 108.908 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.49 ' HB3' ' HB2' ' A' ' 103' ' ' GLN . 50.3 tp60 -101.62 136.13 41.97 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -119.24 98.14 6.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.268 1.027 . . . . 0.0 108.289 177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -100.33 108.92 21.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.219 0.608 . . . . 0.0 110.396 -175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 m -65.9 134.96 54.12 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.268 0.627 . . . . 0.0 111.101 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 99' ' ' GLY . 8.7 pt-20 -143.89 151.09 51.96 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.147 0.979 . . . . 0.0 109.995 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.2 83.56 0.15 Allowed 'Trans proline' 0 C--N 1.376 1.997 0 C-N-CA 122.658 2.239 . . . . 0.0 110.896 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 159.76 -45.38 0.43 Allowed Glycine 0 C--N 1.337 0.613 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.135 -176.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.4 ' H ' ' HG3' ' A' ' 96' ' ' GLU . . . 178.63 -131.61 1.76 Allowed Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.795 -0.447 . . . . 0.0 112.554 -175.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 31.6 m -142.85 119.81 11.32 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.298 1.039 . . . . 0.0 109.885 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 10.0 t90 -84.52 95.49 8.84 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.812 0.845 . . . . 0.0 109.134 175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' GLN . 60.9 t -89.51 109.95 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.949 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 92' ' ' GLN . 99.4 mt-30 -104.1 105.1 15.15 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.16 0.984 . . . . 0.0 109.284 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -93.27 108.98 20.52 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 123.242 0.617 . . . . 0.0 110.188 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 33.4 m -104.81 107.87 19.06 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 173.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.492 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 45.9 p90 -123.32 151.21 42.69 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.065 0.946 . . . . 0.0 108.537 -173.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.477 ' HB3' ' HA ' ' A' ' 87' ' ' ARG . 4.2 t70 -83.78 146.28 28.24 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 172.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -121.58 162.86 19.87 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.769 -169.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' HG3' HH21 ' A' ' 87' ' ' ARG . 1.2 mp0 -86.54 116.67 24.82 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.122 178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.7 p -78.12 -16.57 57.85 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.142 0.977 . . . . 0.0 111.884 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.7 m -68.99 -30.14 68.49 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.428 0.632 . . . . 0.0 109.692 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -99.74 154.66 18.13 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.492 1.117 . . . . 0.0 109.718 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 40.4 p -69.2 125.35 91.89 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 123.193 0.597 . . . . 0.0 109.962 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -54.12 -25.92 39.5 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.373 3.382 . . . . 0.0 114.313 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.96 65.71 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.521 0.729 . . . . 0.0 111.582 170.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -71.81 -31.64 66.77 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.64 0.776 . . . . 0.0 111.482 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -65.26 -52.54 53.77 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.592 0.757 . . . . 0.0 111.414 176.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.492 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 63.1 tt0 -62.69 -50.34 71.54 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.083 0.953 . . . . 0.0 110.558 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.99 -27.52 66.64 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.597 0.759 . . . . 0.0 111.887 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.11 -50.96 30.52 Favored Glycine 0 C--N 1.349 1.256 0 O-C-N 123.715 0.635 . . . . 0.0 111.845 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 39.9 m95 -75.84 -33.08 60.03 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 122.963 0.505 . . . . 0.0 111.746 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.524 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 6.1 tp-100 -71.31 -22.88 61.88 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 172.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.04 -48.11 61.69 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 115.195 -0.912 . . . . 0.0 111.826 168.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.19 -39.19 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.001 0.52 . . . . 0.0 110.329 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 38.3 tp -72.41 -31.57 65.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.733 0.813 . . . . 0.0 110.202 178.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.45 -52.95 61.52 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.992 0.917 . . . . 0.0 110.717 171.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -62.3 -35.83 80.23 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.297 0.639 . . . . 0.0 110.614 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.1 t80 -63.78 -55.18 25.04 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 124.185 0.928 . . . . 0.0 110.158 174.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HG3' HG12 ' A' ' 9' ' ' ILE . 57.4 tttm -56.49 -60.22 3.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.74 1.216 . . . . 0.0 111.834 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -62.99 -27.16 69.22 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.615 0.572 . . . . 0.0 111.261 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -69.93 -46.35 65.54 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 123.698 0.624 . . . . 0.0 110.881 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 128' ' ' PHE . 74.0 t -64.44 -40.15 88.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.853 0.861 . . . . 0.0 110.634 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 70.9 mt-10 -73.39 -39.86 64.78 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.003 0.921 . . . . 0.0 111.593 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.17 -24.35 43.29 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 122.935 0.494 . . . . 0.0 110.746 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.66 -37.14 70.81 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.88 -45.55 3.33 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.514 177.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 54.3 mt 54.74 91.44 0.03 OUTLIER 'General case' 0 C--N 1.36 1.063 0 C-N-CA 125.25 1.42 . . . . 0.0 110.291 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -58.0 105.76 0.3 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 -163.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -130.02 21.74 5.35 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.811 168.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.8 m-70 -114.37 150.28 34.84 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.711 0.805 . . . . 0.0 110.159 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -76.19 85.93 3.02 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 121.529 0.681 . . . . 0.0 109.335 175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -119.68 3.14 11.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.339 -169.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 31.1 p80 47.6 -165.0 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 126.064 1.746 . . . . 0.0 113.195 -175.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.994 -0.527 . . . . 0.0 111.263 178.746 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.483 1.204 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -122.26 158.81 28.67 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.049 0.94 . . . . 0.0 109.688 173.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.73 138.13 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 C-N-CA 124.356 1.063 . . . . 0.0 108.619 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.2 m -112.25 123.73 50.92 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.249 0.619 . . . . 0.0 110.301 176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.9 pt -116.91 170.49 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.966 1.306 . . . . 0.0 109.225 170.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -158.77 163.5 36.68 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.211 0.604 . . . . 0.0 111.139 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.68 141.78 14.73 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.863 0.865 . . . . 0.0 109.871 -173.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -103.66 113.61 27.25 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.0 mt -113.56 114.98 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -82.51 73.08 9.57 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.282 1.039 . . . . 0.0 109.643 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -153.5 166.28 33.22 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 113.975 -1.466 . . . . 0.0 108.703 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -72.96 147.87 44.81 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.544 0.737 . . . . 0.0 109.648 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 77' ' ' THR . 14.8 tt -66.24 -25.28 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 CA-C-O 120.981 0.42 . . . . 0.0 110.673 -177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -65.67 -49.06 69.97 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.504 171.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.63 -29.85 65.11 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.149 0.98 . . . . 0.0 112.249 -174.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.9 t -72.56 -45.4 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 123.494 0.717 . . . . 0.0 109.837 174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 68.1 t-105 -62.49 -37.06 84.52 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.193 0.597 . . . . 0.0 110.987 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 77.1 t90 -58.47 -57.73 11.65 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.379 175.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.69 -20.97 65.39 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 124.104 0.878 . . . . 0.0 112.156 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.427 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 67.9 t-105 -75.53 -46.95 29.11 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.701 0.4 . . . . 0.0 111.642 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -101.06 -14.01 17.98 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -171.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 14.7 t70 -64.57 121.64 74.08 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 123.614 0.766 . . . . 0.0 110.116 178.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -62.23 -30.81 82.08 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.002 2.468 . . . . 0.0 113.621 -173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.6 -34.18 58.4 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 120.831 0.348 . . . . 0.0 110.369 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.429 ' HG ' ' HH ' ' A' ' 131' ' ' TYR . 67.1 m -64.52 -49.53 70.92 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.3 mt -59.32 -29.47 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 124.37 1.068 . . . . 0.0 112.206 175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.544 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -61.08 -36.11 78.79 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.016 -0.428 . . . . 0.0 110.682 174.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -86.79 -58.58 2.55 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 123.721 0.808 . . . . 0.0 111.107 -174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 49.0 p-90 -97.26 139.52 33.11 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 37' ' ' HIS . 2.2 p30 -175.38 -51.81 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.98 0.912 . . . . 0.0 109.148 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -102.26 164.73 11.52 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 124.143 0.977 . . . . 0.0 109.098 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.44 -49.14 57.75 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.3 m -52.73 124.46 13.93 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.08 0.952 . . . . 0.0 112.243 174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 33.3 p -68.68 -23.56 64.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.148 0.979 . . . . 0.0 111.654 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -96.12 15.32 21.13 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.942 0.497 . . . . 0.0 111.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -117.68 133.5 55.88 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 171.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.643 ' HA ' HD21 ' A' ' 30' ' ' ASN . 6.6 p80 -150.53 149.54 30.08 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.908 -168.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.544 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 86.5 m -77.1 116.44 17.75 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.6 p -86.62 -12.06 49.62 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.473 1.109 . . . . 0.0 111.503 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -165.65 106.63 0.27 Allowed Glycine 0 C--N 1.351 1.362 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 178.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 40.0 t -101.07 102.38 13.33 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.504 0.721 . . . . 0.0 110.047 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -79.66 123.31 27.53 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 166.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.6 t -136.22 103.59 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.942 0.897 . . . . 0.0 108.624 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.55 78.69 1.18 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 170.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 50.5 tp -72.09 81.53 0.96 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.235 -174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 15.3 m -144.19 165.5 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 124.983 1.313 . . . . 0.0 108.893 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.7 t -75.55 102.17 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 114.38 -10.68 21.97 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-N 115.087 -0.961 . . . . 0.0 111.571 -173.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.02 157.99 45.74 Favored Glycine 0 C--N 1.349 1.279 0 C-N-CA 123.156 0.407 . . . . 0.0 113.794 -178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.4 mmt180 -104.89 152.79 22.21 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.627 0.771 . . . . 0.0 111.492 -173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -142.14 156.41 45.36 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.9 t -150.84 132.84 15.2 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -122.47 96.2 4.94 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 38' ' ' THR . 51.9 t-80 -72.21 100.36 2.56 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.506 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 58.4 mtt -79.02 140.34 37.97 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 174.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -149.87 150.49 32.0 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.266 0.627 . . . . 0.0 109.637 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -70.87 160.28 33.08 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 122.946 0.498 . . . . 0.0 110.698 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -91.82 -29.72 16.59 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.154 0.582 . . . . 0.0 109.631 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -102.86 0.22 32.25 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.254 1.422 . . . . 0.0 111.157 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.85 154.16 25.54 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-N 116.019 -0.537 . . . . 0.0 112.265 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.4 t -80.89 -4.11 53.72 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 124.158 0.983 . . . . 0.0 111.009 176.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.26 136.99 48.38 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 111.547 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.5 165.79 26.66 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 123.246 0.341 . . . . 0.0 113.942 -172.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.506 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 71.0 t80 -141.83 125.76 17.17 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.07 1.348 . . . . 0.0 108.276 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -84.59 122.23 28.74 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 172.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -116.08 81.3 1.58 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 176.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.2 t -123.23 148.49 45.8 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.207 -169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.63 -174.64 39.38 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.64 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.6 m -129.97 124.25 32.57 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.966 0.906 . . . . 0.0 109.114 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.577 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 80.6 m-85 -65.64 123.58 20.09 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.083 0.553 . . . . 0.0 110.822 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.45 HG21 HG23 ' A' ' 82' ' ' VAL . 25.5 p -100.11 -24.13 14.67 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.099 0.96 . . . . 0.0 110.899 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.8 ttm180 -149.84 125.8 10.55 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.77 0.828 . . . . 0.0 108.939 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.21 95.53 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 171.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 36.2 tt0 -106.35 71.61 0.88 Allowed 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -69.24 129.59 91.78 Favored Pre-proline 0 CA--C 1.545 0.762 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.901 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 26.4 Cg_endo -102.36 10.3 16.41 Favored 'Cis proline' 0 C--N 1.374 1.909 0 CA-C-N 119.32 0.793 . . . . 0.0 113.677 -5.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 13' ' ' ILE . 40.1 p -82.02 -11.12 58.99 Favored 'General case' 0 N--CA 1.473 0.711 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -166.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 18.8 ttp180 -170.49 146.95 2.87 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 118.335 0.516 . . . . 0.0 111.077 -176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 28.9 tp -142.53 123.08 14.09 Favored 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 123.816 0.846 . . . . 0.0 108.842 173.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.586 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 23.0 t -124.44 145.87 49.24 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.577 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 18.1 p90 -160.58 144.16 13.6 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.182 -177.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.45 HG23 HG21 ' A' ' 71' ' ' THR . 87.6 t -107.03 127.86 62.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 176.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.3 mmt -72.54 161.57 30.62 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.85 0.86 . . . . 0.0 109.733 -177.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -67.88 -14.27 62.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.805 0.842 . . . . 0.0 111.568 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -90.94 7.6 39.34 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.745 0.818 . . . . 0.0 110.822 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 80.74 -2.43 79.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 123.169 0.414 . . . . 0.0 113.482 178.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.5 mmp_? -70.8 107.22 3.89 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.258 0.623 . . . . 0.0 109.401 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -78.01 138.29 38.74 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 98.3 t -135.49 128.58 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -175.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -133.55 104.04 6.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.417 0.627 . . . . 0.0 109.937 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.504 HG22 ' HG2' ' A' ' 104' ' ' GLU . 5.3 t -93.79 135.2 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -125.61 122.35 36.2 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.701 0.8 . . . . 0.0 108.999 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -106.88 104.71 14.45 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -90.06 116.01 27.76 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 45.3 p -70.68 117.54 12.34 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 175.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -118.67 151.49 50.01 Favored Pre-proline 0 N--CA 1.484 1.243 0 C-N-CA 124.307 1.043 . . . . 0.0 110.095 -169.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -63.35 -15.63 49.52 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 122.536 2.157 . . . . 0.0 113.074 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.14 -9.14 20.74 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.688 -0.507 . . . . 0.0 113.955 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 169.24 -129.42 1.85 Allowed Glycine 0 C--N 1.348 1.195 0 CA-C-N 117.886 0.843 . . . . 0.0 113.266 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.7 m -146.08 110.95 5.23 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 124.563 1.145 . . . . 0.0 108.698 178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -86.34 99.65 11.75 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.743 0.817 . . . . 0.0 109.025 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 58.6 t -88.82 113.45 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.002 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -100.54 163.91 12.14 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 172.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.504 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.5 OUTLIER -152.67 139.26 18.73 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.3 m -137.17 111.27 8.35 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -117.19 129.98 56.3 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.1 109.98 2.01 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 167.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.77 179.55 6.47 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.784 -174.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -95.46 124.25 39.4 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.232 175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.2 t -71.0 -12.36 61.49 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-O 120.914 0.387 . . . . 0.0 110.329 171.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.1 t -69.18 -32.56 71.95 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.206 1.003 . . . . 0.0 111.703 175.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -108.63 162.08 14.48 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.276 0.63 . . . . 0.0 109.996 177.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 22.2 p -74.27 124.96 90.33 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.273 0.629 . . . . 0.0 110.644 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -54.92 -35.98 90.74 Favored 'Trans proline' 0 C--N 1.382 2.296 0 C-N-CA 123.477 2.785 . . . . 0.0 114.348 -176.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.98 -43.67 94.98 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 122.975 0.51 . . . . 0.0 111.849 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -64.2 -49.29 72.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.927 0.891 . . . . 0.0 110.819 179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -64.12 -39.86 94.95 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.074 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -63.94 -45.96 86.89 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.379 178.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -63.45 -32.67 74.18 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.695 0.798 . . . . 0.0 111.752 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -72.22 -53.89 8.55 Favored Glycine 0 C--N 1.341 0.816 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.87 -179.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 38.3 m95 -65.93 -32.06 73.34 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.701 0.4 . . . . 0.0 111.162 177.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -73.63 -27.89 61.51 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.59 -39.19 97.33 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 170.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 76.9 mt -74.1 -38.41 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 124.297 1.039 . . . . 0.0 111.618 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 44.9 tp -75.78 -36.23 59.86 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.973 0.509 . . . . 0.0 110.211 -176.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.9 -27.87 62.13 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.158 173.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -68.37 -40.63 81.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.019 0.527 . . . . 0.0 109.648 172.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.404 ' O ' HG23 ' A' ' 132' ' ' VAL . 32.2 t80 -66.75 -43.34 84.4 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.385 0.674 . . . . 0.0 110.155 175.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 28.0 ttmt -56.26 -61.33 2.47 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.766 . . . . 0.0 110.266 177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 ttt85 -64.73 -26.19 68.25 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.846 -173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.429 ' HH ' ' HG ' ' A' ' 25' ' ' CYS . 37.3 t80 -57.88 -56.71 18.44 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 123.243 0.34 . . . . 0.0 110.351 170.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 128' ' ' PHE . 57.1 t -67.71 -35.28 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.326 0.65 . . . . 0.0 110.793 -174.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 14.0 mm-40 -71.75 -44.41 64.12 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.43 0.692 . . . . 0.0 111.187 -178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -76.69 -25.81 54.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.235 0.614 . . . . 0.0 110.675 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.57 -52.39 32.36 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.379 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.76 -38.46 3.17 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 115.36 -0.837 . . . . 0.0 112.777 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.3 mt 60.92 105.43 0.02 OUTLIER 'General case' 0 C--N 1.36 1.038 0 C-N-CA 125.641 1.576 . . . . 0.0 110.492 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -58.27 101.82 0.09 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.429 1.092 . . . . 0.0 113.199 -161.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.47 108.33 7.18 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 169.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 62.08 75.72 0.39 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.168 0.987 . . . . 0.0 109.712 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -64.72 -46.5 82.01 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.407 -174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -68.54 -32.74 72.89 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.712 176.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 24.8 p-80 46.22 -161.55 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 125.498 1.519 . . . . 0.0 112.055 -176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 . . . . . 0 C--O 1.248 1.015 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.063 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 67.9 mttm -120.09 125.6 48.67 Favored 'General case' 0 C--O 1.239 0.502 0 C-N-CA 123.56 0.744 . . . . 0.0 109.676 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.543 HD11 ' HB3' ' A' ' 114' ' ' PRO . 59.9 mt -84.6 136.54 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.09 0.956 . . . . 0.0 109.022 175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 37.0 m -118.22 122.05 42.0 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.517 0.727 . . . . 0.0 109.872 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 44.0 pt -121.36 171.87 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.247 1.019 . . . . 0.0 110.287 175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 102' ' ' VAL . 10.8 pt-20 -150.94 169.21 22.3 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.413 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -164.98 127.77 2.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.975 1.31 . . . . 0.0 109.173 170.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.7 m-70 -96.97 86.61 4.03 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.474 HG12 ' HG3' ' A' ' 129' ' ' LYS . 32.3 mt -74.01 117.86 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -75.29 82.21 2.41 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 122.009 0.909 . . . . 0.0 109.329 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -162.49 166.15 25.25 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.512 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.27 142.2 54.18 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.979 0.912 . . . . 0.0 110.224 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 tt -65.28 -26.08 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 123.241 0.617 . . . . 0.0 110.465 -179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -65.72 -44.52 85.8 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.335 0.654 . . . . 0.0 110.319 174.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.23 -36.02 63.88 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.665 -176.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -50.65 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.446 174.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.44 ' HH2' HD13 ' A' ' 79' ' ' LEU . 52.4 t-105 -63.12 -38.59 91.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.138 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 70.3 t90 -59.97 -51.79 68.17 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.35 0.407 . . . . 0.0 110.151 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.39 -32.21 73.58 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.283 0.633 . . . . 0.0 111.418 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -68.15 -32.05 72.05 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.479 0.712 . . . . 0.0 111.096 178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -100.07 -27.55 13.5 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.004 0.922 . . . . 0.0 112.301 -171.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -73.15 122.46 87.7 Favored Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 123.799 0.84 . . . . 0.0 111.369 -170.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -60.0 -36.28 90.28 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 123.122 2.548 . . . . 0.0 113.994 -175.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.49 -36.23 68.37 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.891 0.476 . . . . 0.0 110.64 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 88.6 m -66.66 -51.97 50.16 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.697 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.6 mt -56.66 -34.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.866 1.267 . . . . 0.0 111.819 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.74 -27.96 68.33 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.641 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 ttt180 -88.9 -55.22 3.78 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.585 0.754 . . . . 0.0 110.863 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -83.58 -168.08 1.97 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 118.255 0.48 . . . . 0.0 110.053 175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.419 ' HA ' HG23 ' A' ' 124' ' ' ILE . 3.4 t-20 82.27 -42.5 0.13 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 125.075 1.35 . . . . 0.0 112.667 171.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -54.9 127.55 29.2 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 123.396 0.679 . . . . 0.0 110.245 174.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.71 62.13 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.998 0.919 . . . . 0.0 112.747 -174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 80.2 p -158.69 176.24 12.62 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.587 0.755 . . . . 0.0 109.871 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.9 m -73.39 -24.63 60.33 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.07 0.548 . . . . 0.0 110.651 173.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 57' ' ' ALA . 17.0 t70 -63.56 -35.35 80.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.824 174.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -96.87 151.74 19.38 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.825 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -135.34 122.71 21.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.5 m -69.26 101.66 1.54 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 50.6 p -85.66 -27.15 25.57 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.242 1.017 . . . . 0.0 110.819 -170.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.2 144.77 7.19 Favored Glycine 0 C--N 1.336 0.562 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.598 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.0 m -138.87 133.71 32.33 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.337 0.655 . . . . 0.0 110.052 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 mtm105 -97.88 144.68 27.2 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 165.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG13 ' HZ ' ' A' ' 70' ' ' PHE . 96.0 t -140.52 100.76 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 173.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -92.67 78.02 4.88 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 177.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.26 66.29 1.72 Allowed 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 124.453 1.101 . . . . 0.0 111.663 -167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.7 m -144.76 153.03 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 126.729 2.012 . . . . 0.0 108.066 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 72' ' ' ARG . 92.9 t -70.16 105.03 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 120.32 -22.9 8.24 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.95 172.71 49.08 Favored Glycine 0 C--N 1.345 1.047 0 N-CA-C 112.17 -0.372 . . . . 0.0 112.17 175.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.1 ttp-105 -136.47 149.41 48.2 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 117.235 0.517 . . . . 0.0 110.371 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 18.3 p90 -110.57 160.88 16.25 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.0 p -158.67 118.9 3.22 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 54.5 m-70 -106.95 99.66 9.21 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -76.02 122.23 23.92 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 62.9 mtt -117.48 143.48 46.0 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -154.31 137.01 15.22 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 35' ' ' ASP . . . -64.42 154.66 34.97 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.956 169.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -50.47 -43.18 55.26 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 -166.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -72.54 -26.47 61.76 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.79 16.25 49.23 Favored Glycine 0 C--N 1.349 1.281 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.726 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.5 t -78.41 -37.92 42.78 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.895 0.878 . . . . 0.0 111.461 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.06 128.28 55.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.408 0.683 . . . . 0.0 109.387 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.4 154.55 22.09 Favored Glycine 0 C--N 1.347 1.185 0 O-C-N 123.734 0.646 . . . . 0.0 112.191 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -148.3 143.57 27.01 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.799 1.24 . . . . 0.0 108.785 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -119.35 109.3 15.63 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.537 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 16.0 t80 -89.32 90.42 8.32 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.6 p -95.88 167.48 11.23 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.677 -177.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . 175.96 116.37 0.45 Allowed Glycine 0 C--N 1.345 1.04 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.679 176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.5 m -84.56 122.97 29.77 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.439 ' HZ ' HG13 ' A' ' 43' ' ' VAL . 88.3 m-85 -65.0 111.21 2.76 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.82 0.848 . . . . 0.0 110.315 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.0 p -87.46 -27.24 22.81 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.062 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.5 ' HG2' ' HG2' ' A' ' 74' ' ' GLU . 37.5 ttm-85 -161.88 128.06 3.68 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.856 0.863 . . . . 0.0 109.742 175.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 96.3 t -107.55 103.97 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 72' ' ' ARG . 13.7 mm-40 -102.02 54.9 0.8 Allowed 'General case' 0 C--O 1.213 -0.847 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -65.63 129.98 94.47 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.847 -0.596 . . . . 0.0 111.555 -172.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.9 Cg_endo -98.11 10.4 32.89 Favored 'Cis proline' 0 C--N 1.379 2.164 0 CA-C-N 119.886 0.995 . . . . 0.0 113.362 -4.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.7 m -66.53 -34.36 77.73 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 125.515 1.526 . . . . 0.0 112.925 -169.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.43 ' HG3' ' HA ' ' A' ' 92' ' ' GLN . 31.8 ttp180 -166.48 159.66 14.68 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.212 0.605 . . . . 0.0 110.118 -174.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.44 HD13 ' HH2' ' A' ' 17' ' ' TRP . 19.2 tp -137.94 114.85 10.73 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.965 0.506 . . . . 0.0 109.827 175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -104.6 126.6 51.83 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 124.287 1.035 . . . . 0.0 109.13 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.534 ' CE2' ' HB ' ' A' ' 89' ' ' VAL . 32.1 p90 -154.35 158.25 39.81 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.19 0.519 . . . . 0.0 110.564 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.8 t -128.15 127.67 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.412 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 52.5 ttm -69.12 151.29 46.58 Favored 'General case' 0 C--O 1.241 0.63 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.41 -11.58 59.87 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 118.359 0.527 . . . . 0.0 111.495 -175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -84.49 0.1 50.99 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.506 1.122 . . . . 0.0 110.206 176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.11 -16.98 56.7 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.857 0.741 . . . . 0.0 113.572 177.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.509 ' NH2' ' HG3' ' A' ' 109' ' ' GLU . 3.8 mpt_? -76.28 108.8 9.48 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.62 0.768 . . . . 0.0 110.739 -170.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -86.18 132.19 34.07 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.964 0.906 . . . . 0.0 109.471 -175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.534 ' HB ' ' CE2' ' A' ' 81' ' ' PHE . 23.7 t -134.09 131.88 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.063 0.945 . . . . 0.0 108.858 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -127.22 108.3 10.77 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.0 t -99.33 107.23 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.528 HE22 ' HB2' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -101.06 123.45 45.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.584 1.154 . . . . 0.0 108.422 -172.375 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -105.82 97.87 7.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -176.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.528 ' HB2' HE22 ' A' ' 92' ' ' GLN . . . -97.95 96.67 8.33 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.353 0.661 . . . . 0.0 110.466 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.9 p -61.23 130.41 46.1 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 122.702 0.401 . . . . 0.0 109.988 176.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -139.7 158.06 68.76 Favored Pre-proline 0 N--CA 1.475 0.779 0 C-N-CA 124.124 0.97 . . . . 0.0 109.5 -170.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.18 85.83 0.33 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.28 1.987 . . . . 0.0 110.73 172.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 142.58 -14.6 2.47 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.621 -0.718 . . . . 0.0 113.342 -177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.94 -126.55 1.61 Allowed Glycine 0 C--N 1.348 1.212 0 CA-C-N 117.738 0.769 . . . . 0.0 113.491 174.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.2 m -146.07 113.37 6.24 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.006 0.922 . . . . 0.0 109.123 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 18.1 t90 -80.14 97.72 7.0 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 6' ' ' GLU . 58.9 t -87.02 98.69 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 4' ' ' SER . 54.8 tp60 -102.2 106.59 17.44 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.845 -176.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -99.07 142.68 30.25 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.437 0.695 . . . . 0.0 109.69 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 96.0 m -137.2 120.17 16.5 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.839 0.856 . . . . 0.0 109.354 175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -136.0 145.28 45.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.652 1.181 . . . . 0.0 108.669 -174.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 1.2 p30 -81.7 150.08 28.17 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-O 121.483 0.658 . . . . 0.0 111.803 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -82.13 138.15 34.82 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.26 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.597 ' HG2' ' H ' ' A' ' 111' ' ' SER . 37.0 tt0 -101.63 147.24 26.66 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.451 1.5 . . . . 0.0 109.574 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.8 p -82.78 -19.31 38.03 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.573 0.582 . . . . 0.0 112.573 -178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.597 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 16.1 m -72.4 -53.15 13.08 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.99 0.516 . . . . 0.0 110.507 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 175.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 81.5 p -66.87 151.57 96.74 Favored Pre-proline 0 CA--C 1.554 1.114 0 O-C-N 123.544 0.528 . . . . 0.0 111.098 -175.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.543 ' HB3' HD11 ' A' ' 3' ' ' ILE . 71.0 Cg_exo -46.65 -36.4 18.88 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.877 3.051 . . . . 0.0 114.08 178.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.32 69.82 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.57 0.748 . . . . 0.0 112.093 175.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -61.28 -49.11 78.37 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.193 0.597 . . . . 0.0 110.375 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -57.82 -59.47 5.18 Favored 'General case' 0 C--N 1.347 0.472 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.913 -178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -58.86 -33.28 70.28 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.696 0.799 . . . . 0.0 111.23 -175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.1 -36.7 82.51 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.802 0.441 . . . . 0.0 110.958 175.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.73 -54.66 17.56 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.33 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CH2' HG21 ' A' ' 89' ' ' VAL . 97.4 m95 -62.58 -45.75 91.46 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.629 0.772 . . . . 0.0 111.546 -178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -60.14 -39.7 87.24 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.006 0.523 . . . . 0.0 110.33 177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.34 -43.28 98.78 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 113.19 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.419 HG23 ' HA ' ' A' ' 30' ' ' ASN . 81.1 mt -70.05 -33.0 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.496 0.718 . . . . 0.0 110.447 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 40.5 tp -74.52 -41.48 60.57 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.77 0.828 . . . . 0.0 110.876 -176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -68.31 -32.2 72.16 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.469 0.708 . . . . 0.0 111.165 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -72.38 -33.7 67.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.033 0.533 . . . . 0.0 109.886 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -71.79 -50.42 30.06 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.185 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HG3' HG12 ' A' ' 9' ' ' ILE . 34.0 ttpt -56.8 -49.4 75.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.457 1.103 . . . . 0.0 110.665 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -58.58 -38.7 78.47 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 124.135 0.897 . . . . 0.0 111.222 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -62.82 -53.57 52.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.119 0.568 . . . . 0.0 110.925 178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 137' ' ' LEU . 57.7 t -68.32 -44.37 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.271 0.628 . . . . 0.0 110.84 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -59.89 -51.38 69.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.48 1.112 . . . . 0.0 110.357 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.29 -32.64 71.92 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 122.999 0.52 . . . . 0.0 111.053 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.51 -32.85 73.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.368 0.667 . . . . 0.0 110.555 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 63.7 55.42 25.05 Favored Glycine 0 C--N 1.348 1.24 0 O-C-N 123.994 0.809 . . . . 0.0 112.02 178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 132' ' ' VAL . 93.5 mt -71.13 9.42 0.74 Allowed 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.3 1.04 . . . . 0.0 113.428 -172.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.42 3.4 18.56 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.767 1.227 . . . . 0.0 112.034 171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -61.42 93.03 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.512 0.672 . . . . 0.0 110.995 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -84.83 175.14 9.32 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.593 172.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 61.4 83.65 0.15 Allowed 'General case' 0 N--CA 1.482 1.161 0 O-C-N 123.961 0.788 . . . . 0.0 109.639 -177.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -164.09 -179.92 6.51 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.784 -176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -163.64 -59.55 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.815 0.846 . . . . 0.0 109.611 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 . . . . . 0 N--CA 1.481 1.108 0 C-N-CA 124.938 1.295 . . . . 0.0 107.718 -177.536 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttp . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.4 pttm -78.85 137.31 37.62 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.721 0.408 . . . . 0.0 110.381 -175.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 73.5 mt -126.26 131.95 70.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 124.863 1.265 . . . . 0.0 108.56 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.4 m -99.21 130.6 45.52 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.355 0.662 . . . . 0.0 109.275 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 28.5 pt -118.6 167.04 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 124.874 1.269 . . . . 0.0 108.124 170.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.87 157.11 43.37 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -174.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -169.32 121.99 0.76 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.693 1.197 . . . . 0.0 109.225 174.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 23.9 p80 -97.87 99.1 10.4 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.0 mt -73.59 128.47 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -77.37 63.61 2.59 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.517 0.675 . . . . 0.0 110.562 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.636 HE21 ' HB2' ' A' ' 137' ' ' LEU . 5.1 tp60 -159.13 154.86 26.22 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.114 0.965 . . . . 0.0 109.698 -173.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -63.02 145.32 55.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.24 1.016 . . . . 0.0 110.993 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.702 HD11 ' HA ' ' A' ' 77' ' ' THR . 18.6 tt -60.08 -33.2 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.2 1.0 . . . . 0.0 111.939 -177.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -71.84 -40.15 69.25 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.126 0.57 . . . . 0.0 111.111 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.54 ' HA ' ' CD1' ' A' ' 18' ' ' TRP . . . -70.59 -38.29 74.0 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 122.765 0.426 . . . . 0.0 111.383 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 77.2 t -62.82 -39.55 85.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.874 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.851 171.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.3 t-105 -67.29 -48.38 67.82 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.54 ' CD1' ' HA ' ' A' ' 15' ' ' ALA . 31.2 p-90 -71.27 -28.86 64.45 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.565 0.62 . . . . 0.0 110.349 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.04 -31.09 72.15 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.915 0.486 . . . . 0.0 111.106 170.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 35.7 t-105 -77.72 -34.77 52.53 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 123.747 0.819 . . . . 0.0 110.598 176.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.02 -37.23 20.63 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.557 0.743 . . . . 0.0 110.71 -170.125 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 16.2 t70 -60.84 119.47 44.87 Favored Pre-proline 0 N--CA 1.482 1.162 0 C-N-CA 123.914 0.885 . . . . 0.0 110.721 -168.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.59 -36.17 86.76 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 123.148 2.565 . . . . 0.0 113.219 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 28' ' ' ARG . 22.8 t70 -72.52 -28.25 62.75 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.589 178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 22' ' ' ASP . 98.0 m -73.12 -38.71 66.21 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.875 0.47 . . . . 0.0 110.437 173.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.407 HG22 HG21 ' A' ' 38' ' ' THR . 39.7 mm -53.78 -37.85 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 123.381 0.673 . . . . 0.0 110.403 172.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -64.44 -29.95 71.0 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.098 175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 24' ' ' ASP . 71.6 mtt180 -81.01 -58.72 2.95 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.551 0.74 . . . . 0.0 110.511 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.1 p-90 -93.57 -149.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 123.358 0.663 . . . . 0.0 109.307 175.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.4 t30 83.13 -54.11 0.17 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 126.399 1.88 . . . . 0.0 108.924 -178.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' HG3' ' A' ' 55' ' ' MET . . . -87.24 114.74 24.12 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 161.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 124' ' ' ILE . . . -72.82 -53.79 10.54 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.314 0.645 . . . . 0.0 109.647 176.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.2 m -63.18 130.19 43.54 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.682 -1.144 . . . . 0.0 111.802 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.6 p -72.47 -8.75 56.73 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.213 1.005 . . . . 0.0 112.41 -177.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -73.01 -21.74 60.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.835 0.854 . . . . 0.0 111.001 172.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 78.4 m95 -122.19 170.36 9.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.494 1.117 . . . . 0.0 108.977 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -172.88 144.06 1.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.078 0.951 . . . . 0.0 109.08 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.54 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 12.0 m -72.54 107.5 5.1 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -83.64 -26.05 30.24 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.489 0.716 . . . . 0.0 110.768 -176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.1 154.32 25.25 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -165.05 128.44 2.31 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 117.24 0.52 . . . . 0.0 111.755 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -89.67 139.65 30.34 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 163.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.0 t -136.63 104.01 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 177.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -110.74 73.87 0.85 Allowed 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 175.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.3 tp -74.43 77.78 1.91 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.053 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.4 m -144.88 166.27 11.74 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 126.05 1.74 . . . . 0.0 108.049 175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.1 t -73.77 105.13 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 176.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.17 -3.81 40.9 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.454 -0.794 . . . . 0.0 112.389 -176.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -84.65 146.93 22.66 Favored Glycine 0 C--N 1.347 1.172 0 N-CA-C 112.264 -0.335 . . . . 0.0 112.264 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 8.0 mpt_? -99.62 167.74 10.39 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.297 0.639 . . . . 0.0 109.928 -173.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -152.5 158.01 41.95 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 67' ' ' THR . 54.7 m -152.29 127.41 9.77 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 87.9 m-70 -115.83 94.72 4.8 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -67.77 102.15 1.18 Allowed 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.478 ' HG3' ' HB2' ' A' ' 31' ' ' ALA . 43.8 ttm -96.72 103.54 15.47 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.92 156.34 25.2 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.336 1.054 . . . . 0.0 109.879 -172.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -81.15 165.88 21.17 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 122.671 0.388 . . . . 0.0 111.25 -177.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -68.0 -58.1 5.08 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.494 0.718 . . . . 0.0 111.284 -172.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -104.01 -15.0 15.73 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.897 0.479 . . . . 0.0 110.141 174.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -87.42 131.74 10.78 Favored Glycine 0 C--N 1.344 1.003 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.951 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.5 m -84.97 5.59 28.56 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.573 0.749 . . . . 0.0 112.03 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.48 152.51 42.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.163 0.585 . . . . 0.0 109.879 171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.62 117.71 0.79 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 116.441 -0.345 . . . . 0.0 112.831 -173.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -95.04 118.59 32.12 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.049 0.94 . . . . 0.0 108.926 172.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -91.43 130.42 37.27 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.769 0.427 . . . . 0.0 110.423 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.473 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 37.4 t80 -100.87 88.44 3.56 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.674 HG22 ' SG ' ' A' ' 52' ' ' CYS . 5.3 p -87.26 171.25 10.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.564 0.746 . . . . 0.0 111.751 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 163.46 -177.44 39.39 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.196 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 31.9 m -142.57 126.43 17.15 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 124.492 1.117 . . . . 0.0 108.867 175.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.514 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 77.8 m-85 -65.95 112.72 3.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.823 0.849 . . . . 0.0 110.047 176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 82' ' ' VAL . 46.5 p -84.88 -29.53 25.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.455 0.702 . . . . 0.0 110.725 -177.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 39.6 ttm180 -160.04 126.3 4.26 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 -178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.4 t -114.58 101.23 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -108.31 70.4 0.76 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -78.58 140.85 59.91 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 111.561 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -94.68 11.47 47.38 Favored 'Cis proline' 0 C--N 1.373 1.858 0 C-N-CA 124.906 -0.873 . . . . 0.0 113.17 -2.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.702 ' HA ' HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -86.55 -13.96 44.32 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -163.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -170.16 148.15 3.28 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.21 0.529 . . . . 0.0 110.527 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 28.6 tp -140.94 116.97 10.51 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.799 0.84 . . . . 0.0 109.066 176.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.455 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 11.5 t -112.9 130.68 56.02 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -177.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 31.5 p90 -156.45 148.53 23.14 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.486 0.714 . . . . 0.0 110.17 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.403 HG23 HG21 ' A' ' 71' ' ' THR . 90.2 t -114.9 131.69 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.418 ' SD ' ' HH2' ' A' ' 121' ' ' TRP . 90.3 mtp -73.14 156.2 38.89 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.956 0.902 . . . . 0.0 109.215 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -65.56 -18.03 65.01 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.465 0.706 . . . . 0.0 111.672 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -88.81 3.98 49.24 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.822 0.849 . . . . 0.0 111.638 176.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 95.2 -8.35 69.67 Favored Glycine 0 C--N 1.353 1.519 0 C-N-CA 123.014 0.34 . . . . 0.0 113.736 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.42 ' HA ' ' HB3' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -72.94 104.88 4.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.222 0.609 . . . . 0.0 110.99 -176.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -82.49 106.73 14.6 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.52 0.728 . . . . 0.0 109.815 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 106' ' ' PHE . 21.6 t -110.29 122.4 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.696 0.798 . . . . 0.0 109.659 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -127.72 105.63 8.59 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 104' ' ' GLU . 26.0 t -93.67 114.49 30.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.243 1.017 . . . . 0.0 109.436 -177.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -99.7 138.41 36.81 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -119.7 102.16 8.41 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -89.06 116.34 27.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 27.0 p -68.12 117.9 10.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 122.929 0.492 . . . . 0.0 109.719 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -112.33 155.21 43.98 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 123.813 0.845 . . . . 0.0 109.569 -175.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.24 -22.5 53.48 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.188 1.926 . . . . 0.0 111.824 170.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -106.22 2.82 37.62 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.827 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 152.0 -124.01 1.58 Allowed Glycine 0 N--CA 1.473 1.1 0 CA-C-N 117.621 0.711 . . . . 0.0 112.48 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 85.1 m -148.7 113.17 5.3 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.138 0.975 . . . . 0.0 109.683 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 20.0 t90 -88.35 100.91 13.38 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.65 0.78 . . . . 0.0 109.423 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.4 t -89.43 117.83 33.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 123.687 0.795 . . . . 0.0 109.921 -175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -112.31 104.24 12.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.282 1.033 . . . . 0.0 109.153 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 91' ' ' VAL . 36.3 tt0 -96.29 110.18 22.54 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 42.3 m -99.86 106.76 18.64 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 50.5 p90 -117.3 139.7 50.5 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.729 0.811 . . . . 0.0 108.861 -173.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 32.3 t70 -75.25 131.98 40.74 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -125.35 161.79 26.22 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.576 1.151 . . . . 0.0 109.456 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -82.59 126.29 32.13 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.884 0.874 . . . . 0.0 110.403 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -21.22 63.76 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.734 0.814 . . . . 0.0 112.068 -178.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -80.04 -22.21 42.6 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.334 0.654 . . . . 0.0 111.201 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -101.26 156.57 17.36 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.509 0.724 . . . . 0.0 109.894 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 46.7 m -59.97 116.63 18.0 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 123.548 0.739 . . . . 0.0 111.117 -174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -52.25 -47.35 27.28 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 123.481 2.787 . . . . 0.0 113.178 -179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.59 -36.55 84.18 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.577 0.751 . . . . 0.0 112.68 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -64.57 -45.15 88.26 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.179 0.591 . . . . 0.0 110.669 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -71.66 -35.67 70.41 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.499 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.529 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 35.3 tt0 -57.82 -52.88 63.64 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 123.931 0.769 . . . . 0.0 109.773 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.51 -29.55 69.0 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.578 179.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.05 -56.05 16.14 Favored Glycine 0 C--N 1.348 1.23 0 C-N-CA 123.087 0.375 . . . . 0.0 112.772 -177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.418 ' HH2' ' SD ' ' A' ' 83' ' ' MET . 27.5 m95 -70.9 -31.97 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.205 0.602 . . . . 0.0 110.745 177.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.475 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 57.2 tp60 -58.3 -33.64 69.69 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -54.58 -42.33 76.3 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 123.429 0.456 . . . . 0.0 112.624 174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.48 ' HA ' ' HB2' ' A' ' 32' ' ' ALA . 1.9 mp -76.19 -42.92 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 123.617 0.767 . . . . 0.0 110.963 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 66.4 tp -70.75 -49.2 49.34 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.162 0.506 . . . . 0.0 111.011 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB2' ' NE2' ' A' ' 122' ' ' GLN . 15.5 t70 -58.4 -39.57 80.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.558 1.143 . . . . 0.0 110.729 176.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -63.1 -39.29 94.25 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.597 173.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -65.86 -31.85 73.04 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 123.674 0.609 . . . . 0.0 110.323 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -60.52 -46.07 91.51 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 122.857 0.463 . . . . 0.0 110.215 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -65.36 -37.45 87.09 Favored 'General case' 0 N--CA 1.484 1.243 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.817 175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.438 ' OH ' ' HD2' ' A' ' 28' ' ' ARG . 80.6 t80 -58.88 -54.36 47.93 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.669 0.788 . . . . 0.0 110.53 -178.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.34 -49.41 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 O-C-N 124.066 0.854 . . . . 0.0 111.11 -176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -72.31 -30.83 65.14 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.087 0.555 . . . . 0.0 112.109 -174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -83.91 -31.42 25.67 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 122.557 0.343 . . . . 0.0 110.264 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.74 91.36 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.54 75.39 0.56 Allowed Glycine 0 C--N 1.351 1.366 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.635 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.636 ' HB2' HE21 ' A' ' 11' ' ' GLN . 25.8 mt -88.91 23.45 2.36 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 123.793 0.837 . . . . 0.0 110.575 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -69.17 102.87 1.77 Allowed 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.525 1.13 . . . . 0.0 109.949 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.7 p80 -88.44 55.02 3.24 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.821 0.82 . . . . 0.0 110.019 177.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -173.07 157.9 3.59 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.14 1.376 . . . . 0.0 108.332 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 67.65 97.29 0.06 Allowed 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.7 1.2 . . . . 0.0 110.24 -173.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -98.41 156.44 16.75 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.553 0.741 . . . . 0.0 110.506 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 77.7 m-70 -85.88 95.29 9.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.205 0.602 . . . . 0.0 110.568 -177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 118.41 -0.805 . . . . 0.0 109.185 175.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ttt . . . . . 0 N--CA 1.485 1.318 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 98.4 mttt -106.61 111.18 23.61 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 59.5 mt -90.49 125.62 43.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 105' ' ' THR . 65.5 p -102.02 151.77 21.75 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.12 0.568 . . . . 0.0 109.519 174.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.2 pt -129.96 137.92 55.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 124.724 1.209 . . . . 0.0 107.809 174.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' HB3' ' NE1' ' A' ' 101' ' ' TRP . 7.2 mp0 -119.86 151.28 39.11 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.923 0.489 . . . . 0.0 109.905 -174.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -155.15 129.6 9.06 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.739 0.816 . . . . 0.0 110.045 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -89.06 82.57 6.62 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.535 HD12 HG21 ' A' ' 102' ' ' VAL . 30.9 mt -74.7 118.46 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -89.93 71.48 7.52 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 122.318 1.056 . . . . 0.0 109.119 -170.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -160.35 158.95 30.56 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 113.892 -1.503 . . . . 0.0 108.147 -174.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.26 136.58 57.31 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.777 0.831 . . . . 0.0 110.321 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.38 -32.25 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 C-N-CA 124.141 0.976 . . . . 0.0 111.466 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -70.33 -40.36 74.19 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 123.718 0.807 . . . . 0.0 110.439 178.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.609 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -70.94 -37.28 72.84 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 123.28 0.363 . . . . 0.0 111.79 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.37 -35.64 75.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.42 0.688 . . . . 0.0 109.875 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.7 t-105 -66.03 -50.53 63.9 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 123.209 0.604 . . . . 0.0 111.976 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.609 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 19.9 p-90 -72.24 -26.45 62.02 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.397 0.544 . . . . 0.0 110.984 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.87 -26.47 61.46 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.869 0.468 . . . . 0.0 111.016 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.456 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 24.7 t-105 -78.73 -29.54 45.36 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.015 0.526 . . . . 0.0 109.773 174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.28 -35.81 47.49 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.409 0.683 . . . . 0.0 109.414 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -61.5 108.37 1.52 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 124.031 0.932 . . . . 0.0 111.405 -168.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.31 -27.55 83.31 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.158 2.572 . . . . 0.0 112.783 -176.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.32 -37.42 77.72 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.602 0.761 . . . . 0.0 110.504 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.1 t -67.4 -48.1 68.35 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 HG21 ' A' ' 43' ' ' VAL . 58.3 mt -62.89 -25.94 39.66 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 124.763 1.225 . . . . 0.0 111.748 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.31 -27.61 68.73 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 122.173 -0.33 . . . . 0.0 110.802 174.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -88.01 -60.59 1.93 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 123.463 0.705 . . . . 0.0 110.859 177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -90.56 118.25 29.87 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.646 HD21 ' HB3' ' A' ' 53' ' ' HIS . 63.6 t30 -175.64 -44.52 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB2' ' SD ' ' A' ' 55' ' ' MET . . . -114.45 114.99 26.56 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.645 0.778 . . . . 0.0 108.927 175.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.66 -50.55 64.53 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.479 0.711 . . . . 0.0 111.095 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 m -61.72 126.14 26.3 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.115 0.566 . . . . 0.0 110.713 172.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' HE3' ' A' ' 58' ' ' LYS . 72.2 p -74.95 -10.72 59.75 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.052 0.941 . . . . 0.0 111.608 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -65.89 -25.29 67.1 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.241 0.616 . . . . 0.0 110.618 168.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -109.72 167.02 10.46 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 124.168 0.987 . . . . 0.0 108.789 -177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -161.0 163.45 31.69 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.5 m -76.41 121.24 22.77 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 169.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.7 m -87.55 -22.02 25.07 Favored 'General case' 0 CA--C 1.556 1.18 0 C-N-CA 123.207 0.603 . . . . 0.0 109.705 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.55 136.04 2.12 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.557 174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 61.2 p -142.62 125.45 16.06 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 117.957 0.878 . . . . 0.0 110.863 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -116.07 126.31 53.58 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 169.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 26' ' ' ILE . 69.0 t -125.93 116.42 45.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -113.06 91.97 3.84 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.2 tp -78.71 79.19 5.14 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.281 -170.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.35 164.44 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.152 0.981 . . . . 0.0 108.682 171.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 46.8 t -73.92 106.76 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 99.92 1.04 56.16 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.127 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -82.99 157.84 35.85 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.837 -0.505 . . . . 0.0 111.837 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -112.79 156.69 22.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.57 0.7 . . . . 0.0 112.151 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -124.59 151.71 44.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.586 1.155 . . . . 0.0 108.659 172.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HB3' HG22 ' A' ' 67' ' ' THR . 7.5 p -145.07 118.76 9.18 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.25 1.02 . . . . 0.0 109.715 175.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.646 ' HB3' HD21 ' A' ' 30' ' ' ASN . 75.7 m-70 -109.19 84.64 1.96 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.701 0.801 . . . . 0.0 109.638 179.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -74.69 114.45 13.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.475 ' SD ' ' HB2' ' A' ' 31' ' ' ALA . 57.1 mtm -125.3 151.91 45.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.775 0.83 . . . . 0.0 109.185 178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -160.3 164.8 32.3 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.638 177.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.77 152.28 45.53 Favored 'General case' 0 C--O 1.242 0.693 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.382 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 34' ' ' SER . 9.7 mtmp? -66.32 -26.22 67.2 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.3 0.64 . . . . 0.0 111.337 177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.32 -16.28 35.54 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.651 0.78 . . . . 0.0 111.101 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.69 26.59 62.61 Favored Glycine 0 C--N 1.35 1.323 0 O-C-N 123.376 0.423 . . . . 0.0 112.17 -172.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.6 m -59.84 -35.12 74.1 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.282 1.033 . . . . 0.0 111.215 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -167.2 175.72 7.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.546 1.138 . . . . 0.0 109.168 173.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -147.62 150.63 22.89 Favored Glycine 0 C--N 1.347 1.153 0 N-CA-C 112.247 -0.341 . . . . 0.0 112.247 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -136.85 120.27 16.97 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.553 1.141 . . . . 0.0 109.616 175.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -108.63 140.59 41.78 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.963 0.905 . . . . 0.0 108.87 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -124.64 91.75 3.51 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.976 0.91 . . . . 0.0 109.527 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 52' ' ' CYS . 58.5 p -92.27 175.77 6.73 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.083 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.36 -178.46 34.6 Favored Glycine 0 C--N 1.333 0.386 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 172.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 55.9 m -120.83 134.22 55.3 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.968 0.507 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 83.0 m-85 -68.52 106.45 2.57 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.982 0.913 . . . . 0.0 109.065 170.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.0 p -82.33 -24.02 34.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.747 -175.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.549 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 36.4 ttp180 -159.97 121.31 3.16 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.87 0.868 . . . . 0.0 109.792 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.35 103.58 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.42 67.98 1.05 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.453 0.701 . . . . 0.0 109.291 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -72.12 138.27 81.86 Favored Pre-proline 0 N--CA 1.477 0.907 0 C-N-CA 123.463 0.705 . . . . 0.0 112.247 -169.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 36.2 Cg_endo -99.88 14.02 24.76 Favored 'Cis proline' 0 C--N 1.383 2.376 0 CA-C-N 119.467 0.845 . . . . 0.0 112.736 -4.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.566 HG22 ' HG3' ' A' ' 78' ' ' ARG . 59.1 m -70.28 -57.97 4.28 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.898 0.879 . . . . 0.0 111.433 -172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.566 ' HG3' HG22 ' A' ' 77' ' ' THR . 68.3 mtp180 -137.88 164.03 29.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 122.137 0.97 . . . . 0.0 111.379 -174.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.4 tp -137.5 145.83 43.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.524 173.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 49.9 m -143.11 135.17 27.0 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.653 0.781 . . . . 0.0 109.617 177.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 70' ' ' PHE . 15.6 p90 -155.95 167.09 31.51 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.86 0.864 . . . . 0.0 109.371 -177.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.2 t -129.1 135.39 62.1 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 65.5 mtm -79.56 158.14 27.22 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -58.98 -20.87 56.71 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 124.332 1.053 . . . . 0.0 111.822 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -65.59 -22.73 66.71 Favored 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 124.99 1.316 . . . . 0.0 111.173 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 106.26 -26.87 18.98 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.795 -0.638 . . . . 0.0 112.236 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 52.8 mtm180 -77.35 131.37 38.05 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 117.11 0.455 . . . . 0.0 111.181 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 133.11 34.99 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.333 1.053 . . . . 0.0 109.956 -174.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.1 t -127.53 129.49 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.732 0.813 . . . . 0.0 110.032 179.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -131.93 150.87 52.03 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 124.296 1.038 . . . . 0.0 108.56 176.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.456 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 21.3 t -124.31 140.78 46.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -123.94 124.58 42.91 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.689 0.796 . . . . 0.0 109.791 177.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -104.87 95.95 6.22 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.68 116.58 29.0 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.308 0.643 . . . . 0.0 110.727 -177.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.2 m -76.28 123.59 26.16 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.481 0.712 . . . . 0.0 110.517 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -142.84 164.34 32.84 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.486 0.714 . . . . 0.0 110.511 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -54.56 -25.13 39.53 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 122.81 2.34 . . . . 0.0 114.382 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.86 -19.1 68.47 Favored Glycine 0 C--N 1.348 1.212 0 N-CA-C 113.984 0.353 . . . . 0.0 113.984 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.68 -149.46 20.6 Favored Glycine 0 C--N 1.348 1.207 0 N-CA-C 112.214 -0.354 . . . . 0.0 112.214 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 36.6 m -93.92 108.56 20.34 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 172.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.443 ' NE1' ' HB3' ' A' ' 6' ' ' GLU . 16.9 t90 -83.44 94.33 7.98 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.535 HG21 HD12 ' A' ' 9' ' ' ILE . 60.5 t -89.12 126.04 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.38 -174.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.414 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 38.3 mt-30 -125.23 100.58 6.6 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -92.41 103.64 16.05 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 91.0 m -93.68 121.66 35.34 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 114.749 -1.114 . . . . 0.0 108.579 178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.474 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 34.3 p90 -132.17 141.07 48.97 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 23.0 t70 -76.06 135.24 39.91 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 173.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -90.11 156.47 18.34 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.618 1.167 . . . . 0.0 110.471 -176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -103.36 116.26 32.1 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.971 0.908 . . . . 0.0 109.773 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 13.1 t -70.58 -12.61 61.67 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 123.292 0.637 . . . . 0.0 111.788 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.8 t -77.77 -17.57 57.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.016 0.526 . . . . 0.0 110.102 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -116.56 168.27 10.32 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.285 1.034 . . . . 0.0 110.787 172.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 36.3 p -77.23 116.73 60.08 Favored Pre-proline 0 CA--C 1.554 1.104 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.992 176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -60.59 -35.83 88.2 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 123.517 2.811 . . . . 0.0 113.886 -172.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.66 88.1 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.928 0.491 . . . . 0.0 111.525 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -62.59 -43.86 97.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.255 0.622 . . . . 0.0 110.373 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -62.34 -46.38 88.94 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.585 178.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.474 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 53.3 tt0 -56.62 -42.83 79.47 Favored 'General case' 0 C--O 1.218 -0.584 0 C-N-CA 123.504 0.721 . . . . 0.0 110.73 178.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.43 -36.73 85.12 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.597 0.759 . . . . 0.0 111.518 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -69.03 -59.51 5.85 Favored Glycine 0 C--N 1.348 1.245 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.573 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.453 ' HA ' HD12 ' A' ' 124' ' ' ILE . 55.2 m95 -57.64 -40.89 80.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.941 0.496 . . . . 0.0 111.154 177.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -62.41 -36.73 83.28 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.25 -36.41 92.39 Favored Glycine 0 C--N 1.346 1.091 0 O-C-N 123.537 0.523 . . . . 0.0 112.898 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 121' ' ' TRP . 57.7 mt -70.98 -42.39 77.0 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 C-N-CA 123.924 0.889 . . . . 0.0 110.822 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 54.5 tp -71.72 -40.93 69.12 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.651 0.78 . . . . 0.0 110.873 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -62.51 -36.24 81.93 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.872 1.269 . . . . 0.0 110.337 174.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -69.14 -37.14 78.14 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.202 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.525 ' O ' HG23 ' A' ' 132' ' ' VAL . 19.8 t80 -68.17 -46.3 71.08 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 123.503 0.502 . . . . 0.0 110.466 176.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' GLU . 8.0 tmtm? -56.81 -53.0 62.86 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -56.67 -39.38 73.66 Favored 'General case' 0 N--CA 1.473 0.699 0 O-C-N 124.563 1.164 . . . . 0.0 111.028 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -60.82 -48.18 82.99 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.778 177.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.7 t -64.43 -33.82 65.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 O-C-N 123.494 0.496 . . . . 0.0 110.942 -176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' A' ' 129' ' ' LYS . 40.7 mm-40 -77.85 -36.66 49.68 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 122.504 0.322 . . . . 0.0 111.548 -177.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -84.31 -44.73 13.53 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.016 0.526 . . . . 0.0 110.72 -174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -74.51 -28.8 61.14 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.593 0.757 . . . . 0.0 110.726 175.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.2 -62.59 2.47 Favored Glycine 0 C--N 1.342 0.91 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.618 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.406 HD12 HG13 ' A' ' 132' ' ' VAL . 91.7 mt 65.39 23.89 12.02 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.554 1.141 . . . . 0.0 111.005 -177.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 49.92 105.2 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.498 1.519 . . . . 0.0 113.475 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.1 t-80 -66.92 -24.01 66.04 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -175.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -127.63 70.2 1.32 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.818 0.447 . . . . 0.0 110.852 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -58.22 -64.18 1.0 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.653 0.781 . . . . 0.0 110.48 170.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 52.03 77.28 0.15 Allowed 'General case' 0 C--N 1.358 0.939 0 O-C-N 124.293 0.996 . . . . 0.0 108.36 -170.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 62.4 t60 -48.16 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 O-C-N 124.656 1.222 . . . . 0.0 112.949 -163.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 10.2 p80 . . . . . 0 C--O 1.251 1.173 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.199 178.299 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ttt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' ASP . 25.3 pttm -76.11 125.01 28.35 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -176.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 62.1 mt -110.19 124.55 67.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 171.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.0 m -100.04 125.08 46.05 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.167 0.587 . . . . 0.0 110.225 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.8 pt -115.51 172.8 3.98 Favored 'Isoleucine or valine' 0 C--O 1.247 0.961 0 C-N-CA 125.249 1.42 . . . . 0.0 108.597 170.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -153.33 166.31 33.01 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.313 0.577 . . . . 0.0 111.861 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -156.84 121.61 4.52 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.96 1.304 . . . . 0.0 108.325 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -91.42 113.83 26.2 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.0 mt -105.17 119.82 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 C-N-CA 123.836 0.854 . . . . 0.0 109.662 -177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -76.85 86.49 3.43 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 175.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -168.06 160.17 11.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.972 1.709 . . . . 0.0 108.18 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 141.26 50.17 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 tt -58.49 -30.87 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 124.25 1.02 . . . . 0.0 112.196 -173.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -62.29 -42.37 99.3 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.944 0.498 . . . . 0.0 110.835 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' HA ' ' NE1' ' A' ' 18' ' ' TRP . . . -77.5 -32.92 54.49 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.989 -178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.6 t -64.6 -38.58 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 O-C-N 123.672 0.608 . . . . 0.0 110.046 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 74.2 t-105 -64.22 -50.73 66.88 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.415 0.686 . . . . 0.0 111.822 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.527 ' NE1' ' HA ' ' A' ' 15' ' ' ALA . 41.7 p-90 -71.1 -29.2 64.98 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 118.534 0.606 . . . . 0.0 110.614 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.01 68.88 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 122.399 0.28 . . . . 0.0 110.65 174.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.483 ' O ' HD11 ' A' ' 26' ' ' ILE . 31.6 t-105 -85.69 -22.85 27.67 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 122.817 0.447 . . . . 0.0 110.962 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 18' ' ' TRP . 2.5 t-20 -85.05 -37.53 20.22 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.268 0.627 . . . . 0.0 112.434 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.9 m-20 -77.24 110.94 13.82 Favored Pre-proline 0 N--CA 1.473 0.687 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.262 -168.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HB3' HG23 ' A' ' 43' ' ' VAL . 19.2 Cg_endo -56.94 -30.37 85.81 Favored 'Trans proline' 0 C--N 1.385 2.49 0 C-N-CA 123.916 3.077 . . . . 0.0 113.218 -177.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -68.37 -39.49 81.77 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.494 0.318 . . . . 0.0 110.353 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' CE2' ' A' ' 131' ' ' TYR . 47.6 t -67.86 -47.32 69.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 123.708 0.803 . . . . 0.0 110.642 177.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.546 HD12 HG21 ' A' ' 43' ' ' VAL . 52.3 mt -58.81 -40.27 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.971 0.908 . . . . 0.0 111.121 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -49.88 -25.36 3.11 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.273 1.029 . . . . 0.0 113.22 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -83.87 -58.81 2.64 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.689 176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 42.3 p-90 -86.27 -20.06 28.99 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -161.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.659 ' HA ' HG23 ' A' ' 124' ' ' ILE . 1.7 p-10 -71.25 -14.59 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 118.323 0.511 . . . . 0.0 110.575 -178.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.48 120.22 23.57 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 123.546 0.738 . . . . 0.0 109.229 168.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.404 ' HA ' ' ND2' ' A' ' 127' ' ' ASN . . . -79.73 7.08 9.23 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.75 0.82 . . . . 0.0 111.72 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.1 t -149.88 148.13 28.77 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 123.901 0.88 . . . . 0.0 109.333 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 66.5 m -71.77 -18.56 62.11 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.277 0.631 . . . . 0.0 110.842 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.28 -32.77 73.53 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.488 0.715 . . . . 0.0 109.805 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -100.93 155.52 17.91 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.601 -176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -158.08 133.13 8.6 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 30.9 m -81.78 112.09 18.62 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 m -85.53 -22.05 28.32 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 124.225 0.953 . . . . 0.0 111.01 -173.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -142.82 88.85 0.17 Allowed Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.8 t -112.65 111.06 21.59 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.931 0.893 . . . . 0.0 108.887 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 mtm105 -112.98 148.53 34.87 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 168.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.546 HG21 HD12 ' A' ' 26' ' ' ILE . 72.5 t -138.36 123.86 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.846 0.858 . . . . 0.0 109.168 173.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -110.92 78.99 1.16 Allowed 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.3 tp -68.74 78.48 0.3 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.364 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.1 m -144.55 152.16 15.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 125.615 1.566 . . . . 0.0 107.49 175.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.7 t -70.66 117.39 13.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.721 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 101.58 -19.53 50.07 Favored Glycine 0 CA--C 1.528 0.902 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.427 -175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -87.1 178.73 48.21 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.19 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -147.77 170.88 16.64 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 117.689 0.745 . . . . 0.0 112.207 -175.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -116.22 166.81 11.62 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.98 171.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 p -140.26 121.82 15.19 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.967 0.907 . . . . 0.0 109.114 173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -114.51 96.62 5.85 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 176.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -82.06 87.47 6.46 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.443 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 65.3 mtp -83.21 133.85 34.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.063 -0.972 . . . . 0.0 110.061 -177.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.27 145.41 45.53 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 124.11 0.964 . . . . 0.0 108.969 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.28 -177.2 4.48 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.379 0.672 . . . . 0.0 110.37 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -23.59 63.02 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.129 0.572 . . . . 0.0 111.834 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.64 -27.86 14.6 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.056 0.942 . . . . 0.0 112.022 -177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.44 -15.0 56.57 Favored Glycine 0 CA--C 1.537 1.468 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 177.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.8 m -76.48 -41.23 47.88 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 118.085 0.942 . . . . 0.0 109.342 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -75.71 109.63 9.46 Favored 'General case' 0 C--N 1.347 0.495 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 171.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.9 139.69 8.91 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 112.323 -0.311 . . . . 0.0 112.323 -177.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -130.13 125.73 35.79 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.031 0.933 . . . . 0.0 108.949 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -98.06 127.13 43.82 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -124.53 87.1 2.66 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.602 0.761 . . . . 0.0 109.367 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.8 p -93.71 141.5 28.42 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.232 173.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -145.64 125.2 2.25 Favored Glycine 0 C--N 1.35 1.31 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.5 m -91.59 122.13 33.89 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.353 0.661 . . . . 0.0 110.08 -176.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -69.36 108.29 3.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.618 0.767 . . . . 0.0 110.348 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -87.95 -22.15 24.49 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.952 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 24.9 ttt85 -156.22 118.84 4.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.148 0.579 . . . . 0.0 109.602 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.7 t -110.11 96.52 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -108.38 70.57 0.76 Allowed 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -178.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -66.85 131.89 93.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.692 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 43.9 Cg_endo -105.25 17.06 10.65 Favored 'Cis proline' 0 C--N 1.378 2.105 0 CA-C-N 119.566 0.881 . . . . 0.0 113.539 -7.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.1 p -74.6 -40.1 61.79 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.163 0.585 . . . . 0.0 112.432 -170.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -158.43 152.72 24.2 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.232 0.539 . . . . 0.0 110.687 -174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.8 tp -140.56 132.6 27.84 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.558 1.143 . . . . 0.0 109.155 -178.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 39.6 t -129.69 134.5 47.68 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.043 0.937 . . . . 0.0 109.096 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -156.34 151.39 26.32 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.917 0.887 . . . . 0.0 109.776 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.58 HG22 ' HG3' ' A' ' 88' ' ' GLU . 45.5 t -111.75 130.76 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.418 ' HG2' ' O ' ' A' ' 87' ' ' ARG . 23.7 ptp -76.87 165.77 24.25 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -70.85 -20.43 62.54 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 122.538 0.335 . . . . 0.0 111.89 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -73.48 -7.27 51.1 Favored 'General case' 0 CA--C 1.562 1.424 0 C-N-CA 123.386 0.674 . . . . 0.0 110.705 174.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.4 -7.78 60.05 Favored Glycine 0 C--N 1.356 1.652 0 CA-C-N 115.874 -0.603 . . . . 0.0 114.561 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.418 ' O ' ' HG2' ' A' ' 83' ' ' MET . 2.7 mpt_? -86.95 137.69 32.15 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 117.363 0.582 . . . . 0.0 110.185 -176.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.58 ' HG3' HG22 ' A' ' 82' ' ' VAL . 9.2 mp0 -84.01 144.1 29.34 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.412 0.685 . . . . 0.0 109.709 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 46.3 t -132.49 120.8 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -115.73 107.63 15.32 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.84 151.41 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.756 1.222 . . . . 0.0 109.09 176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -144.98 140.36 28.14 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.805 0.842 . . . . 0.0 109.635 -173.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -128.16 121.74 30.23 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.257 1.023 . . . . 0.0 108.246 -178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HB3' ' HE3' ' A' ' 101' ' ' TRP . . . -135.72 128.3 30.68 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.604 0.762 . . . . 0.0 109.564 178.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 m -67.38 144.51 55.75 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.57 0.748 . . . . 0.0 110.217 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.2 158.55 64.02 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 123.653 0.781 . . . . 0.0 110.413 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.87 90.96 0.24 Allowed 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 122.186 1.924 . . . . 0.0 111.006 172.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 146.74 -30.02 1.55 Allowed Glycine 0 C--N 1.346 1.104 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.968 -177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 168.92 -127.42 1.52 Allowed Glycine 0 C--N 1.348 1.226 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -175.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 89.1 m -138.7 124.51 19.81 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.428 1.091 . . . . 0.0 109.575 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.403 ' HE3' ' HB3' ' A' ' 94' ' ' ALA . 29.1 t90 -81.21 115.09 20.45 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.952 0.901 . . . . 0.0 109.146 174.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.56 115.88 46.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 173.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -104.08 131.5 51.29 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' HB3' HD22 ' A' ' 125' ' ' LEU . 30.2 tt0 -124.57 112.47 16.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.621 0.724 . . . . 0.0 109.43 172.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.5 m -100.77 128.59 46.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.478 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 37.3 p90 -129.04 142.55 50.87 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 2' ' ' LYS . 18.5 t70 -83.02 132.83 35.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -120.37 169.15 10.57 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 124.727 1.211 . . . . 0.0 108.618 -174.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -120.49 150.14 41.3 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.149 0.579 . . . . 0.0 110.618 -172.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -80.04 -5.37 55.7 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 176.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 11.8 p -91.14 -2.25 57.59 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.422 0.689 . . . . 0.0 109.989 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -121.65 153.87 37.55 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 161.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 28.2 m -75.08 118.82 73.44 Favored Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.734 177.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.92 -32.72 48.7 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 124.057 3.171 . . . . 0.0 114.399 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.9 -51.95 65.81 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.667 0.787 . . . . 0.0 111.681 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.51 -41.01 69.75 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.29 0.636 . . . . 0.0 111.155 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -57.97 -51.27 70.34 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.047 0.539 . . . . 0.0 110.872 178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.478 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 48.8 tt0 -61.93 -40.48 95.67 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.388 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.92 -33.04 74.91 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.307 0.643 . . . . 0.0 111.178 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.44 -55.79 11.51 Favored Glycine 0 C--N 1.347 1.154 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.822 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -65.91 -38.81 89.67 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 123.116 0.566 . . . . 0.0 112.145 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -63.11 -35.32 79.89 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.004 0.522 . . . . 0.0 109.728 176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -59.98 -48.31 86.7 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 124.045 0.841 . . . . 0.0 111.729 172.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.659 HG23 ' HA ' ' A' ' 30' ' ' ASN . 84.6 mt -59.82 -50.17 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 124.315 1.046 . . . . 0.0 111.815 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.437 HD22 ' HB3' ' A' ' 104' ' ' GLU . 54.2 tp -72.14 -36.73 69.44 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.998 -175.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -71.83 -23.54 61.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.74 0.416 . . . . 0.0 111.029 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.404 ' ND2' ' HA ' ' A' ' 32' ' ' ALA . 85.4 m-20 -76.02 -25.68 55.91 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 119.434 -0.317 . . . . 0.0 110.278 172.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -70.36 -48.25 57.2 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 123.701 0.626 . . . . 0.0 109.51 171.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -57.09 -49.25 76.45 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.946 0.898 . . . . 0.0 111.063 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 -63.74 -44.67 92.81 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.084 0.954 . . . . 0.0 111.134 -179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.481 ' CE2' ' SG ' ' A' ' 25' ' ' CYS . 10.8 t80 -51.95 -56.31 14.98 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.203 0.939 . . . . 0.0 110.339 175.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.8 -51.22 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.879 0.871 . . . . 0.0 111.697 -172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -75.02 -32.19 61.53 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.004 0.521 . . . . 0.0 111.522 -171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.91 -24.06 33.28 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 122.486 0.314 . . . . 0.0 110.907 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.9 -45.28 59.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 171.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.89 -41.14 3.07 Favored Glycine 0 C--N 1.343 0.951 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.675 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.5 mp 53.37 -80.42 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.008 1.723 . . . . 0.0 111.66 -171.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -95.26 111.86 23.66 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.358 1.063 . . . . 0.0 109.562 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -121.7 50.47 1.42 Allowed 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 67.41 171.55 0.26 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 113.766 -1.561 . . . . 0.0 109.479 -163.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -74.73 138.32 42.66 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -57.61 111.33 1.09 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 124.112 0.882 . . . . 0.0 112.136 -174.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 22.7 p80 -110.99 -174.62 2.51 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.001 1.721 . . . . 0.0 110.887 -173.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 . . . . . 0 N--CA 1.48 1.046 0 C-N-CA 123.416 0.686 . . . . 0.0 110.044 178.471 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.408 ' NZ ' ' HB2' ' A' ' 88' ' ' GLU . 75.0 mmtt -104.59 141.17 36.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.515 0.598 . . . . 0.0 110.765 -177.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.5 mt -122.5 113.7 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 171.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 48.2 p -89.45 121.54 31.78 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 175.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 104' ' ' GLU . 36.1 pt -116.61 135.26 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 174.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -105.99 164.61 11.83 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.222 0.609 . . . . 0.0 110.27 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -162.8 105.57 1.06 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -98.24 85.25 3.4 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.534 HG12 ' HG3' ' A' ' 129' ' ' LYS . 20.6 mt -89.37 139.92 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -87.25 66.41 9.2 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 172.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.431 HE22 ' HG3' ' A' ' 138' ' ' GLU . 9.0 tp-100 -146.64 148.47 32.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.713 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.96 147.91 52.62 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.922 0.889 . . . . 0.0 110.863 -175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.542 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.9 tt -63.94 -30.95 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 123.515 0.726 . . . . 0.0 111.674 -171.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.78 -41.66 71.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.279 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' HB3' ' HG3' ' A' ' 11' ' ' GLN . . . -67.07 -45.11 78.33 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.655 0.782 . . . . 0.0 111.717 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.9 t -58.21 -41.62 81.39 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.427 1.091 . . . . 0.0 109.662 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 76.5 t-105 -64.35 -37.7 88.44 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 118.673 -0.679 . . . . 0.0 111.844 178.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 45.9 m0 -56.13 -55.5 32.31 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-O 121.769 0.795 . . . . 0.0 109.218 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.21 -22.91 66.35 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.78 -176.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.403 ' HE1' HD23 ' A' ' 79' ' ' LEU . 66.3 t-105 -84.11 -36.78 22.7 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.29 0.636 . . . . 0.0 111.19 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -94.52 -33.69 12.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.679 0.792 . . . . 0.0 112.664 -167.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -68.72 119.67 70.64 Favored Pre-proline 0 N--CA 1.482 1.131 0 CA-C-O 118.351 -0.833 . . . . 0.0 109.875 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' O ' ' A' ' 41' ' ' SER . 42.2 Cg_exo -58.78 -17.97 38.98 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 123.445 2.763 . . . . 0.0 113.041 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.99 -55.02 37.83 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.393 1.077 . . . . 0.0 109.636 170.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 57.4 m -68.66 -47.75 65.74 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.572 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 23' ' ' PRO . 84.4 mt -54.79 -43.44 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 124.934 1.293 . . . . 0.0 111.781 -178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.7 -7.78 3.86 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -109.95 -57.8 2.14 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.319 1.048 . . . . 0.0 112.076 -178.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.3 p-90 -84.16 -25.08 29.87 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -64.76 -40.21 94.9 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 123.405 0.44 . . . . 0.0 111.865 -169.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -86.21 96.6 9.98 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 164.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 124' ' ' ILE . . . -58.96 -51.64 69.18 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 124.178 0.991 . . . . 0.0 111.18 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -63.16 128.49 36.11 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.504 0.722 . . . . 0.0 110.181 172.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 m -72.41 -12.93 61.32 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.323 0.649 . . . . 0.0 111.793 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.63 -30.99 71.4 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.888 0.875 . . . . 0.0 109.603 172.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -103.09 127.25 50.42 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -120.31 121.78 39.39 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 27.6 m -71.56 104.16 3.21 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 171.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 p -82.63 -27.47 31.37 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.502 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -148.85 116.34 0.79 Allowed Glycine 0 C--N 1.344 0.997 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 176.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 52' ' ' CYS . 27.0 p -122.19 103.31 8.69 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.517 0.727 . . . . 0.0 109.134 177.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -94.64 127.51 40.65 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -128.12 115.63 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 178.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' HB2' ' H ' ' A' ' 50' ' ' ARG . 13.9 m-20 -102.19 87.97 3.2 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 170.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.4 tp -76.59 75.4 3.29 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.533 0.682 . . . . 0.0 110.642 -171.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.6 m -143.9 164.58 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 124.757 1.223 . . . . 0.0 108.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 49.1 t -77.26 108.2 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 C-N-CA 123.504 0.721 . . . . 0.0 109.29 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.71 19.79 36.35 Favored Glycine 0 N--CA 1.466 0.654 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -79.59 -172.04 42.71 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 114.226 0.45 . . . . 0.0 114.226 -177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.532 ' H ' ' HB2' ' A' ' 44' ' ' ASP . 26.0 mtt85 -126.15 134.46 51.3 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.815 0.846 . . . . 0.0 109.1 -171.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -128.82 138.29 51.98 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 166.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.551 ' SG ' HG22 ' A' ' 67' ' ' THR . 58.9 m -137.34 118.48 14.46 Favored 'General case' 0 C--O 1.223 -0.32 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 66.9 m-70 -114.22 89.09 3.0 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -70.54 101.81 2.09 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.0 mtt -104.63 124.45 49.36 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -120.4 152.1 38.39 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.901 0.88 . . . . 0.0 109.321 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.98 153.99 24.72 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 122.824 0.45 . . . . 0.0 110.253 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -69.82 -26.4 64.22 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.101 0.56 . . . . 0.0 111.38 -176.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -90.74 -9.02 48.21 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.337 0.655 . . . . 0.0 110.766 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.83 22.74 78.28 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 123.568 0.542 . . . . 0.0 112.673 -175.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.7 p -75.41 -45.36 39.39 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.232 1.013 . . . . 0.0 111.119 -176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.434 ' HB1' ' HE1' ' A' ' 64' ' ' PHE . . . -134.87 145.99 48.8 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.757 0.823 . . . . 0.0 109.464 -179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.82 113.27 0.56 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 -175.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.434 ' HE1' ' HB1' ' A' ' 62' ' ' ALA . 58.6 m-85 -130.93 134.85 47.12 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.865 0.866 . . . . 0.0 110.245 -174.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -83.4 151.53 25.46 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.963 0.905 . . . . 0.0 110.29 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.563 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 87.6 m-85 -122.36 77.97 1.46 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.551 HG22 ' SG ' ' A' ' 52' ' ' CYS . 32.0 p -87.69 170.72 11.01 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.053 -1.43 . . . . 0.0 110.92 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.513 ' HA3' ' HA ' ' A' ' 83' ' ' MET . . . 161.34 -177.49 37.64 Favored Glycine 0 C--N 1.345 1.071 0 O-C-N 123.175 0.297 . . . . 0.0 112.869 175.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.5 m -121.02 128.22 52.47 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.906 0.883 . . . . 0.0 111.174 -173.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -66.36 130.86 44.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.16 0.584 . . . . 0.0 110.374 171.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 p -98.54 -40.65 8.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.929 0.491 . . . . 0.0 111.508 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 30.9 ttm180 -143.62 118.79 10.12 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 72.3 t -116.08 113.38 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.37 83.62 1.98 Allowed 'General case' 0 C--O 1.239 0.531 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -68.28 139.12 92.11 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 123.551 0.74 . . . . 0.0 109.854 177.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 41.9 Cg_endo -100.01 18.65 23.18 Favored 'Cis proline' 0 C--N 1.373 1.846 0 CA-C-N 120.055 1.055 . . . . 0.0 113.472 -6.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.542 ' HA ' HD11 ' A' ' 13' ' ' ILE . 16.8 p -87.42 -29.94 21.09 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -164.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -162.32 144.48 10.99 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.657 0.383 . . . . 0.0 110.681 -178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 HD23 ' HE1' ' A' ' 20' ' ' TRP . 37.8 tp -135.83 110.12 8.41 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 174.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.609 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 25.3 m -109.85 135.31 50.94 Favored 'General case' 0 C--O 1.243 0.717 0 C-N-CA 124.096 0.958 . . . . 0.0 108.848 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -162.56 153.78 17.68 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 123.787 0.835 . . . . 0.0 110.851 -175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.6 t -117.99 134.29 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.438 1.495 . . . . 0.0 107.14 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.603 ' HG2' ' H ' ' A' ' 85' ' ' ASP . 1.8 pmm? -89.99 -176.84 5.03 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 118.826 0.739 . . . . 0.0 109.814 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.03 -25.6 68.19 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.983 0.913 . . . . 0.0 112.024 -175.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.603 ' H ' ' HG2' ' A' ' 83' ' ' MET . 3.0 m-20 -74.08 -8.83 57.58 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.447 0.699 . . . . 0.0 111.433 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 90.52 0.43 76.09 Favored Glycine 0 C--N 1.354 1.558 0 C-N-CA 123.014 0.34 . . . . 0.0 113.692 177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.556 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 74.4 mtt-85 -87.46 143.04 27.42 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.264 0.625 . . . . 0.0 110.09 -175.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' HB2' ' NZ ' ' A' ' 2' ' ' LYS . 33.3 mt-10 -91.93 146.09 24.03 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.553 0.741 . . . . 0.0 110.585 -174.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.3 t -140.17 127.4 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 124.609 1.164 . . . . 0.0 108.218 177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -127.06 105.31 8.5 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.4 t -91.18 106.05 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -100.14 120.58 40.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 124.916 1.286 . . . . 0.0 109.163 -173.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -103.72 160.86 14.41 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.03 118.52 3.05 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.4 t -66.74 120.61 13.79 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 121.184 0.516 . . . . 0.0 110.174 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -89.68 165.76 23.77 Favored Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 124.3 1.04 . . . . 0.0 109.823 -177.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.47 -16.35 35.13 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.132 1.888 . . . . 0.0 113.866 171.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -154.17 49.33 0.5 Allowed Glycine 0 C--N 1.342 0.878 0 N-CA-C 112.007 -0.437 . . . . 0.0 112.007 175.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 156.95 -140.15 6.96 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 121.323 -0.465 . . . . 0.0 112.755 172.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 97.5 m -148.89 126.89 11.95 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.384 1.074 . . . . 0.0 110.097 174.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 33.1 t90 -85.63 132.94 34.07 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.004 170.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 41.6 t -115.54 146.11 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.437 ' HA ' ' O ' ' A' ' 5' ' ' ILE . 19.0 tt0 -148.65 104.04 3.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 5' ' ' ILE . 42.4 tt0 -87.69 101.22 13.46 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.0 m -92.97 108.29 19.89 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 177.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -120.52 156.58 31.25 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.912 -0.774 . . . . 0.0 108.912 -172.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -90.1 127.24 36.04 Favored 'General case' 0 C--O 1.243 0.73 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -63.25 132.2 50.89 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.622 1.169 . . . . 0.0 112.245 -168.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.437 ' HB2' ' OE1' ' A' ' 117' ' ' GLN . 27.0 mt-10 -75.98 157.48 33.06 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.409 177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.1 t -90.95 -7.42 52.11 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.788 -0.57 . . . . 0.0 112.109 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.2 t -58.11 -40.92 82.42 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.877 0.871 . . . . 0.0 112.355 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -139.42 -176.34 4.5 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.756 0.822 . . . . 0.0 109.868 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 73.2 p -81.45 151.04 68.31 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-O 119.074 -0.489 . . . . 0.0 110.178 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -46.15 -38.98 20.26 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.97 3.113 . . . . 0.0 114.533 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.29 -45.74 90.02 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.606 0.762 . . . . 0.0 112.268 177.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -68.39 -42.78 78.58 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.925 0.49 . . . . 0.0 110.705 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 109' ' ' GLU . 18.8 mt-30 -74.44 -27.64 60.69 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.634 0.774 . . . . 0.0 111.168 -177.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -63.57 -43.68 96.3 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -68.21 -27.45 66.39 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 123.787 0.679 . . . . 0.0 111.466 175.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -76.41 -59.37 3.33 Favored Glycine 0 C--N 1.348 1.204 0 O-C-N 123.097 0.248 . . . . 0.0 112.92 -177.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.9 m95 -63.26 -41.35 99.03 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.623 0.769 . . . . 0.0 111.245 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.429 ' HA ' ' HB3' ' A' ' 125' ' ' LEU . 29.1 tt0 -76.37 -16.81 59.65 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.55 -48.32 85.35 Favored Glycine 0 C--N 1.343 0.943 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 165.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.596 HG12 ' HB2' ' A' ' 32' ' ' ALA . 45.1 mt -66.84 -40.08 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 124.228 1.011 . . . . 0.0 110.743 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.429 ' HB3' ' HA ' ' A' ' 122' ' ' GLN . 62.0 tp -69.86 -31.21 68.93 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.854 0.862 . . . . 0.0 110.561 178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -76.58 -30.62 57.1 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.704 0.802 . . . . 0.0 111.598 175.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -70.22 -37.71 75.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 172.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' O ' HG23 ' A' ' 132' ' ' VAL . 36.3 t80 -60.31 -52.96 63.04 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.02 0.928 . . . . 0.0 109.827 173.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.534 ' HG3' HG12 ' A' ' 9' ' ' ILE . 29.4 ttmt -54.05 -52.7 60.07 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.968 1.307 . . . . 0.0 111.408 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -62.66 -36.15 81.96 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.904 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -65.19 -43.22 92.31 Favored 'General case' 0 N--CA 1.479 1.012 0 O-C-N 123.915 0.759 . . . . 0.0 111.03 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 128' ' ' PHE . 71.8 t -61.81 -49.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.877 0.871 . . . . 0.0 110.677 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -72.23 -27.25 62.39 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.658 -176.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.32 -42.39 30.82 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.205 0.602 . . . . 0.0 110.552 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.33 62.96 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.96 0.904 . . . . 0.0 110.81 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 86.87 -62.79 4.17 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.383 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 72.1 mt 69.41 -67.65 0.22 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.658 1.583 . . . . 0.0 110.77 -177.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.431 ' HG3' HE22 ' A' ' 11' ' ' GLN . 0.0 OUTLIER -68.91 -22.88 64.14 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.98 -0.45 . . . . 0.0 111.291 175.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -72.18 80.79 0.98 Allowed 'General case' 0 C--N 1.353 0.72 0 C-N-CA 123.591 0.756 . . . . 0.0 109.365 168.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 69.39 152.72 0.1 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.966 1.707 . . . . 0.0 111.795 178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -74.91 133.9 41.7 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.184 0.594 . . . . 0.0 111.471 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -130.12 -65.08 0.83 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.441 1.097 . . . . 0.0 108.879 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -126.54 139.33 53.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.563 0.745 . . . . 0.0 110.003 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 . . . . . 0 N--CA 1.481 1.112 0 C-N-CA 125.526 1.53 . . . . 0.0 110.276 -174.724 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 tpt . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -108.01 129.24 55.14 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.701 0.8 . . . . 0.0 109.275 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 60.9 mt -114.18 130.74 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 124.193 0.997 . . . . 0.0 109.116 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.8 m -104.91 135.28 46.57 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.819 0.848 . . . . 0.0 109.315 175.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.6 pt -123.01 146.09 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 172.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.418 ' HB2' ' HE1' ' A' ' 101' ' ' TRP . 9.8 pt-20 -117.66 156.87 27.45 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 122.873 0.469 . . . . 0.0 111.421 -172.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' A' ' 129' ' ' LYS . . . -171.51 115.57 0.39 Allowed 'General case' 0 C--N 1.35 0.591 0 C-N-CA 124.012 0.925 . . . . 0.0 109.562 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 101' ' ' TRP . 0.7 OUTLIER -94.49 116.16 28.45 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 176.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.587 HG12 ' HG3' ' A' ' 129' ' ' LYS . 34.6 mt -91.27 123.5 43.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 124.669 1.188 . . . . 0.0 108.629 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -78.77 73.87 5.31 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 122.55 1.167 . . . . 0.0 109.293 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.456 ' NE2' ' HB2' ' A' ' 139' ' ' HIS . 50.9 tp60 -163.46 159.98 22.79 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.495 -173.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 139' ' ' HIS . 45.3 mm-40 -60.36 141.22 56.56 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.997 0.519 . . . . 0.0 110.376 175.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' A' ' 77' ' ' THR . 17.1 tt -62.4 -24.28 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 O-C-N 124.241 0.963 . . . . 0.0 110.561 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -58.88 -50.1 75.3 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 123.997 0.919 . . . . 0.0 111.032 170.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.17 -29.84 54.67 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.674 0.79 . . . . 0.0 112.422 -175.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.2 t -66.84 -48.67 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 123.664 0.786 . . . . 0.0 109.463 174.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 56.7 t-105 -63.14 -38.94 93.17 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.807 0.843 . . . . 0.0 110.644 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -59.37 -48.26 82.32 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.074 0.95 . . . . 0.0 109.988 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.53 -35.26 80.4 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.56 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CZ2' HG21 ' A' ' 91' ' ' VAL . 59.9 t-105 -75.68 -36.26 60.13 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.065 0.546 . . . . 0.0 112.466 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -106.99 -31.48 8.29 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 -168.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 1.1 m-20 -71.59 123.18 89.02 Favored Pre-proline 0 N--CA 1.486 1.369 0 CA-C-N 118.23 0.468 . . . . 0.0 110.255 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.07 -34.59 98.91 Favored 'Trans proline' 0 C--N 1.374 1.913 0 C-N-CA 123.724 2.949 . . . . 0.0 113.957 -172.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.92 -40.6 98.09 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.966 1.307 . . . . 0.0 110.568 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.459 ' SG ' ' HB2' ' A' ' 22' ' ' ASP . 33.4 m -69.44 -45.37 69.27 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 114.88 -1.055 . . . . 0.0 110.812 178.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.466 HD13 ' CE1' ' A' ' 53' ' ' HIS . 66.2 mt -64.17 -30.06 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 C-N-CA 124.328 1.051 . . . . 0.0 111.276 -177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.491 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -66.45 -20.71 66.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.431 0.693 . . . . 0.0 111.705 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 66.8 mtt180 -87.56 -47.56 8.62 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.831 0.853 . . . . 0.0 110.883 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -95.95 -157.48 0.58 Allowed 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 8.0 t30 83.03 -26.61 0.13 Allowed 'General case' 0 N--CA 1.502 2.166 0 C-N-CA 125.113 1.365 . . . . 0.0 112.955 166.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -58.94 112.46 1.67 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.124 0.57 . . . . 0.0 109.796 173.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.47 -27.33 69.05 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.961 0.905 . . . . 0.0 112.391 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.8 t -140.43 167.42 22.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.019 0.928 . . . . 0.0 110.465 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.0 t -78.89 -15.97 57.65 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.498 0.719 . . . . 0.0 111.099 176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -77.87 -9.95 59.32 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.462 0.705 . . . . 0.0 110.44 170.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 60.6 m95 -122.68 159.05 28.74 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.49 1.116 . . . . 0.0 109.244 -173.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.419 ' HA ' ' HB2' ' A' ' 31' ' ' ALA . 24.0 p80 -156.81 139.89 15.44 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.491 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 18.4 m -69.8 104.71 2.53 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.3 m -83.82 -23.78 31.26 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.266 1.027 . . . . 0.0 110.628 -174.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -159.97 164.09 34.08 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.688 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.8 t -158.82 109.54 2.06 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 175.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.457 ' HB2' ' SG ' ' A' ' 52' ' ' CYS . 94.7 mtt180 -97.58 129.71 44.68 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 66.5 t -138.33 118.59 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.225 0.61 . . . . 0.0 109.583 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -114.32 81.53 1.56 Allowed 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.7 tp -68.94 77.64 0.32 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.285 1.034 . . . . 0.0 111.819 -174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 m -145.54 160.18 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.77 1.228 . . . . 0.0 108.449 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.2 t -72.65 103.19 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.64 -18.89 14.75 Favored Glycine 0 N--CA 1.471 1.006 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.044 -174.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.83 152.81 37.45 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 112.279 -0.328 . . . . 0.0 112.279 177.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 69' ' ' THR . 60.7 mtt85 -106.84 168.27 9.3 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.442 0.697 . . . . 0.0 110.268 -172.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -148.57 169.25 20.73 Favored 'General case' 0 C--O 1.244 0.812 0 C-N-CA 123.462 0.705 . . . . 0.0 109.97 171.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.457 ' SG ' ' HB2' ' A' ' 42' ' ' ARG . 12.2 p -158.36 130.98 7.1 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.297 1.039 . . . . 0.0 108.818 175.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 14.8 m-70 -110.69 90.3 3.29 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -73.82 128.6 35.95 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.589 0.756 . . . . 0.0 110.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 31' ' ' ALA . 36.0 mtm -122.14 142.55 50.28 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -125.69 140.93 52.29 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 173.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.25 152.88 32.27 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 124.137 0.898 . . . . 0.0 109.339 166.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -66.6 -26.39 67.07 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.019 0.527 . . . . 0.0 111.681 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.99 -24.75 64.27 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.464 0.706 . . . . 0.0 111.037 172.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.91 -0.23 79.11 Favored Glycine 0 C--N 1.35 1.312 0 CA-C-N 116.316 -0.402 . . . . 0.0 113.133 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.2 t -85.3 -12.89 51.29 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.248 1.019 . . . . 0.0 111.459 -173.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -137.31 145.57 43.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.076 0.95 . . . . 0.0 109.769 -178.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -149.01 127.11 2.41 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 112.083 -0.407 . . . . 0.0 112.083 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -122.15 132.6 54.55 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -118.05 144.73 45.34 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.623 0.769 . . . . 0.0 109.809 -174.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.543 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 95.5 m-85 -103.14 78.55 1.65 Allowed 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 32.3 p -86.41 136.86 32.96 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 83' ' ' MET . . . -160.91 174.97 37.61 Favored Glycine 0 C--N 1.338 0.64 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 176.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 50' ' ' ARG . 42.3 m -137.46 123.59 20.41 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HA ' ' HB3' ' A' ' 81' ' ' PHE . 59.9 m-85 -65.42 118.21 9.07 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.975 0.91 . . . . 0.0 110.867 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.531 HG21 HG23 ' A' ' 82' ' ' VAL . 36.0 p -95.42 -35.05 11.88 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.796 0.838 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 40.0 ttm180 -145.65 116.96 7.94 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.3 99.52 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.239 1.016 . . . . 0.0 108.272 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 42.9 mt-10 -105.44 69.23 0.83 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.1 131.51 88.85 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.403 0.681 . . . . 0.0 111.479 -173.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 29.8 Cg_endo -97.58 10.43 35.52 Favored 'Cis proline' 0 C--N 1.374 1.888 0 CA-C-N 119.459 0.843 . . . . 0.0 113.932 -3.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 13' ' ' ILE . 48.6 p -80.16 -14.49 58.43 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 114.584 1.328 . . . . 0.0 114.584 -166.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.451 ' HB3' ' HB2' ' A' ' 74' ' ' GLU . 25.9 ttm-85 -169.95 147.58 3.32 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.499 0.666 . . . . 0.0 110.125 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 HD11 ' CD1' ' A' ' 70' ' ' PHE . 25.3 tp -133.69 130.32 38.02 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.527 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 19.8 t -135.08 141.95 46.18 Favored 'General case' 0 C--O 1.242 0.658 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' CE1' ' HB ' ' A' ' 89' ' ' VAL . 31.9 p90 -161.03 164.19 31.07 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.839 0.712 . . . . 0.0 110.593 -175.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.692 HG22 ' HG2' ' A' ' 88' ' ' GLU . 59.6 t -116.21 130.88 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 171.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.403 ' HA ' ' HA2' ' A' ' 68' ' ' GLY . 66.0 mtt -67.31 163.56 20.34 Favored 'General case' 0 C--O 1.241 0.626 0 O-C-N 123.306 0.379 . . . . 0.0 110.308 177.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.19 -25.67 68.18 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.298 0.639 . . . . 0.0 111.058 175.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -83.95 -2.9 57.44 Favored 'General case' 0 CA--C 1.568 1.645 0 C-N-CA 124.398 1.079 . . . . 0.0 111.218 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.09 -8.06 64.83 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 167.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.463 ' HB3' ' HB3' ' A' ' 107' ' ' ASP . 5.5 mpt_? -86.77 135.52 33.33 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 118.811 1.305 . . . . 0.0 109.835 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.692 ' HG2' HG22 ' A' ' 82' ' ' VAL . 51.4 mt-10 -85.3 137.59 32.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.587 0.755 . . . . 0.0 110.845 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.441 ' HB ' ' CE1' ' A' ' 81' ' ' PHE . 61.9 t -127.85 123.5 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 124.568 1.147 . . . . 0.0 108.798 174.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -118.75 104.53 10.68 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.455 HG21 ' CZ2' ' A' ' 20' ' ' TRP . 16.8 t -95.85 115.49 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -99.91 143.1 30.52 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.738 0.815 . . . . 0.0 109.119 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -128.44 90.07 3.01 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -93.33 100.18 12.56 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.287 0.635 . . . . 0.0 110.134 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.9 m -56.55 127.0 29.07 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.025 0.53 . . . . 0.0 110.413 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -127.76 155.53 77.16 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 123.906 0.882 . . . . 0.0 109.544 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.59 93.53 0.12 Allowed 'Trans proline' 0 C--N 1.373 1.848 0 C-N-CA 122.383 2.055 . . . . 0.0 111.305 170.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 130.01 -10.98 5.94 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-O 119.297 -0.724 . . . . 0.0 113.715 -176.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 162.01 -130.71 2.36 Favored Glycine 0 C--N 1.353 1.52 0 CA-C-N 118.04 0.92 . . . . 0.0 114.31 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 81.7 m -145.36 109.83 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.815 0.846 . . . . 0.0 109.874 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' HIS . 19.7 t90 -82.55 101.95 11.08 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.823 0.849 . . . . 0.0 110.478 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 t -89.81 130.81 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 123.917 0.887 . . . . 0.0 110.096 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -122.58 104.72 9.54 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -86.69 102.31 14.09 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.3 m -93.74 127.32 39.4 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 32.9 p90 -141.99 139.77 32.5 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.15 0.58 . . . . 0.0 109.441 -178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 87' ' ' ARG . 24.4 t70 -76.92 109.51 10.79 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -87.28 62.07 7.03 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.622 0.769 . . . . 0.0 112.144 -165.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.569 ' HA ' HE22 ' A' ' 117' ' ' GLN . 9.4 pt-20 -138.07 72.62 1.42 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.11 0.957 . . . . 0.0 109.932 157.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.468 ' H ' HE22 ' A' ' 117' ' ' GLN . 71.0 p -127.33 -32.6 2.44 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.921 174.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.6 m -113.42 -48.5 2.95 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.496 -161.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.1 m80 -171.53 -165.42 0.38 Allowed 'General case' 0 N--CA 1.507 2.398 0 C-N-CA 124.836 1.254 . . . . 0.0 109.672 -159.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 53.4 p -57.75 139.85 81.58 Favored Pre-proline 0 CA--C 1.561 1.396 0 CA-C-O 118.557 -0.735 . . . . 0.0 109.824 165.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -48.54 -48.09 18.43 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 123.682 2.921 . . . . 0.0 114.198 -174.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.45 -48.14 72.09 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 123.441 0.696 . . . . 0.0 112.449 175.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -61.44 -29.16 69.77 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.449 0.7 . . . . 0.0 111.159 177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.569 HE22 ' HA ' ' A' ' 109' ' ' GLU . 36.9 mt-30 -76.54 -31.62 57.72 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.571 177.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 122' ' ' GLN . 30.0 tt0 -59.29 -42.66 91.81 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 173.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -70.78 -39.79 72.97 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 124.356 1.035 . . . . 0.0 111.752 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -74.22 -50.14 10.94 Favored Glycine 0 C--N 1.352 1.455 0 O-C-N 123.163 0.289 . . . . 0.0 113.368 -174.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -65.75 -25.06 67.11 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.445 0.698 . . . . 0.0 111.588 173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 19.3 tp60 -60.2 -34.4 73.57 Favored 'General case' 0 C--O 1.214 -0.805 0 O-C-N 123.175 0.297 . . . . 0.0 110.413 169.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -60.07 -37.54 92.93 Favored Glycine 0 C--N 1.345 1.078 0 O-C-N 123.816 0.697 . . . . 0.0 113.17 174.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 48.6 mm -70.16 -51.97 34.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 123.799 0.839 . . . . 0.0 111.328 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 30.3 tp -67.84 -36.08 79.7 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 122.733 0.413 . . . . 0.0 110.997 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 130' ' ' ARG . 16.0 t70 -59.57 -55.51 33.54 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.67 0.788 . . . . 0.0 109.768 172.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -58.77 -34.21 71.17 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 124.052 0.845 . . . . 0.0 111.097 -176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 132' ' ' VAL . 28.2 t80 -62.5 -57.05 12.58 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.531 -1.213 . . . . 0.0 110.787 173.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.587 ' HG3' HG12 ' A' ' 9' ' ' ILE . 83.1 tttt -56.53 -45.69 81.03 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.101 0.96 . . . . 0.0 111.826 -178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 26.8 mmt180 -59.92 -41.47 91.81 Favored 'General case' 0 C--N 1.352 0.693 0 O-C-N 124.212 0.945 . . . . 0.0 110.095 179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -60.15 -51.37 69.88 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 123.898 0.749 . . . . 0.0 111.819 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 128' ' ' PHE . 20.8 t -60.56 -41.78 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 O-C-N 123.451 0.469 . . . . 0.0 110.866 -173.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -86.59 -25.86 24.75 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.482 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.81 45.91 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 118.403 0.547 . . . . 0.0 109.622 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.71 -54.49 18.99 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 64.86 93.52 0.03 OUTLIER Glycine 0 C--N 1.353 1.483 0 O-C-N 124.544 1.153 . . . . 0.0 111.778 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -81.34 -140.9 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -170.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -67.1 -75.16 0.1 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.922 0.489 . . . . 0.0 110.289 -175.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.511 ' HA ' ' HG2' ' A' ' 12' ' ' GLU . 16.2 t-80 60.74 7.1 1.31 Allowed 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.375 1.07 . . . . 0.0 112.851 175.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 39.2 46.78 1.29 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 125.057 1.343 . . . . 0.0 111.893 -164.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.12 164.87 15.49 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.715 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 34.7 t60 -87.67 -142.79 0.12 Allowed 'General case' 0 CA--C 1.563 1.446 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 177.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -60.33 -33.37 72.3 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.509 0.724 . . . . 0.0 110.556 172.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.244 0.807 0 C-N-CA 124.012 0.925 . . . . 0.0 108.97 173.782 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 25.5 ptm . . . . . 0 N--CA 1.475 0.792 0 CA-C-O 121.028 0.442 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -120.61 154.91 34.8 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.083 0.953 . . . . 0.0 109.554 171.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG21 ' HB2' ' A' ' 118' ' ' GLN . 74.4 mt -121.13 134.72 63.63 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 123.678 0.791 . . . . 0.0 109.067 175.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 44.6 m -105.72 128.36 53.63 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.604 0.762 . . . . 0.0 109.555 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.7 pt -126.32 161.15 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 124.777 1.231 . . . . 0.0 109.216 175.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HB3' ' NE2' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -157.03 161.7 39.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.872 0.469 . . . . 0.0 112.195 175.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.479 ' HB2' HE22 ' A' ' 122' ' ' GLN . . . -153.11 142.37 21.53 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.048 0.939 . . . . 0.0 110.184 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -96.09 114.92 26.67 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 171.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 31.7 mt -101.36 124.1 54.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 170.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.78 82.02 3.38 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 174.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' H ' ' HA2' ' A' ' 99' ' ' GLY . 6.8 tp-100 -171.34 148.0 2.54 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.629 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -67.19 147.78 52.64 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.514 0.726 . . . . 0.0 110.178 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.655 HD11 ' HA ' ' A' ' 77' ' ' THR . 16.0 tt -60.92 -30.48 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 123.783 0.833 . . . . 0.0 112.315 -173.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -69.05 -44.54 72.44 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.581 0.551 . . . . 0.0 109.58 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 137' ' ' LEU . . . -67.53 -38.14 83.79 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.765 0.826 . . . . 0.0 112.33 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 73.2 t -63.94 -41.84 93.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.143 173.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 77.5 t-105 -68.48 -35.05 76.99 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.666 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' A' ' 15' ' ' ALA . 34.7 m0 -60.07 -53.17 60.93 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.75 -26.46 68.65 Favored 'General case' 0 CA--C 1.557 1.226 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.074 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.515 ' HE1' HD23 ' A' ' 79' ' ' LEU . 52.4 t-105 -87.41 -29.63 21.33 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.086 0.555 . . . . 0.0 111.914 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.99 -24.35 13.65 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -172.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -69.2 118.42 61.73 Favored Pre-proline 0 N--CA 1.478 0.971 0 CA-C-O 118.028 -0.986 . . . . 0.0 110.03 -176.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_endo -55.08 -33.34 83.31 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 123.369 2.713 . . . . 0.0 114.749 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -72.92 -40.89 65.11 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.973 0.509 . . . . 0.0 110.882 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.529 ' SG ' ' HE2' ' A' ' 131' ' ' TYR . 42.7 t -71.42 -39.88 70.8 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.62 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.631 HD13 HG21 ' A' ' 43' ' ' VAL . 25.2 mt -55.34 -39.48 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 125.595 1.558 . . . . 0.0 111.618 171.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.0 3.97 4.79 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.366 0.667 . . . . 0.0 112.321 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -102.63 -38.34 7.54 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.068 0.947 . . . . 0.0 110.814 174.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -109.02 132.84 53.73 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.373 0.606 . . . . 0.0 112.074 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.537 HD22 ' N ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -178.62 -23.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 125.872 1.669 . . . . 0.0 109.734 168.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' N ' HD22 ' A' ' 30' ' ' ASN . . . -69.38 118.09 11.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.424 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.06 -11.47 60.77 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.188 0.995 . . . . 0.0 111.002 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.471 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 45.0 t -152.16 150.67 30.11 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.603 1.161 . . . . 0.0 108.966 178.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.9 m -63.55 -21.02 66.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.657 0.383 . . . . 0.0 111.77 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -60.49 -23.01 64.17 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.607 1.163 . . . . 0.0 111.758 172.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 85.1 m95 -106.38 151.95 24.22 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.066 0.946 . . . . 0.0 109.532 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -140.53 152.06 45.25 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 123.851 0.86 . . . . 0.0 109.076 -177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.0 m -75.64 118.82 18.89 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 168.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.1 t -96.08 -25.97 15.68 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 172.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.8 141.09 5.27 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.381 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.0 m -148.08 125.42 11.58 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.925 0.89 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 -111.94 145.61 39.27 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.453 0.701 . . . . 0.0 109.135 170.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.631 HG21 HD13 ' A' ' 26' ' ' ILE . 73.7 t -136.25 133.2 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.14 0.976 . . . . 0.0 109.461 175.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -117.41 83.94 2.07 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.2 tp -79.19 81.49 5.45 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 -172.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 22.9 m -141.62 163.92 19.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 C-N-CA 125.183 1.393 . . . . 0.0 107.943 170.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 55.8 t -72.92 102.14 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 118.62 -17.49 11.09 Favored Glycine 0 C--N 1.344 0.975 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.9 -173.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.54 162.49 52.2 Favored Glycine 0 C--N 1.347 1.189 0 C-N-CA 122.784 0.23 . . . . 0.0 113.352 -179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -118.86 159.43 23.77 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.453 0.701 . . . . 0.0 110.332 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.588 ' HB2' HG22 ' A' ' 43' ' ' VAL . 20.3 p90 -135.24 166.5 22.96 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 170.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 45.9 t -154.14 129.14 9.54 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.67 0.788 . . . . 0.0 109.377 174.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 72.3 m80 -115.73 97.73 6.29 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -74.51 103.7 4.94 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 64' ' ' PHE . 65.5 mtt -81.13 126.7 31.79 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.103 175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -129.55 122.59 29.48 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -64.81 174.06 2.01 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.421 0.688 . . . . 0.0 111.414 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -50.21 -42.41 51.45 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.209 1.403 . . . . 0.0 113.721 -170.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -92.99 -16.15 25.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.592 0.757 . . . . 0.0 110.265 -176.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.47 11.64 84.63 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 116.042 -0.527 . . . . 0.0 112.459 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.8 t -79.42 -23.73 43.01 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.179 0.592 . . . . 0.0 110.759 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.51 129.65 56.31 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.053 0.941 . . . . 0.0 109.221 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.87 136.91 8.64 Favored Glycine 0 C--N 1.349 1.305 0 O-C-N 123.334 0.396 . . . . 0.0 112.335 -178.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.441 ' HB3' ' HB2' ' A' ' 55' ' ' MET . 79.7 t80 -132.74 152.51 51.73 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.762 1.225 . . . . 0.0 109.477 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -116.83 103.91 10.79 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.385 0.674 . . . . 0.0 109.578 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.619 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.6 t80 -93.33 76.63 4.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.661 HG23 ' HB2' ' A' ' 84' ' ' ASP . 7.2 t -119.18 146.94 44.75 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.172 -1.376 . . . . 0.0 110.163 -171.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.5 -179.43 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.32 -177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.3 m -129.84 124.75 34.04 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.691 0.797 . . . . 0.0 109.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -67.68 118.97 11.67 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.007 0.923 . . . . 0.0 110.832 -178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 34.5 p -94.32 -25.39 17.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.264 1.026 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 35.7 ttm180 -148.92 131.14 15.49 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.109 0.964 . . . . 0.0 108.764 -176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -128.57 106.44 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -121.59 84.75 2.29 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.788 0.835 . . . . 0.0 109.64 176.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -70.27 136.14 86.7 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 122.952 0.501 . . . . 0.0 110.542 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 53.1 Cg_endo -98.24 11.77 31.89 Favored 'Cis proline' 0 C--N 1.375 1.957 0 CA-C-N 119.855 0.984 . . . . 0.0 113.153 -7.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.655 ' HA ' HD11 ' A' ' 13' ' ' ILE . 15.0 t -96.45 -7.1 35.75 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -160.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 60.8 ttt180 -168.26 144.32 3.8 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 118.794 0.725 . . . . 0.0 110.945 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.515 HD23 ' HE1' ' A' ' 20' ' ' TRP . 34.7 tp -145.86 128.28 15.94 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.248 1.019 . . . . 0.0 108.491 173.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.587 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 4.7 m -131.18 140.98 50.01 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -176.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -154.09 166.34 33.37 Favored 'General case' 0 C--O 1.22 -0.467 0 C-N-CA 124.078 0.951 . . . . 0.0 109.821 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 128.1 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.1 171.23 12.33 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.835 0.854 . . . . 0.0 111.459 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.661 ' HB2' HG23 ' A' ' 67' ' ' THR . 30.3 t70 -54.66 -33.14 60.26 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.363 1.465 . . . . 0.0 113.238 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -83.17 6.05 20.66 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.11 1.02 90.56 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.87 -0.405 . . . . 0.0 113.199 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 107' ' ' ASP . 74.0 mtt180 -77.84 119.5 21.42 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.322 0.649 . . . . 0.0 110.252 -177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -77.52 140.93 39.84 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.698 0.799 . . . . 0.0 110.349 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 89.3 t -135.16 131.36 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 124.693 1.197 . . . . 0.0 108.85 -176.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' GLU . 27.6 t70 -133.25 107.45 8.16 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 122.752 0.421 . . . . 0.0 110.533 -175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.553 HG22 ' HG2' ' A' ' 104' ' ' GLU . 10.5 t -101.64 108.99 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -99.63 140.27 34.07 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -114.63 110.46 19.81 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.63 106.46 18.42 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.6 p -61.51 138.66 58.29 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.047 0.539 . . . . 0.0 110.909 176.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -131.63 151.04 77.95 Favored Pre-proline 0 N--CA 1.475 0.82 0 C-N-CA 123.597 0.759 . . . . 0.0 109.057 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.76 97.39 0.27 Allowed 'Trans proline' 0 C--N 1.366 1.468 0 C-N-CA 121.919 1.746 . . . . 0.0 109.95 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.35 26.94 10.4 Favored Glycine 0 C--N 1.347 1.142 0 CA-C-N 115.724 -0.671 . . . . 0.0 113.7 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.402 ' HA2' ' H ' ' A' ' 11' ' ' GLN . . . 167.39 -170.59 41.69 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-N 117.638 0.719 . . . . 0.0 114.311 177.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.7 m -149.52 117.28 6.23 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 124.682 1.193 . . . . 0.0 108.62 176.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -85.92 101.84 13.22 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 26.7 t -87.68 116.66 30.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -100.41 151.5 21.46 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.135 1.374 . . . . 0.0 108.656 176.023 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.553 ' HG2' HG22 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -152.49 139.4 19.04 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 38.3 m -139.32 123.42 17.9 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.632 0.773 . . . . 0.0 109.228 171.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -128.92 151.82 49.24 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.813 0.845 . . . . 0.0 109.118 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 87' ' ' ARG . 2.7 m-20 -74.48 119.16 18.29 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 172.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.477 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -74.32 140.85 45.16 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 123.809 0.693 . . . . 0.0 110.572 -176.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -66.01 116.31 6.99 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.558 1.143 . . . . 0.0 109.569 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -64.82 -23.9 67.38 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.566 0.746 . . . . 0.0 112.205 -175.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.2 t -76.27 -36.38 58.46 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.185 0.594 . . . . 0.0 111.298 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.463 ' HE1' ' HG2' ' A' ' 116' ' ' GLN . 19.6 t-80 -97.45 155.37 16.95 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.336 0.255 . . . . 0.0 111.327 -172.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.453 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 24.6 p -63.22 116.02 22.09 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.119 0.968 . . . . 0.0 110.681 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -53.28 -45.34 41.8 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.658 2.905 . . . . 0.0 114.139 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.42 83.19 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.463 ' HG2' ' HE1' ' A' ' 112' ' ' HIS . 61.1 tp60 -63.64 -37.9 89.08 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 122.797 0.439 . . . . 0.0 110.854 174.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 113' ' ' THR . 61.6 mt-30 -67.83 -41.18 83.42 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.229 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.422 ' HB2' HG21 ' A' ' 3' ' ' ILE . 61.8 tt0 -59.72 -45.27 92.67 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.215 0.606 . . . . 0.0 109.924 176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.0 72.81 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.324 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -71.05 -54.65 8.9 Favored Glycine 0 C--N 1.348 1.214 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.485 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 29.6 m95 -66.68 -41.13 88.59 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.211 1.004 . . . . 0.0 111.934 -179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.479 HE22 ' HB2' ' A' ' 7' ' ' ALA . 53.4 tp60 -67.78 -27.0 66.38 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 173.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.09 -37.76 93.38 Favored Glycine 0 C--N 1.343 0.949 0 O-C-N 123.794 0.684 . . . . 0.0 112.686 170.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 120' ' ' GLY . 70.7 mt -70.24 -43.48 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.941 0.896 . . . . 0.0 110.103 177.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.2 tp -69.49 -38.14 77.51 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.499 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 130' ' ' ARG . 27.5 t70 -72.5 -33.3 66.83 Favored 'General case' 0 C--O 1.216 -0.695 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.418 175.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -67.59 -39.5 84.81 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 121.528 0.68 . . . . 0.0 109.239 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 132' ' ' VAL . 60.6 t80 -58.68 -50.82 72.48 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.133 -1.394 . . . . 0.0 109.895 171.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -56.78 -48.18 78.5 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.082 0.953 . . . . 0.0 111.517 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 68.8 mtm-85 -60.84 -36.68 79.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.422 0.689 . . . . 0.0 110.488 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.529 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 91.3 t80 -69.54 -45.6 68.42 Favored 'General case' 0 CA--C 1.55 0.971 0 O-C-N 123.999 0.812 . . . . 0.0 110.861 178.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 128' ' ' PHE . 59.5 t -60.02 -43.43 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 123.921 0.888 . . . . 0.0 110.743 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -85.63 -15.68 41.67 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 123.951 0.782 . . . . 0.0 111.754 -178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.34 -36.0 73.94 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.259 0.552 . . . . 0.0 109.747 172.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -83.15 -37.68 23.39 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.208 172.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.2 3.21 11.19 Favored Glycine 0 C--N 1.352 1.464 0 CA-C-N 115.079 -0.964 . . . . 0.0 113.396 -174.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.602 ' HG ' ' HB1' ' A' ' 15' ' ' ALA . 3.7 mm? 56.09 16.7 2.34 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 125.081 1.352 . . . . 0.0 111.987 -163.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -89.08 174.92 7.61 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.17 1.388 . . . . 0.0 109.701 178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.1 m80 45.93 67.8 0.69 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.165 1.386 . . . . 0.0 111.724 169.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -142.03 26.7 1.84 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 114.811 -1.086 . . . . 0.0 108.847 -176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -59.35 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.112 1.365 . . . . 0.0 111.078 -176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -166.08 28.69 0.05 OUTLIER 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.038 0.935 . . . . 0.0 109.517 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 43.8 m80 67.18 18.5 10.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.983 1.313 . . . . 0.0 112.799 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 12.0 p80 . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 173.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 108' ' ' ALA . 13.9 tpt . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -153.88 140.3 18.71 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 123.667 0.787 . . . . 0.0 109.6 177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 57.8 mt -116.86 127.05 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 18.7 t -113.94 117.89 32.64 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.637 HD12 HE21 ' A' ' 122' ' ' GLN . 9.7 pt -120.4 164.48 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.671 0.788 . . . . 0.0 108.919 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -151.37 166.76 30.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 122.376 0.27 . . . . 0.0 111.432 -171.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -166.16 162.98 17.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.764 1.225 . . . . 0.0 109.55 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -120.77 112.61 19.05 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 171.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.484 ' HA ' ' HE3' ' A' ' 129' ' ' LYS . 22.4 mt -91.5 125.06 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.8 74.04 4.36 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.503 ' HG2' HG12 ' A' ' 132' ' ' VAL . 6.8 tp60 -167.41 161.25 13.92 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 114.364 -1.289 . . . . 0.0 108.784 -171.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -71.75 142.02 49.75 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.774 0.829 . . . . 0.0 110.462 176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.9 tt -60.87 -32.18 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.577 1.151 . . . . 0.0 111.872 -175.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -75.05 -30.01 60.9 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.79 0.836 . . . . 0.0 111.226 -178.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.09 -38.57 61.17 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.452 0.701 . . . . 0.0 111.103 174.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.1 t -63.0 -47.65 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.044 0 C-N-CA 123.947 0.899 . . . . 0.0 109.675 174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -63.76 -42.21 97.85 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.66 1.184 . . . . 0.0 110.976 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 85.1 t90 -56.09 -53.72 53.66 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.885 0.874 . . . . 0.0 110.207 176.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -66.69 -29.27 69.22 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.364 -177.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 46.1 t-105 -67.66 -34.78 77.63 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.336 0.588 . . . . 0.0 110.161 177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -87.78 -33.06 18.79 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.89 0.876 . . . . 0.0 112.003 -179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.17 125.81 91.56 Favored Pre-proline 0 N--CA 1.485 1.289 0 C-N-CA 124.148 0.979 . . . . 0.0 111.847 -168.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.2 -37.31 41.99 Favored 'Trans proline' 0 C--N 1.381 2.241 0 C-N-CA 123.537 2.825 . . . . 0.0 113.898 -174.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -67.3 -34.56 77.65 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.026 0.53 . . . . 0.0 110.415 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.491 ' SG ' ' HB1' ' A' ' 19' ' ' ALA . 46.0 t -69.11 -47.22 65.73 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.663 175.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.3 mt -61.29 -25.49 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 124.606 1.162 . . . . 0.0 111.82 176.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.555 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -60.45 -31.6 70.59 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.946 -0.472 . . . . 0.0 110.972 173.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.34 -59.09 2.28 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.246 1.018 . . . . 0.0 111.402 -178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 41.2 p-90 -96.03 137.58 34.9 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 51.9 t30 170.77 -42.89 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 177.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -90.34 153.99 20.03 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-N 113.711 -1.586 . . . . 0.0 111.265 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -92.39 -1.46 57.0 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.273 -1.331 . . . . 0.0 110.75 174.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -138.27 134.1 33.94 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.93 0.892 . . . . 0.0 109.823 -171.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.6 t -65.47 -19.4 65.92 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.808 1.243 . . . . 0.0 112.75 -174.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 58' ' ' LYS . 8.6 p-10 -84.7 16.53 3.2 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.255 0.622 . . . . 0.0 111.958 179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 57' ' ' ALA . 70.4 m95 -127.31 166.43 17.83 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.181 0.992 . . . . 0.0 109.398 172.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -167.93 143.47 3.82 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.519 1.128 . . . . 0.0 108.423 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 11.1 m -81.34 112.35 18.55 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.1 t -82.73 -20.06 36.72 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.732 0.813 . . . . 0.0 111.191 -173.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.92 144.71 9.7 Favored Glycine 0 C--N 1.338 0.652 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -148.16 145.84 28.49 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.449 0.624 . . . . 0.0 110.474 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -132.96 127.51 34.39 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 171.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.83 135.73 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 177.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -117.13 90.01 3.24 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.6 tp -80.02 74.55 6.78 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.091 0.472 . . . . 0.0 110.038 -174.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 m -145.01 165.19 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 C-N-CA 125.92 1.688 . . . . 0.0 108.019 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 73' ' ' VAL . 47.9 t -69.47 103.91 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 175.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 111.26 -10.92 28.84 Favored Glycine 0 N--CA 1.462 0.425 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.459 -178.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.86 153.22 48.43 Favored Glycine 0 C--N 1.348 1.212 0 CA-C-N 116.704 0.252 . . . . 0.0 112.854 178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -107.85 147.68 30.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.185 0.594 . . . . 0.0 110.026 -173.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 44.8 p90 -124.5 148.43 47.73 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.7 0.8 . . . . 0.0 109.677 171.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.559 ' SG ' HG22 ' A' ' 67' ' ' THR . 41.8 t -144.01 110.02 5.36 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 123.418 0.687 . . . . 0.0 109.362 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 7.8 m-70 -105.78 98.79 8.44 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -75.33 92.76 2.81 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.183 0.593 . . . . 0.0 109.711 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 43.9 ttm -88.06 108.19 19.11 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -176.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.28 132.53 54.09 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.526 1.13 . . . . 0.0 108.83 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 36' ' ' TRP . . . -68.25 145.99 53.75 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 122.999 0.52 . . . . 0.0 109.633 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 35' ' ' ASP . 18.7 ptpt -64.92 -31.7 73.06 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.386 0.675 . . . . 0.0 111.561 -175.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -72.36 -27.4 62.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.366 0.667 . . . . 0.0 111.003 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.83 12.02 64.68 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 115.334 0.894 . . . . 0.0 115.334 172.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.5 t -78.47 -45.71 21.45 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 118.063 0.931 . . . . 0.0 111.146 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.92 149.52 37.11 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.898 0.479 . . . . 0.0 111.114 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.5 104.77 0.25 Allowed Glycine 0 C--N 1.341 0.855 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -102.52 136.55 42.14 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.625 0.77 . . . . 0.0 110.143 -176.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -86.58 113.18 22.26 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.635 0.774 . . . . 0.0 109.718 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 16.7 m-85 -95.14 70.24 3.24 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 122.202 1.001 . . . . 0.0 108.338 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.559 HG22 ' SG ' ' A' ' 52' ' ' CYS . 75.7 p -86.97 157.91 19.37 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 113.771 -1.558 . . . . 0.0 109.936 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.7 175.61 43.24 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 77.2 m -134.42 130.03 36.21 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -64.01 114.79 4.36 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.486 0.714 . . . . 0.0 109.578 172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.8 t -95.17 -16.08 22.83 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.239 0.616 . . . . 0.0 110.841 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 74.4 ttt180 -164.68 125.76 2.1 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.161 0.984 . . . . 0.0 108.839 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.501 ' H ' HG22 ' A' ' 47' ' ' VAL . 60.7 t -134.14 116.95 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 122.979 0.512 . . . . 0.0 109.758 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -125.7 90.07 3.15 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.125 0.97 . . . . 0.0 108.705 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -73.24 128.81 86.99 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.717 0.807 . . . . 0.0 111.137 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 91.3 Cg_endo -105.18 19.8 10.91 Favored 'Cis proline' 0 C--N 1.375 1.967 0 CA-C-N 119.202 0.751 . . . . 0.0 113.341 -6.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 66.6 p -80.96 -44.39 18.26 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.659 0.784 . . . . 0.0 113.058 -165.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -138.62 144.56 39.8 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.528 0.731 . . . . 0.0 109.874 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.0 tp -136.89 135.83 38.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 27.3 t -137.94 134.05 34.47 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.424 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 30.7 p90 -157.86 141.56 15.61 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.057 0.943 . . . . 0.0 109.251 -174.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.46 HG22 ' HA ' ' A' ' 88' ' ' GLU . 60.8 t -116.22 122.19 69.14 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.438 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -86.93 178.38 6.97 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.279 0.561 . . . . 0.0 110.008 -177.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -67.83 -10.04 49.55 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.619 1.168 . . . . 0.0 112.978 -171.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -86.73 -22.35 26.05 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.755 0.422 . . . . 0.0 111.297 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 100.16 5.16 54.9 Favored Glycine 0 N--CA 1.473 1.112 0 CA-C-N 116.646 -0.252 . . . . 0.0 113.19 -175.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.438 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 6.7 mmp_? -69.91 110.36 4.97 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.46 ' HA ' HG22 ' A' ' 82' ' ' VAL . 37.7 mt-10 -88.06 102.1 14.43 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.811 0.844 . . . . 0.0 109.247 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.1 t -105.84 131.04 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 123.656 0.782 . . . . 0.0 110.687 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -122.84 103.67 8.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.148 0.979 . . . . 0.0 108.657 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.9 t -100.33 110.0 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 175.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -98.97 133.18 43.61 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.593 1.157 . . . . 0.0 108.516 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 76' ' ' PRO . 33.4 m-85 -113.84 107.77 16.17 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 176.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.51 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -106.92 92.44 4.09 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 0.0 109.957 -173.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 61.4 p -59.57 144.01 48.69 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.107 0.563 . . . . 0.0 111.767 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.9 150.9 47.77 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -59.29 95.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 121.813 1.675 . . . . 0.0 110.641 170.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 118.04 13.63 7.01 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 118.969 -0.906 . . . . 0.0 114.689 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 157.56 -159.66 30.0 Favored Glycine 0 C--N 1.357 1.738 0 CA-C-N 119.152 1.476 . . . . 0.0 114.038 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 m -140.15 117.32 11.23 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.735 0.814 . . . . 0.0 109.228 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.51 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 14.3 t90 -81.13 93.07 6.37 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 59.7 t -88.69 106.74 17.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.36 102.17 13.33 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.36 101.26 13.99 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.7 m -106.74 132.44 52.72 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -134.67 131.2 37.44 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -64.22 137.62 58.03 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 171.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 1' ' ' MET . . . -126.1 -177.12 3.84 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.207 1.003 . . . . 0.0 109.248 -175.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.698 ' HG2' ' H ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -137.31 176.84 8.35 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 123.085 0.554 . . . . 0.0 109.597 173.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.4 t -93.48 13.05 22.96 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.107 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.698 ' H ' ' HG2' ' A' ' 109' ' ' GLU . 17.7 m -96.38 -51.72 4.26 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 121.833 -0.542 . . . . 0.0 110.517 -176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -79.1 146.56 33.15 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 171.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.411 ' O ' ' HG3' ' A' ' 117' ' ' GLN . 28.2 m -65.39 113.98 13.7 Favored Pre-proline 0 CA--C 1.546 0.825 0 CA-C-O 118.387 -0.816 . . . . 0.0 110.082 178.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.0 -45.18 42.94 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 123.7 2.933 . . . . 0.0 113.314 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.85 73.72 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 177.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -70.1 -41.08 74.51 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.383 0.673 . . . . 0.0 110.376 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 113' ' ' THR . 62.0 mt-30 -62.71 -46.83 86.3 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.172 0.589 . . . . 0.0 109.435 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -55.81 -49.05 74.3 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.131 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.75 -35.85 82.41 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.32 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 124' ' ' ILE . . . -66.34 -54.36 23.95 Favored Glycine 0 C--N 1.347 1.156 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.589 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -64.0 -35.91 82.27 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.409 0.684 . . . . 0.0 111.59 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.637 HE21 HD12 ' A' ' 5' ' ' ILE . 13.7 mm-40 -62.27 -32.78 73.54 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.403 0.281 . . . . 0.0 110.954 171.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.76 -40.8 84.97 Favored Glycine 0 C--N 1.345 1.082 0 O-C-N 123.682 0.614 . . . . 0.0 112.623 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 120' ' ' GLY . 63.6 mt -66.75 -44.67 89.22 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.166 0.986 . . . . 0.0 110.563 177.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 43.5 tp -70.64 -35.28 72.82 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 111.069 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -66.94 -43.62 82.72 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.1 0.96 . . . . 0.0 111.373 174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -63.99 -39.22 93.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 132' ' ' VAL . 51.9 t80 -59.8 -59.64 5.11 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.07 -1.423 . . . . 0.0 111.013 175.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.484 ' HE3' ' HA ' ' A' ' 9' ' ' ILE . 84.4 tttt -56.86 -47.76 79.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.81 0.844 . . . . 0.0 111.574 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -60.37 -36.05 77.14 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.469 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -66.21 -49.91 65.66 Favored 'General case' 0 N--CA 1.476 0.874 0 O-C-N 123.172 0.295 . . . . 0.0 111.169 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 128' ' ' PHE . 39.8 t -63.15 -34.85 69.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-O 121.277 0.56 . . . . 0.0 110.674 -171.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -85.22 -27.41 26.1 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.939 179.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.15 -43.53 70.69 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.289 0.566 . . . . 0.0 109.522 176.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.96 -43.82 91.43 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.496 176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 87.85 -50.45 3.96 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.585 176.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.449 ' HB2' HE22 ' A' ' 11' ' ' GLN . 94.7 mt 56.87 24.56 9.42 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.266 1.426 . . . . 0.0 111.871 -177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.71 155.27 24.4 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 125.089 1.356 . . . . 0.0 108.601 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 44.2 m-70 -86.41 40.85 0.91 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.833 0.853 . . . . 0.0 111.071 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -60.59 -38.6 85.16 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.717 1.207 . . . . 0.0 111.338 -176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -92.86 -6.1 49.5 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.663 0.785 . . . . 0.0 111.452 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 84.8 t60 66.77 9.06 6.44 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 124.62 1.168 . . . . 0.0 111.314 -177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 48.4 t-80 -166.15 109.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 . . . . . 0 C--O 1.253 1.246 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -179.851 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.8 ttt . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptpp? -91.96 130.59 37.68 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.864 0.364 . . . . 0.0 110.266 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 118' ' ' GLN . 67.8 mt -104.81 129.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.568 0.747 . . . . 0.0 109.481 172.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 p -101.2 120.68 40.6 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.467 0.707 . . . . 0.0 109.445 175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 ' HB ' ' OE1' ' A' ' 122' ' ' GLN . 46.6 pt -115.76 160.16 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.347 1.459 . . . . 0.0 108.877 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -152.08 167.29 28.96 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -163.51 125.6 2.49 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.108 1.363 . . . . 0.0 108.504 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.9 t-80 -98.9 114.07 26.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG12 ' HG3' ' A' ' 129' ' ' LYS . 50.5 mt -106.92 135.45 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.768 0.827 . . . . 0.0 109.749 -177.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -86.31 61.76 7.02 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 122.09 0.948 . . . . 0.0 110.683 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.597 HE21 ' HB2' ' A' ' 137' ' ' LEU . 0.6 OUTLIER -144.27 165.97 26.37 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.841 0.856 . . . . 0.0 110.01 -179.468 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 14' ' ' GLU . 10.5 tp10 -63.28 145.08 56.29 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.844 173.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD11 ' HA ' ' A' ' 77' ' ' THR . 15.3 tt -59.28 -32.44 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.561 0.745 . . . . 0.0 111.007 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.559 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 36.5 mt-10 -71.39 -34.86 70.78 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.706 1.202 . . . . 0.0 110.911 178.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.0 -47.51 61.86 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.457 0.703 . . . . 0.0 110.766 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -61.89 -46.0 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.227 178.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 54.1 t-105 -58.05 -47.53 82.85 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.675 0.79 . . . . 0.0 110.672 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 82.5 t90 -56.65 -53.73 54.32 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.973 0.796 . . . . 0.0 109.813 -178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.39 -21.33 66.6 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.437 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 54.8 t-105 -73.74 -44.28 56.73 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 123.298 0.639 . . . . 0.0 110.681 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.469 ' HB2' HG11 ' A' ' 43' ' ' VAL . 9.9 p30 -98.08 -19.93 17.66 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -69.51 122.21 84.89 Favored Pre-proline 0 N--CA 1.485 1.281 0 C-N-CA 123.222 0.609 . . . . 0.0 111.025 -175.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -59.85 -34.65 95.47 Favored 'Trans proline' 0 C--N 1.373 1.847 0 C-N-CA 123.206 2.604 . . . . 0.0 113.347 -173.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -67.8 -41.67 82.77 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.415 0.447 . . . . 0.0 110.124 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.87 -45.4 92.71 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.251 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.0 mt -61.09 -23.61 30.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.922 1.289 . . . . 0.0 111.911 176.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.451 ' HA ' ' OG1' ' A' ' 38' ' ' THR . . . -72.2 -25.69 61.76 Favored 'General case' 0 N--CA 1.48 1.053 0 O-C-N 121.985 -0.447 . . . . 0.0 111.394 172.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 -60.08 2.19 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 28.3 p-90 -90.82 -156.15 0.42 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.7 t30 59.84 35.51 21.92 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 123.158 1.456 . . . . 0.0 109.357 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 36' ' ' TRP . . . -123.92 153.66 40.86 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 113.505 -1.68 . . . . 0.0 108.153 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -77.16 -25.81 52.33 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.164 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -162.03 -179.29 7.01 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.91 0.884 . . . . 0.0 109.882 176.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.5 t -74.04 -5.29 40.59 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.55 0.74 . . . . 0.0 110.663 171.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -92.32 9.67 33.02 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.306 1.042 . . . . 0.0 110.624 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' HB2' ' HB1' ' A' ' 31' ' ' ALA . 60.5 m95 -128.09 153.56 46.69 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 124.19 0.996 . . . . 0.0 108.964 174.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -167.27 146.21 5.05 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -174.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' HIS . 62.5 p -88.06 133.77 33.9 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 118.587 0.631 . . . . 0.0 110.967 177.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.3 p -84.87 -22.8 29.25 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.073 0.949 . . . . 0.0 109.869 177.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.57 132.75 2.58 Favored Glycine 0 C--N 1.342 0.893 0 CA-C-N 114.687 -1.142 . . . . 0.0 110.707 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -137.01 102.33 4.82 Favored 'General case' 0 CA--C 1.521 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 109.49 179.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -82.67 136.59 34.72 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 21' ' ' ASN . 91.4 t -130.59 106.01 12.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -97.7 83.0 3.13 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 106.438 -1.689 . . . . 0.0 106.438 175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 tp -82.63 71.19 9.71 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.353 -166.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -132.37 166.9 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.602 1.161 . . . . 0.0 108.29 171.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 40.0 t -72.21 102.84 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 115.01 -17.57 17.21 Favored Glycine 0 N--CA 1.466 0.694 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.588 -176.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.85 161.72 54.09 Favored Glycine 0 C--N 1.35 1.321 0 CA-C-O 120.186 -0.23 . . . . 0.0 113.037 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp180 -115.57 159.97 20.57 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-O 121.443 0.639 . . . . 0.0 111.978 -176.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -127.23 150.14 49.68 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.612 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 56.5 m -143.57 105.99 4.43 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 177.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 66' ' ' PHE . 31.7 m170 -108.42 103.71 12.91 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.583 0.753 . . . . 0.0 109.355 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.457 ' O ' ' HA ' ' A' ' 38' ' ' THR . 78.6 m80 -80.18 94.07 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.042 0.537 . . . . 0.0 110.82 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 55.5 mtt -79.23 109.43 13.55 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -114.32 135.35 54.17 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.53 165.13 25.26 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 122.786 0.434 . . . . 0.0 110.34 175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -69.92 -29.66 66.89 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.311 0.644 . . . . 0.0 110.878 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -73.25 -25.26 60.64 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.377 0.671 . . . . 0.0 110.576 171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.74 -34.78 4.08 Favored Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.431 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.4 t -62.21 -40.35 95.79 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.284 1.033 . . . . 0.0 111.745 -173.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -88.4 132.46 34.44 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.422 0.689 . . . . 0.0 109.523 176.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.16 134.85 4.37 Favored Glycine 0 C--N 1.34 0.779 0 O-C-N 123.413 0.446 . . . . 0.0 112.462 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -119.07 143.59 47.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.991 0.917 . . . . 0.0 108.765 173.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -106.64 130.01 54.45 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.049 0.452 . . . . 0.0 110.207 177.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 42.4 t80 -109.48 88.11 2.66 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 176.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -124.25 165.09 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.758 -174.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.64 -163.5 37.24 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.916 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 35.6 m -135.81 126.18 26.65 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.581 0.753 . . . . 0.0 110.151 -175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.406 ' CZ ' HG13 ' A' ' 43' ' ' VAL . 68.7 m-85 -67.64 120.02 13.34 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.454 0.702 . . . . 0.0 110.708 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 38.2 p -98.63 -31.16 12.08 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.9 0.88 . . . . 0.0 110.837 -177.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 80' ' ' SER . 69.8 ttt180 -144.79 119.83 10.05 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -173.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.88 108.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 122.801 0.441 . . . . 0.0 110.158 -177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -121.31 93.76 4.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 168.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -75.93 129.8 80.06 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.513 ' HG3' ' HG2' ' A' ' 14' ' ' GLU . 14.3 Cg_endo -104.5 22.77 11.65 Favored 'Cis proline' 0 C--N 1.37 1.699 0 CA-C-N 119.751 0.947 . . . . 0.0 114.454 -2.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.606 ' HA ' HD11 ' A' ' 13' ' ' ILE . 45.3 p -84.48 -58.58 2.68 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -130.68 146.98 52.3 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.657 -0.652 . . . . 0.0 111.673 -174.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 26.0 tp -142.79 115.19 8.48 Favored 'General case' 0 C--O 1.223 -0.333 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.017 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.578 ' HB2' ' HB3' ' A' ' 72' ' ' ARG . 3.3 m -118.56 141.8 48.23 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -151.11 142.82 23.72 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.51 0.724 . . . . 0.0 109.69 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 85.4 t -111.35 130.33 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 65.5 mtt -72.02 160.05 33.16 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.66 -7.51 53.47 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -84.07 -8.19 59.18 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 123.562 0.745 . . . . 0.0 110.469 169.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 102.0 -6.37 54.02 Favored Glycine 0 C--N 1.349 1.273 0 C-N-CA 123.587 0.613 . . . . 0.0 113.441 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.442 ' HB2' ' SD ' ' A' ' 83' ' ' MET . 22.9 mmm180 -68.72 110.3 4.23 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.304 0.641 . . . . 0.0 112.12 -173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -84.4 125.83 32.69 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.06 0.544 . . . . 0.0 109.807 -177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 61.6 t -127.7 130.5 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.812 0.845 . . . . 0.0 108.967 175.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -120.29 120.97 37.6 Favored 'General case' 0 C--O 1.211 -0.941 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.464 HG22 ' HG3' ' A' ' 104' ' ' GLU . 11.7 t -113.08 147.3 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -148.4 147.07 28.78 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.83 0.852 . . . . 0.0 109.755 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -129.39 117.66 20.94 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.477 1.111 . . . . 0.0 108.316 -173.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 101' ' ' TRP . . . -99.35 102.13 13.63 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.293 0.637 . . . . 0.0 109.915 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 t -65.44 135.71 55.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.714 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -142.74 162.67 42.87 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.367 1.067 . . . . 0.0 110.709 -171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.01 -23.07 47.05 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 122.721 2.281 . . . . 0.0 112.43 167.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -82.41 -30.11 34.52 Favored Glycine 0 C--N 1.349 1.283 0 C-N-CA 122.983 0.325 . . . . 0.0 112.389 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 159.61 -117.18 0.76 Allowed Glycine 0 C--N 1.34 0.804 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.5 m -148.77 120.34 8.0 Favored 'General case' 0 C--O 1.244 0.777 0 C-N-CA 124.219 1.008 . . . . 0.0 108.884 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.452 ' HB3' ' HB3' ' A' ' 94' ' ' ALA . 27.3 t90 -82.23 104.03 12.26 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 172.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 39.8 t -86.33 130.95 35.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -143.79 124.0 13.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' HG3' HG22 ' A' ' 91' ' ' VAL . 38.3 tt0 -109.54 144.95 37.13 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 54.1 m -133.44 108.93 8.96 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -120.64 151.63 39.23 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -171.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -81.99 132.38 35.26 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.44 132.15 35.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.455 1.102 . . . . 0.0 109.345 -176.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -71.89 121.75 19.58 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 124.585 1.178 . . . . 0.0 109.802 -176.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 9.8 t -68.02 -18.44 64.71 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.411 0.684 . . . . 0.0 112.256 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -73.23 -32.05 64.51 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.165 0.586 . . . . 0.0 111.813 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -117.55 165.54 13.44 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.649 0.78 . . . . 0.0 110.558 -177.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 86.7 m -69.8 119.33 70.59 Favored Pre-proline 0 CA--C 1.556 1.185 0 C-N-CA 123.03 0.532 . . . . 0.0 111.092 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.37 -44.06 52.21 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 123.855 3.037 . . . . 0.0 113.855 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.02 80.29 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.52 0.728 . . . . 0.0 112.479 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -60.43 -38.11 83.05 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.674 -0.693 . . . . 0.0 111.31 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -67.36 -46.36 73.59 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.2 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.463 ' HB2' HD13 ' A' ' 3' ' ' ILE . 56.8 tt0 -56.16 -50.25 71.69 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.728 0.811 . . . . 0.0 110.756 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.36 -35.59 77.85 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 124.405 1.066 . . . . 0.0 111.167 178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.95 -57.21 9.98 Favored Glycine 0 C--N 1.35 1.354 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.389 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -59.89 -38.42 82.16 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.806 0.843 . . . . 0.0 111.481 176.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.406 ' OE1' ' HB ' ' A' ' 5' ' ' ILE . 55.3 tp60 -64.41 -35.85 82.23 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.787 0.835 . . . . 0.0 110.337 175.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -68.23 -36.61 85.33 Favored Glycine 0 C--N 1.347 1.172 0 O-C-N 123.663 0.602 . . . . 0.0 113.162 175.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 87.7 mt -72.66 -36.79 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 123.998 0.919 . . . . 0.0 110.094 177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 41.8 tp -75.64 -33.08 60.44 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.791 0.837 . . . . 0.0 110.376 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -76.39 -28.93 56.92 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.791 0.836 . . . . 0.0 110.566 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -74.03 -31.85 63.09 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.295 0.638 . . . . 0.0 109.465 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -70.19 -44.73 68.1 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.052 173.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.454 ' HG3' HG12 ' A' ' 9' ' ' ILE . 81.0 tttt -59.08 -43.8 91.82 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.14 0.576 . . . . 0.0 109.781 175.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -58.1 -45.06 87.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.423 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.22 -54.75 40.2 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 123.852 0.72 . . . . 0.0 111.878 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.49 -36.27 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.018 0.527 . . . . 0.0 111.196 -173.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -85.9 -26.52 25.55 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.389 -176.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -82.97 -49.24 9.81 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.305 0.574 . . . . 0.0 110.583 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.26 -36.33 81.38 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.167 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 92.6 -46.98 2.54 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.129 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.597 ' HB2' HE21 ' A' ' 11' ' ' GLN . 61.1 mt 73.27 -34.8 0.3 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 126.21 1.804 . . . . 0.0 113.139 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -74.33 89.65 2.09 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-O 121.234 0.54 . . . . 0.0 109.545 175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 14.7 p-80 -115.81 -22.42 9.11 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.071 0.948 . . . . 0.0 110.51 -178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -84.28 101.78 12.18 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -174.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -85.98 -172.39 4.06 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.996 175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -79.97 65.65 5.19 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-O 121.983 0.897 . . . . 0.0 110.52 176.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 57.5 t60 -69.16 95.67 0.77 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.819 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 . . . . . 0 C--O 1.247 0.925 0 C-N-CA 123.64 0.776 . . . . 0.0 109.425 -175.384 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptm . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.366 0.127 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -152.03 148.27 27.51 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.932 0.893 . . . . 0.0 109.749 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.468 HD13 ' HB2' ' A' ' 118' ' ' GLN . 75.9 mt -118.49 135.54 58.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 123.575 0.75 . . . . 0.0 109.718 177.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 60.1 m -98.71 113.72 25.92 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 124.289 1.036 . . . . 0.0 109.04 174.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' HB ' ' NE2' ' A' ' 122' ' ' GLN . 48.8 pt -115.69 164.49 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 123.625 0.77 . . . . 0.0 109.653 173.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.59 176.26 11.15 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.934 0.397 . . . . 0.0 111.506 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.41 131.96 1.53 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.138 1.375 . . . . 0.0 108.517 175.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m80 -96.08 114.25 25.94 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 32.2 mt -108.51 122.13 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.73 70.73 7.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 122.136 0.97 . . . . 0.0 109.093 178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -152.49 159.59 43.32 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-N 113.779 -1.555 . . . . 0.0 109.086 -177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 16' ' ' VAL . 36.1 tt0 -58.14 135.34 57.03 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.215 1.006 . . . . 0.0 111.907 172.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 77' ' ' THR . 12.1 tt -62.0 -37.61 78.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.987 0 C-N-CA 124.383 1.073 . . . . 0.0 112.447 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -59.67 -46.38 89.22 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 121.23 0.538 . . . . 0.0 110.45 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.694 ' HB1' ' HB3' ' A' ' 137' ' ' LEU . . . -65.54 -38.49 89.77 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.205 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 12' ' ' GLU . 70.5 t -65.38 -40.78 89.5 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 123.327 0.651 . . . . 0.0 110.124 177.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 79' ' ' LEU . 47.2 t-105 -59.85 -46.48 89.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.333 0.653 . . . . 0.0 110.694 175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 90.2 t90 -57.26 -47.84 80.4 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 123.844 0.715 . . . . 0.0 109.63 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.663 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -60.22 -39.49 86.83 Favored 'General case' 0 CA--C 1.55 0.949 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.456 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.5 t-105 -76.84 -36.19 57.01 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 123.787 0.835 . . . . 0.0 112.006 -177.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.566 ' ND2' HD13 ' A' ' 45' ' ' LEU . 29.2 t-20 -109.83 -31.3 7.48 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -60.28 124.43 77.83 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-O 118.659 -0.686 . . . . 0.0 110.015 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -57.29 -42.48 62.05 Favored 'Trans proline' 0 C--N 1.372 1.782 0 C-N-CA 123.01 2.473 . . . . 0.0 113.587 -171.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -69.0 -40.7 78.57 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.368 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 50.4 t -66.05 -39.45 90.12 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.458 177.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.592 HG23 ' ND2' ' A' ' 30' ' ' ASN . 74.4 mt -58.64 -39.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.508 1.123 . . . . 0.0 110.377 174.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.61 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -70.58 2.31 4.19 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.509 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 19.5 ttm180 -108.99 -55.37 2.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.326 0.651 . . . . 0.0 111.01 174.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 53.5 p-90 -83.53 -23.92 31.86 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -172.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.592 ' ND2' HG23 ' A' ' 26' ' ' ILE . 26.0 m-80 -79.46 100.49 7.71 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 118.539 0.609 . . . . 0.0 109.827 176.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -150.87 129.05 11.9 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.043 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.98 92.29 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 123.974 0.797 . . . . 0.0 110.223 174.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.439 ' H ' ' HB2' ' A' ' 36' ' ' TRP . 57.9 m -145.46 178.95 7.73 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.43 1.092 . . . . 0.0 109.8 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.2 p -63.44 -33.54 75.78 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.684 0.794 . . . . 0.0 111.922 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -80.97 -1.95 45.82 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.881 0.872 . . . . 0.0 111.866 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.439 ' HB2' ' H ' ' A' ' 33' ' ' SER . 67.6 m95 -116.02 149.2 39.24 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.012 0.925 . . . . 0.0 109.194 -176.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -160.99 132.19 5.49 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -172.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 27' ' ' ALA . 98.0 m -68.57 104.54 1.97 Allowed 'General case' 0 CA--C 1.551 1.013 0 CA-C-O 121.337 0.589 . . . . 0.0 109.746 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -85.21 -34.26 22.07 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.428 1.091 . . . . 0.0 111.193 -174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -125.59 93.69 0.43 Allowed Glycine 0 C--N 1.347 1.152 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 178.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.6 t -110.07 104.85 13.78 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.078 0.551 . . . . 0.0 109.995 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -110.21 145.38 37.39 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.419 1.088 . . . . 0.0 109.071 172.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 62.6 t -143.22 122.66 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.711 1.204 . . . . 0.0 108.99 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -110.86 85.13 2.05 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 168.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.566 HD13 ' ND2' ' A' ' 21' ' ' ASN . 43.0 tp -73.86 79.15 1.62 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.917 -176.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.3 m -143.38 163.64 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.125 1.37 . . . . 0.0 108.233 170.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.3 t -71.27 109.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.86 4.46 60.27 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.238 0.336 . . . . 0.0 112.522 -175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -85.58 164.34 37.77 Favored Glycine 0 C--N 1.352 1.462 0 C-N-CA 123.066 0.365 . . . . 0.0 112.356 176.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -119.74 157.93 27.55 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.86 0.464 . . . . 0.0 111.156 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 81' ' ' PHE . 48.4 p90 -134.04 158.33 43.84 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.02 0.928 . . . . 0.0 109.358 175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.7 m -142.5 118.16 10.42 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.356 0.662 . . . . 0.0 109.328 175.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -119.28 95.45 4.8 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 122.931 0.492 . . . . 0.0 109.809 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 38' ' ' THR . 57.3 m-70 -76.52 89.07 3.27 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.123 0.569 . . . . 0.0 110.651 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.1 mtt -77.89 102.16 7.16 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.441 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . . . -133.04 139.39 47.17 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.371 -164.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.0 115.75 3.35 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 123.948 0.78 . . . . 0.0 109.736 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -61.95 -22.69 65.84 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.889 0.475 . . . . 0.0 111.844 -176.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -109.85 2.13 19.69 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 124.001 0.92 . . . . 0.0 113.044 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -146.11 160.78 28.23 Favored Glycine 0 N--CA 1.481 1.69 0 CA-C-N 117.91 0.323 . . . . 0.0 113.649 -176.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -74.88 -18.35 60.44 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.41 143.5 57.1 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.661 0.385 . . . . 0.0 111.279 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 56' ' ' ALA . . . -167.74 120.96 0.93 Allowed Glycine 0 C--N 1.347 1.16 0 O-C-N 123.485 0.491 . . . . 0.0 112.833 -175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -84.36 115.4 22.49 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -77.97 120.24 22.55 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 172.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -105.83 78.57 1.35 Allowed 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 73.9 p -94.27 157.98 15.79 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.333 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 179.13 -177.34 48.39 Favored Glycine 0 C--N 1.339 0.744 0 CA-C-N 116.334 -0.394 . . . . 0.0 112.581 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 87.3 m -131.48 126.29 34.62 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.25 0.62 . . . . 0.0 110.799 -177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -62.13 122.23 15.05 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.773 0.829 . . . . 0.0 110.941 172.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.424 HG23 HG23 ' A' ' 82' ' ' VAL . 2.9 p -87.4 -44.92 10.99 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.637 0.775 . . . . 0.0 110.121 174.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -129.84 145.48 51.58 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.529 0.731 . . . . 0.0 109.752 177.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.5 t -138.95 100.89 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.778 1.231 . . . . 0.0 107.872 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -127.39 78.29 1.81 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.666 0.786 . . . . 0.0 109.445 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -71.58 133.13 84.96 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 122.958 0.503 . . . . 0.0 111.124 -176.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 25.3 Cg_endo -100.93 14.9 21.02 Favored 'Cis proline' 0 C--N 1.372 1.784 0 CA-C-N 119.452 0.84 . . . . 0.0 113.441 -5.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.57 ' HA ' HD11 ' A' ' 13' ' ' ILE . 23.7 p -84.28 -18.65 35.69 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -164.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -170.41 143.44 2.3 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.01 0.434 . . . . 0.0 110.706 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 17' ' ' TRP . 30.0 tp -137.78 142.97 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 m -140.23 139.21 35.55 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 177.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.42 ' HB2' ' HE1' ' A' ' 51' ' ' PHE . 40.5 p90 -158.96 151.86 22.11 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.678 0.791 . . . . 0.0 109.678 -177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 HG23 ' A' ' 71' ' ' THR . 8.9 t -107.96 143.2 18.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.417 ' SD ' ' HB2' ' A' ' 87' ' ' ARG . 66.9 mtt -76.62 166.67 23.07 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 173.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -61.22 -26.85 68.02 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.637 0.775 . . . . 0.0 111.464 175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.493 ' HB2' ' HG2' ' A' ' 87' ' ' ARG . 3.7 m-20 -79.89 -2.1 42.17 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.438 1.095 . . . . 0.0 111.619 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.09 8.56 81.82 Favored Glycine 0 C--N 1.35 1.334 0 O-C-N 123.124 0.265 . . . . 0.0 112.947 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.629 ' HG3' ' HB ' ' A' ' 110' ' ' THR . 5.3 mmp_? -77.7 111.73 13.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.745 0.418 . . . . 0.0 111.333 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -77.08 129.83 36.58 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.222 0.609 . . . . 0.0 110.649 -176.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.7 t -127.28 133.95 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 C-N-CA 124.142 0.977 . . . . 0.0 109.835 -177.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -131.62 109.47 10.24 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.984 0.914 . . . . 0.0 109.137 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.0 t -104.29 105.67 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.4 tt0 -99.58 131.48 45.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -106.27 91.09 3.56 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -91.39 90.16 7.57 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.162 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 41.8 t -67.18 140.88 57.48 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.111 0.564 . . . . 0.0 111.326 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.71 152.94 57.32 Favored Pre-proline 0 N--CA 1.481 1.102 0 C-N-CA 124.384 1.073 . . . . 0.0 110.38 -168.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.7 92.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.996 2.464 . . . . 0.0 112.205 172.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 141.92 -21.51 2.49 Favored Glycine 0 C--N 1.346 1.084 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.78 -177.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.61 -127.6 1.8 Allowed Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.928 -0.469 . . . . 0.0 111.928 177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.3 m -142.22 134.65 27.94 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.456 0.702 . . . . 0.0 109.969 -175.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -94.73 102.71 14.6 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 173.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 61.1 t -88.04 123.87 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 172.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.427 ' HG3' ' HB3' ' A' ' 92' ' ' GLN . 3.1 pt20 -135.01 105.64 6.45 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -92.91 144.96 24.75 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 177.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 85.6 m -133.56 116.15 15.57 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 29.7 p90 -120.79 136.21 54.95 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -172.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -68.98 105.19 2.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -94.88 61.65 2.57 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.223 0.535 . . . . 0.0 111.863 -160.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -140.44 70.73 1.36 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.594 0.712 . . . . 0.0 111.097 163.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.629 ' HB ' ' HG3' ' A' ' 87' ' ' ARG . 9.7 t -129.65 -21.48 3.1 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.506 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 17.3 m -111.14 -63.24 1.43 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.778 0.799 . . . . 0.0 109.444 -166.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.557 ' HB2' HE21 ' A' ' 116' ' ' GLN . 18.9 m-70 174.39 -168.69 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 127.105 2.162 . . . . 0.0 107.682 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.6 p -43.84 143.65 1.65 Allowed Pre-proline 0 CA--C 1.574 1.877 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -50.88 -46.55 29.89 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 124.281 3.321 . . . . 0.0 114.541 -173.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -52.06 -42.4 63.12 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.604 0.762 . . . . 0.0 112.382 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.557 HE21 ' HB2' ' A' ' 112' ' ' HIS . 0.7 OUTLIER -67.35 -47.07 71.53 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.371 1.068 . . . . 0.0 109.997 -179.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.506 ' HG2' ' HB2' ' A' ' 111' ' ' SER . 36.1 mt-30 -61.86 -49.93 74.3 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 123.486 0.491 . . . . 0.0 111.324 -178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.468 ' HB2' HD13 ' A' ' 3' ' ' ILE . 58.0 tt0 -59.44 -46.68 88.06 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.072 0.949 . . . . 0.0 111.23 -177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -66.36 -29.77 70.02 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.783 0.677 . . . . 0.0 111.348 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.53 -54.85 23.68 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 123.695 0.622 . . . . 0.0 112.13 175.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -63.09 -43.54 98.23 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.92 0.488 . . . . 0.0 111.858 178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.463 ' NE2' ' HB ' ' A' ' 5' ' ' ILE . 21.3 mm-40 -63.27 -31.08 72.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.125 0.57 . . . . 0.0 111.439 177.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.61 -46.02 91.28 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 123.44 0.462 . . . . 0.0 112.799 172.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 64.6 mt -75.08 -29.8 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.237 0 C-N-CA 123.79 0.836 . . . . 0.0 110.549 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 47.2 tp -83.89 -34.43 24.55 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.435 1.094 . . . . 0.0 110.984 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -59.05 -45.98 89.4 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.883 0.873 . . . . 0.0 110.115 167.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.35 60.27 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.138 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' O ' HG23 ' A' ' 132' ' ' VAL . 55.5 t80 -67.26 -52.93 34.76 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -53.02 -48.73 67.34 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.838 0.855 . . . . 0.0 110.905 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 -64.46 -39.54 94.01 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.718 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.3 -47.41 79.57 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.277 1.031 . . . . 0.0 111.615 177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.463 HG13 ' HG ' ' A' ' 137' ' ' LEU . 75.0 t -63.5 -40.77 90.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 123.643 0.777 . . . . 0.0 111.236 -174.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -84.87 -19.02 33.0 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.408 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -78.14 -45.99 21.82 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 121.358 0.599 . . . . 0.0 109.577 175.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.12 -37.83 84.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.647 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 101.49 -37.2 3.74 Favored Glycine 0 C--N 1.347 1.176 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.229 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.694 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 3.3 mm? 56.31 37.99 29.34 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 124.306 1.042 . . . . 0.0 112.347 172.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.03 169.52 15.8 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.46 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.7 m170 -74.05 81.56 1.73 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.116 0.566 . . . . 0.0 110.308 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -77.63 81.52 4.07 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.625 0.77 . . . . 0.0 110.476 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -151.27 -50.56 0.12 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.637 0.775 . . . . 0.0 109.057 179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -124.39 96.68 5.0 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -84.94 -5.58 59.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.088 0.555 . . . . 0.0 111.341 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 C--O 1.25 1.106 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 172.631 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -89.28 107.64 19.17 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.696 0.76 . . . . 0.0 108.989 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 55.1 mt -85.3 122.74 38.66 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.084 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.2 m -97.62 113.5 25.25 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.428 0.691 . . . . 0.0 109.36 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 ' HB ' ' HG2' ' A' ' 122' ' ' GLN . 45.3 pt -115.39 157.59 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 124.658 1.183 . . . . 0.0 108.332 172.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -143.5 161.53 38.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 122.816 0.446 . . . . 0.0 111.18 -175.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HB1' ' HD3' ' A' ' 129' ' ' LYS . . . -162.77 116.67 1.7 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.844 1.258 . . . . 0.0 108.077 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -106.58 133.76 50.77 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.579 HG12 ' HG3' ' A' ' 129' ' ' LYS . 48.6 mt -116.6 123.64 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.49 1.116 . . . . 0.0 108.641 -170.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -76.3 73.37 3.09 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 121.71 0.767 . . . . 0.0 109.509 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -163.62 160.64 23.13 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.332 -173.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -61.53 140.28 58.12 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.132 0.973 . . . . 0.0 110.769 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 tt -65.7 -20.97 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 123.641 0.588 . . . . 0.0 110.686 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.49 -44.34 91.27 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 122.626 0.371 . . . . 0.0 110.291 170.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.44 -33.28 62.9 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.63 0.772 . . . . 0.0 111.752 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 74.1 t -72.2 -48.58 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.379 0.671 . . . . 0.0 110.201 178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -63.35 -38.32 90.69 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.728 0.411 . . . . 0.0 110.141 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 60.5 t90 -59.17 -54.25 49.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.004 0.522 . . . . 0.0 109.991 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.709 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . . . -57.3 -35.07 69.37 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.534 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 45.7 t-105 -71.91 -51.92 19.81 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.408 -178.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.494 ' HB2' HD22 ' A' ' 45' ' ' LEU . 0.1 OUTLIER -91.14 -34.32 15.09 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -165.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.63 120.94 53.59 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.8 0.84 . . . . 0.0 110.124 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -52.82 -43.19 58.12 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.517 2.811 . . . . 0.0 113.906 -172.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -40.75 95.72 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.049 0.452 . . . . 0.0 110.71 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 19' ' ' ALA . 19.5 t -71.81 -52.21 18.63 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.034 -176.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.724 HG21 HG21 ' A' ' 43' ' ' VAL . 15.5 tt -62.82 -27.57 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.879 0.872 . . . . 0.0 112.145 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.14 -40.94 97.63 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.806 0.692 . . . . 0.0 111.967 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 25' ' ' CYS . 14.0 ptp180 -91.24 -10.9 39.87 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -169.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.589 ' NE1' ' HA ' ' A' ' 26' ' ' ILE . 61.1 p-90 -111.79 -171.08 1.77 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 165.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.4 ' HA ' HG23 ' A' ' 124' ' ' ILE . 0.1 OUTLIER 85.31 -10.38 0.78 Allowed 'General case' 0 N--CA 1.503 2.194 0 C-N-CA 127.231 2.213 . . . . 0.0 111.061 -174.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.447 ' HA ' ' SD ' ' A' ' 55' ' ' MET . . . -63.88 127.45 31.44 Favored 'General case' 0 C--N 1.346 0.433 0 C-N-CA 123.72 0.808 . . . . 0.0 109.846 177.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.46 -24.22 67.55 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.577 0.751 . . . . 0.0 111.996 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.472 ' HB3' ' HD1' ' A' ' 36' ' ' TRP . 32.3 t -160.9 177.59 10.23 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.261 1.024 . . . . 0.0 109.045 176.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.1 t -70.18 -17.58 63.17 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 122.727 0.411 . . . . 0.0 110.74 174.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -65.28 -36.78 85.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.231 1.012 . . . . 0.0 109.873 169.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.472 ' HD1' ' HB3' ' A' ' 33' ' ' SER . 76.6 m95 -95.19 151.3 19.34 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.301 -170.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -166.99 137.01 2.99 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 124.261 1.024 . . . . 0.0 108.779 -176.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 55' ' ' MET . 79.3 m -89.23 112.73 23.83 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 122.964 0.506 . . . . 0.0 110.843 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.7 p -86.74 -33.26 20.04 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.711 0.804 . . . . 0.0 111.6 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.02 81.84 0.31 Allowed Glycine 0 C--N 1.346 1.095 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.4 t -106.33 102.75 12.13 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.208 0.603 . . . . 0.0 110.908 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -104.61 142.35 34.82 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.824 1.25 . . . . 0.0 108.965 167.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.724 HG21 HG21 ' A' ' 26' ' ' ILE . 70.8 t -142.35 106.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 124.517 1.127 . . . . 0.0 108.756 173.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -111.4 85.7 2.18 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.494 HD22 ' HB2' ' A' ' 21' ' ' ASN . 48.8 tp -79.19 81.09 5.49 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.065 0.946 . . . . 0.0 111.125 -174.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 m -141.24 166.37 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 124.54 1.136 . . . . 0.0 108.07 167.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.4 t -69.49 120.24 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 88.25 -4.95 85.31 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.826 -173.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.82 162.89 49.18 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.664 -0.52 . . . . 0.0 112.32 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -125.95 156.45 39.76 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.761 0.791 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -128.92 158.26 39.3 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.558 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.491 ' SG ' HG22 ' A' ' 67' ' ' THR . 87.2 m -144.28 122.9 12.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 176.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 66' ' ' PHE . 99.8 m-70 -124.76 88.99 2.99 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -74.37 85.87 1.98 Allowed 'General case' 0 C--O 1.241 0.637 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 177.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' THR . 56.8 ttp -80.63 147.14 30.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 114.965 -1.016 . . . . 0.0 108.408 174.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -164.06 154.28 14.94 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.64 0.776 . . . . 0.0 109.282 -178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.67 166.32 15.37 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.279 0.632 . . . . 0.0 110.624 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.15 -16.73 63.71 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.19 0.596 . . . . 0.0 112.171 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -81.49 -26.96 34.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.251 0.621 . . . . 0.0 110.141 171.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 73.46 13.42 80.02 Favored Glycine 0 C--N 1.353 1.518 0 O-C-N 123.558 0.536 . . . . 0.0 113.754 -177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 44.3 t -78.74 -43.2 26.25 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.58 0.752 . . . . 0.0 110.31 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.55 133.07 54.8 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.812 0.845 . . . . 0.0 109.448 178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.34 153.64 24.96 Favored Glycine 0 C--N 1.349 1.284 0 O-C-N 123.385 0.428 . . . . 0.0 113.004 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -135.48 125.22 25.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.221 1.009 . . . . 0.0 110.005 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -86.04 124.15 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.607 0.763 . . . . 0.0 109.689 176.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.582 ' HB2' ' HB2' ' A' ' 53' ' ' HIS . 92.3 m-85 -99.63 86.07 3.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 174.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.491 HG22 ' SG ' ' A' ' 52' ' ' CYS . 41.3 p -105.24 136.15 45.28 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 114.311 -1.313 . . . . 0.0 109.354 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.42 155.9 25.88 Favored Glycine 0 C--N 1.346 1.122 0 C-N-CA 121.308 -0.472 . . . . 0.0 113.386 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.5 m -102.92 124.21 48.0 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.86 0.864 . . . . 0.0 108.995 176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -64.43 104.86 0.83 Allowed 'General case' 0 C--N 1.349 0.562 0 C-N-CA 123.271 0.628 . . . . 0.0 109.625 174.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -87.41 -12.54 45.89 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.267 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB3' ' HB3' ' A' ' 80' ' ' SER . 73.6 ttt180 -159.06 118.43 3.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.564 0.746 . . . . 0.0 109.195 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.6 t -123.24 103.64 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.99 79.6 1.89 Allowed 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -67.52 138.74 93.88 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.622 -177.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 75' ' ' ALA . 32.2 Cg_endo -99.96 13.03 24.51 Favored 'Cis proline' 0 C--N 1.365 1.433 0 CA-C-N 119.436 0.834 . . . . 0.0 113.234 -8.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.4 p -73.83 -45.25 52.38 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.556 0.743 . . . . 0.0 111.866 -170.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.7 mtt180 -143.69 149.56 37.38 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.89 0.852 . . . . 0.0 111.261 -176.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.8 tp -141.99 144.56 33.74 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.302 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 41.2 t -150.28 148.06 28.4 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -156.09 139.78 16.06 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.231 -176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 58.8 t -107.94 126.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 64.9 mtm -78.55 161.08 27.28 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 123.084 0.554 . . . . 0.0 110.007 -173.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -67.68 -7.97 31.23 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.763 0.825 . . . . 0.0 111.869 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -82.28 -6.37 59.19 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.191 0.996 . . . . 0.0 110.58 174.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.79 -15.91 61.12 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 123.374 0.511 . . . . 0.0 112.861 -177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.43 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 33.9 mmt180 -85.65 123.67 31.31 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.511 0.724 . . . . 0.0 112.086 -168.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -84.87 134.2 34.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.932 0.893 . . . . 0.0 110.62 -178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 28.1 t -128.14 133.47 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.957 0 C-N-CA 123.917 0.887 . . . . 0.0 109.295 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -127.86 107.03 9.52 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.531 1.132 . . . . 0.0 109.298 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.4 t -103.69 109.06 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 123.198 0.599 . . . . 0.0 109.634 178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -101.03 138.88 37.49 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.493 0.717 . . . . 0.0 109.678 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -115.1 98.11 6.6 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -107.81 111.34 23.44 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.911 0.884 . . . . 0.0 109.995 -173.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 37.7 m -63.21 137.75 58.32 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.577 0.751 . . . . 0.0 111.646 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -134.15 155.26 80.16 Favored Pre-proline 0 N--CA 1.48 1.033 0 C-N-CA 123.534 0.734 . . . . 0.0 110.161 -177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -64.17 93.61 0.19 Allowed 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.505 2.136 . . . . 0.0 110.758 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 135.97 -20.96 3.57 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-O 119.438 -0.646 . . . . 0.0 112.68 -178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 171.06 -133.8 2.89 Favored Glycine 0 C--N 1.353 1.494 0 CA-C-N 117.551 0.675 . . . . 0.0 113.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.6 m -138.68 117.66 12.48 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.196 0.999 . . . . 0.0 109.755 -176.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -82.37 103.07 11.67 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.002 0.521 . . . . 0.0 109.817 174.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 23.4 t -90.33 141.4 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -142.62 122.8 13.77 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -102.73 119.53 38.99 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.347 0.659 . . . . 0.0 109.69 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 86.9 m -110.79 108.3 18.1 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.653 ' HZ ' ' HA ' ' A' ' 118' ' ' GLN . 46.0 p90 -121.61 144.44 48.74 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -171.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.17 138.28 34.74 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -84.1 147.18 27.5 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.914 0.886 . . . . 0.0 110.383 -174.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' HG2' ' HG3' ' A' ' 87' ' ' ARG . 36.9 mt-10 -88.33 129.87 35.28 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.291 1.037 . . . . 0.0 109.792 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.5 p -72.13 -11.46 60.75 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.377 0.671 . . . . 0.0 112.31 -177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 81.5 p -83.28 -41.39 18.36 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.474 0.71 . . . . 0.0 111.057 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -99.89 150.04 22.8 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.537 0.735 . . . . 0.0 110.637 -173.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 23.8 p -66.95 115.84 29.36 Favored Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 123.532 0.733 . . . . 0.0 110.604 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -50.97 -42.96 50.28 Favored 'Trans proline' 0 C--N 1.385 2.499 0 C-N-CA 124.377 3.385 . . . . 0.0 115.261 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.23 -43.14 87.59 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.339 0.656 . . . . 0.0 112.038 176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -63.59 -38.76 92.35 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.917 177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -67.57 -40.01 84.91 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.1 0.56 . . . . 0.0 110.125 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.653 ' HA ' ' HZ ' ' A' ' 106' ' ' PHE . 62.8 tt0 -61.72 -48.6 79.99 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.304 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -64.42 -33.49 75.98 Favored 'General case' 0 CA--C 1.549 0.909 0 O-C-N 124.053 0.846 . . . . 0.0 110.932 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.8 7.76 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.173 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -65.15 -35.32 80.73 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.272 0.629 . . . . 0.0 111.715 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 118' ' ' GLN . 3.9 tm0? -66.59 -32.32 73.57 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -61.72 -41.21 99.57 Favored Glycine 0 C--N 1.345 1.038 0 O-C-N 123.682 0.613 . . . . 0.0 111.995 171.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.4 HG23 ' HA ' ' A' ' 30' ' ' ASN . 76.9 mt -71.69 -36.22 58.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.207 0 C-N-CA 123.935 0.894 . . . . 0.0 111.502 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 39.4 tp -78.01 -35.58 49.74 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.263 0.625 . . . . 0.0 110.353 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -69.68 -32.08 70.5 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.14 0.976 . . . . 0.0 110.034 171.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -64.52 -42.34 95.83 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 173.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.407 ' O ' HG23 ' A' ' 132' ' ' VAL . 41.6 t80 -61.56 -50.76 71.35 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 124.055 0.847 . . . . 0.0 110.684 175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.579 ' HG3' HG12 ' A' ' 9' ' ' ILE . 36.5 ttpt -59.22 -52.05 67.33 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.658 0.783 . . . . 0.0 110.859 -178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -65.62 -29.73 70.35 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.252 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . 0.518 ' HE2' ' SG ' ' A' ' 25' ' ' CYS . 48.8 t80 -63.96 -48.58 75.93 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.06 0.544 . . . . 0.0 110.421 175.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 128' ' ' PHE . 58.7 t -64.94 -48.23 84.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 122.826 0.45 . . . . 0.0 109.808 -178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -61.44 -35.59 78.0 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.509 0.724 . . . . 0.0 111.48 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -93.12 -6.07 48.82 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.307 0.643 . . . . 0.0 112.029 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.64 -42.19 87.09 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 177.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 70.2 57.34 6.94 Favored Glycine 0 C--N 1.348 1.247 0 O-C-N 124.185 0.928 . . . . 0.0 110.979 -177.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.489 HD23 ' HE1' ' A' ' 140' ' ' HIS . 74.6 mt -75.02 74.97 2.23 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.739 0.815 . . . . 0.0 109.994 -178.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.84 64.04 1.61 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.348 1.459 . . . . 0.0 107.475 178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 22.5 p80 47.48 94.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 125.673 1.589 . . . . 0.0 111.817 -172.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' HIS . . . . . 0.489 ' HE1' HD23 ' A' ' 137' ' ' LEU . 36.7 m80 -71.79 74.84 0.86 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.686 0.755 . . . . 0.0 110.106 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -152.88 87.47 1.29 Allowed 'General case' 0 C--O 1.241 0.61 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -57.37 91.19 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.76 0 O-C-N 124.447 1.092 . . . . 0.0 111.493 -170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -75.52 87.84 2.66 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.798 0.839 . . . . 0.0 109.755 -175.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 CA--C 1.553 1.089 0 C-N-CA 125.133 1.373 . . . . 0.0 110.172 -179.654 . . . . . . . . 0 0 . 1 stop_ save_